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                                                              ABSTRACT 
 
Peripheral arterial disease (PAD) is a common disease that is frequently caused by 
atherosclerosis and associated thrombosis, leading to a decrease in the blood supply to the 
lower extremities. PAD has various treatment options due to different physiological 
responses in each patient. One such option includes exercise therapy, since it benefits 
patients with intermittent claudication by improving their overall quality of life. 
However, advising exercise therapy for treatment of PAD is not clearly supported, due to 
the heterogeneity of responses and outcomes found in the scientific literature. This 
heterogeneous response elaborates the importance of assessing the differential changes 
resulted from the interaction of active exercise capacity with PAD between high and low 
intrinsic aerobic capacity phenotypes. High intrinsic aerobic phenotype rat (HCR) 
reported to have prolonged dopamine availability in the brain.  Recently, Dopamine 3 
receptor (D3R) was reported to be associated with decrease dopamine reuptake centrally. 
Despite evidence indicating a role for androgen in dopamine receptors interaction 
centrally, this interaction remains not studied at the level of skeletal muscle. The overall 
goal of this dissertation is to determine the vascular adaptive response in relation to active 
exercise capacity and intrinsic aerobic running capacity phenotypes, HCR and LCR, 
before and after femoral artery ligation. Additionally, this study will test the hypothesis 
that exercise after ligation is harmful for the LCR phenotype, while exercise before 
ligation is protective to ischemic injury, and that post-ischemic repair in skeletal muscle 
cells (SKMC) associates androgen receptor (AR) and dopamine 3 receptor (D3R) In vivo 
study: We found that mild exercise intensity after arterial occlusion in rats of low 
intrinsic aerobic running capacity phenotype (LCR) produces a chronic, ischemia-like 
vascular adaptive response, with more hypoxia-induced angiogenesis than 
inflammogenic-induced vasculogenesis. Furthermore, rats of high intrinsic aerobic 
running capacity phenotype (HCR) showed better muscle-capillary adaptive response to 
ischemia with more inflammogenic-induced vasculogenesis. However, two weeks of 
treadmill exercise before femoral arterial ligation was found to precondition the ischemic 
limb in low intrinsic aerobic running capacity phenotype through remodeling the 
musculovascular adaptive response. Although, this same procedure did not cause a 
significant effect in HCR rats. In vitro study: It was found that HCR and LCR have 
different androgen/dopamine receptor interaction systems, with a stronger protective 
mechanism in HCR than LCR. In LCR, there is crosstalk between androgen and 
dopamine receptor signaling during satellite cell proliferation in response to D3R and AR 
activation respectively. While in HCR, the signaling effect of D3R stimulation does not 
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CHAPTER 1: INTRINSIC EXERCISE CAPACITY ON HIND LIMB ARTERIAL 
LIGATION: DIFFERENTIAL IMPACT OF ACTIVE EXERCISE AND 
ANDROGEN SIGNALING ON POST-ISCHEMIC RECOVERY 
 
Problem and Approach: 
 
Peripheral arterial disease (PAD) is a common disease that is most commonly 
caused by atherosclerosis and associated thrombosis, leading to a decreased blood supply 
to the lower extremities (234). PAD has varying treatment options, such as exercise 
therapy, medical therapy, endovascular therapy, and surgical intervention, due to 
different physiological responses in each patient (136). Exercise training is one of the 
important modalities that is frequently advised for PAD patients, since it benefits patients 
with intermittent claudication by decreasing disease symptoms and improves both 
physical activity and quality of life (243). However, advising exercise therapy for PAD 
patients not clearly supports the different responses seen in the outcomes of patients in 
the scientific literature. The aerobic capacity, which depends on the maximum O2 
consumption (VO2max), is one of the important physiological factors that contributes to 
in endurance running performance (123), as it accounts for 70% of variations in exercise 
capacity (57). Thus, studying the differential effects of exercise capacity on hind limb 
ischemia between the intrinsic aerobic phenotype rats bred for low and high aerobic 
running capacity, would provide a better platform for understanding the differences in the 
effect of exercise pre- and post-ligation on vascular recovery, and angiogenic and 
inflammatory adaptive responses in these phenotypes.
2 
 
Therefore, studying the interaction of genetic factors with active exercise will 
clarify the differences in active exercise outcomes, and elude to the possible roles of 
androgen and dopamine receptors in this relationship. For this reason, we are going to use 
rats with inherently different running capacity that are artificially selected over 
generations to produce strains with genetically determined high and low intrinsic capacity 
(HCR and LCR). 
 
Exercise Physiology: 
Exercise is a set of physical activities applied to the skeletal muscles in different 
ways to keep them fit. It is a form of stressful stimuli that leads to specific changes in the 
muscle physiology. When the internal homeostasis is imbalanced by any physical 
activity, the cellular response to that effect will be activated to deal with that change. 
During exercise, the cellular response to the physical activity will be to limit the internal 
stress in order to maintain normal homeostasis. Therefore, taking part in regular exercise 
will produce chronic physiological adaptations. Exercise physiology is a study of how 
physical activity influences the cardiovascular, endocrine, and musculoskeletal systems. 
There are two reasons for people to exercise; exercising for fitness or rehabilitation. 
“Fitness” is the category encompassing those performing exercise for athletic 
improvement or for individuals looking to promote body health or decrease body weight. 
On the other hand, exercise for rehabilitation is used for individuals to help them recover 
from current injury to improve their livelihoods in the face of chronic medical conditions 
(181). In general, the health benefits that occur as a result from exercise are innumerable.
3 
                                                                                             
General Exercise and Disease:  
Studies have revealed that regular exercise is extremely favorable in the 
promotion of health and treatment of diseases. This reality has persuade some researchers 
and scientists to consider exercise as a medicine (227). A previous study showed that 
exercise leads to an infinite number of health benefits, including the longevity and 
enhancement of one’s lifespan and health, respectively (227). In healthy individuals, 
exercise reduces the risk of death by 20-35% (14,138). A 2004 study showed that middle-
aged women who participate in less than one hour of exercise per week face a 52% 
increase in all causes of mortality, including cardiovascular- and cancer-related mortality, 
in comparison with physically active women (90). Exercise is also beneficial in patients 
either as a preventive or therapeutic modality. For example, studies showed that regular 
exercise has been used to prevent cardiovascular and pulmonary diseases such as, 
coronary heart disease, chronic obstructive pulmonary disease, hypertension, and 
intermittent claudication, metabolic syndromes (type 2 diabetes, obesity, and 
hyperlipidemia), cancer, depression, and musculoskeletal diseases such as osteoporosis, 
rheumatoid arthritis, fibromyalgia, chronic fatigue syndrome (175, 12), and gout (38). 
These studies indicate that exercise can be thought of as having the property of a drug 
when thinking of its optimal or effective dose response. It also suggests the importance of 
understanding the molecular mechanism of exercise in healthy and diseased conditions. 
Owing to these uses, exercise is now prescribed in dosage form, just like any other drug 
(7, 86, 177, 66, 102, 208). The reason for the dosing is that one only achieves optimal 
health from exercise when they observe it in a particular manner, pattern, and extent. 
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Peripheral Arterial Disease (PAD) and Exercise: 
PAD is a common disease in the elderly, usually resulting from atherosclerosis 
and associated thrombosis that prevent blood supply to the lower limbs (176). It affects 
8.5 million people in the US and around 202 million people worldwide (174). If left 
untreated, this disease can cause critical limb ischemia. Critical limb ischemia is 
responsible for more than 150,000 lower limb amputations per year in the United States 
alone (196). Patients’ intolerance to their treatments, such as exercise, due to pain, 
medication, or their incompatibility for surgery due to comorbidity, causes further 
progression of the disease and increased mortality. PAD has various treatment options 
due to the different body responses, including: exercise therapy, medical therapy, 
endovascular therapy, and surgical intervention (136). However, exercise therapy is more 
cost effective, safer, and is associated with improved walking distance, claudication 
symptoms, and most importantly, improved quality of life (243). The mechanisms 
underlying the beneficial effect of exercise include: vasodilation of the collateral vessels 
or arterial remodeling, improved glucose and fat metabolism of ischemic muscles, 
improved energy production, decreased oxidative stress, stimulation of angiogenesis, 
improved peripheral nerve conductance, and increased pain threshold (212). A meta-
analysis study (2) showed that exercise has better outcomes compared with 
revascularization alone in intermittent claudication. This is because revascularization and 
reversal arterial occlusion, while improving blood flow, do not reverse muscle function 
impairment. On the other hand, supervised exercise has the ability to improve muscle 
functional performance in addition to stimulating shear stress response and angiogenesis, 
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therefore improving quality of life (72, 81,146). Although it has robust outcomes and is 
widely available as a treatment to PAD patients, exercise as a treatment modality is not 
adaptable to some patients, for example some patients with asymptomatic PAD.  
Therefore, it is not surprising they are not adaptable to exercise as a treatment if 
they do not have symptoms! Even studies on exercise have various effects in subjects, 
which could be due to differences in protocols or differences in individual intrinsic 
aerobic phenotype. It has been clear that endurance exercise is mainly genetic in origin. It 
accounts for 70% of variations in exercise capacity (86). Thus, studying the different 
effects of exercise after hind limb ischemia between the intrinsic aerobic phenotype rats 
bred for low and high aerobic running capacity would provide a better platform for 
understanding the various effects of exercise, pre- and post-ligation, on vascular adaptive 
response in these phenotype.
 
Active Exercise and Genetic Predisposition:  
Aerobic exercise capacity is a complex trait of an individual that is impacted by 
both genetic and environmental factors, such as training, and has been reported as being a 
predictor of mortality (160). Studies on animals and humans have shown that genes may 
be a driving force for someone being physiologically active (79). In animals, rodent 
strains played a role in the divergence of spontaneous physical activity levels 
(126,131,132). Selective breeding studies of rodents have produced generations of high 
and low active animals that differ clearly in their predisposition for voluntary physical 
activity (114, 95). This activity was associated with adaptive physiological changes such 
as increased cardiac contractility and cardiac hypertrophy (126), suggesting the 
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importance of physiological adaptation in driving the physical activity (79). Studies on 
rodent strain breeding through backcrosses and intercrosses between low and high active 
animals identified multiple quantitative trait loci (QTL) specific for running distance, 
speed, and duration (120,132).  In humans, physical activity has been compared as a 
hereditary factor. Studies showed that physically active parents produced more active 
children than inactive parents, even after controlling the environmental factors (154). The 
variability in the activity among population is related to the variation in genes and the 
type of instrument used in active exercise (79).  Hereditary factor was found to be 
responsible for 9%-80% of physical activity depending on the intensity of the physical 
training (11, 39, 50, 141, 151, 179), suggesting the significance of genes in influencing 
the physical activity.   Several genes have been reported to be associated with exercise 
performance and response to exercise activity (19). These genes responsible for 
influencing the physiological outcomes of exercise or physical training include: body size 
or mass, leanness, lipidemia, glucosemia, and hemodynamics (19).  These biological 
traits and phenotypes are consistent with animal models of physical activity, which will 
help scientists to discover the physiological mechanisms that regulate the capacity of the 
physical training.  
 
HCR/LCR Rats: A Model of Intrinsic Aerobic Capacity:  
The factors involved in regulating aerobic capacity is very complex. Nevertheless, 
we can limit the main influential factors into intrinsic, or genetic, and extrinsic, or 
environmental. When genes are influence the aerobic capacity, we call it intrinsic aerobic 
capacity. This accounts for up to 70% of the variation seen between humans (16) 
7 
However, when the environment or active exercise influence the aerobic capacity, 
we call it extrinsic aerobic capacity or active exercise capacity. This is maximally 
accounted for (10-20%) and influences the intrinsic aerobic capacity (45, 237). This 
suggests the importance of the intrinsic factor on the overall aerobic capacity, as well as 
its dominance in producing the outcomes of diseases that can be prevented or treated by 
active exercise, such as in cardiovascular diseases. Therefore, genetic predisposition and 
intrinsic aerobic capacity are likely to contribute to peripheral arterial disease and 
mortality. Hence, studying this element as an important pathophysiologic mediator in 
peripheral arterial disease outcomes should be investigated. Thus, we used rats with two 
different intrinsic aerobic capacity phenotypes. The animals are artificially selected over 
generations to get strains with phenotypically determined high and low intrinsic aerobic 
capacity with a 30% difference in maximum oxygen uptake. 
Koch and Britton in 2001 generated a rat model with differences in running 
capacity by using genetically heterogeneous outbreed stock of N:NIH rats from each sex. 
These rats were  artificially selected by using a treadmill running test (111-112). At 12 
weeks, two-way artificial selective breeding was used to create low capacity runner 
(LCR) and high capacity runner (HCR) strains that were divergent for treadmill running 
capacity (run time for five days to exhaustion on a graded treadmill exercise test). The 
thirteen lowest and the thirteen highest running capacity rats of each sex were randomly 
paired for mating. This pattern was repeated over subsequent generations to produce the 
divergent strains using a rotational breading scheme. This model is very important in 
studying the interaction of the intrinsic aerobic capacity with the active exercise capacity 
and how that complex shapes the overall end results in treating or preventing the
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peripheral arterial disease.  Early studies using HCR and LCR rat models revealed that 
cardiovascular risk factors emerge after artificial selection for low aerobic capacity (239). 
LCR rats have higher random glucose, fasting glucose, insulin levels, visceral adiposity, 
and free fatty acids when compared to HCR (239). 
Our lab has been working with this model for about ten years. We utilized 
generation thirteen rats to determine the phenotypic differences between HCR and LCR 
in fatty acid disposal as a function of intrinsic oxidation capacity by skeletal muscles 
under normal and high fat diet protocols. This study confirmed what has been reported by 
others, i.e. that the LCR phenotype appears to have insulin resistance. The study also 
revealed the phenotypic differences in the adaptive response to the stress of a high fat diet 
between HCR and LCR. These results will aid further investigations into the phenotypic 
differences in adaptive response to chronic stress between HCR and LCR.
Additional work from our lab used this model to investigate the effect of intrinsic 
aerobic capacity on acute ischemic reperfusion injury. We found that there were 
phenotypic differences in infarct area to ischemic reperfusion injury after fifteen minutes 
of ischemia. However, after thirty minutes the differences vanished. This data suggest the 
significance of the influence of intrinsic aerobic capacity phenotype on the outcome of 
acute ischemic injury although severe injury cannot be protected by high capacity runner 
phenotype. 
 
HCR and LCR also were tested in our lab to determine the vascular and metabolic 
adaptive response to acute peripheral artery ligation. This study showed that LCR 
vascular and metabolic responses deteriorated after acute ischemic injury and that HCR
9 
 was more resistant to the ischemic injury. From this study we developed an interest in 
the effect of the interaction between intrinsic aerobic capacity and active exercise 
capacity and their overall outcome on vascular adaptive response before and after the 
acute peripheral artery ligation. 
 A study has been shown that exercise attenuates improvements in walking 
performance for PAD patients with diabetes, while it improves the walking performance 
in PAD patients without diabetes (137). These studies suggest that genetic susceptibility 
might be responsible for the negative outcomes resulting from exercise training after the 
development of peripheral arterial obstructive disease in diabetic patients. The studies 
also demonstrate that different intrinsic aerobic capacity phenotypic backgrounds might 
be an important factor in shaping the response to exercise therapy in PAD patients. Using 
this animal model is essential in studying the link between intrinsic aerobic capacity and 
active exercise before and after arterial occlusive disease. 
 
Arteriogenesis: 
 Arteriogenesis, or arterial remodeling, occurs when acute arterial occlusion causes 
a sudden pressure gradient between proximal arteries (within non-ischemic region) and 
distal arteries (within ischemic region). This pressure gradient increases blood flow 
through collaterals, activating shear stress in these collaterals, and subsequently causing 
alterations in the gene expressions in both calf (ischemic) and thigh (non-ischemic) 
muscles through shear stress response elements (59, 219). This leads to collateral 
remodeling to ensure sufficient blood flow to ischemic tissue. During acute ischemia, 
inflammatory cytokines produced from injured cells potentiate an infiltration of 
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inflammatory cells into ischemic tissue to remove the debris of necrotic tissue. 
Monocytes and macrophages also play a crucial role in angio/arteriogenesis by releasing 
Ccl2/MCP-1 cytokines (5, 52, 77, 223, 224). Also, invading endothelial progenitor cells, 
which originate from bone marrow mononuclear progenitor cells, a type of stem cell, 
have shown to be involved in arteriogenesis and blood flow recovery (107) in animal 
models of peripheral arterial occlusive disease (246). Variations of collateral arteries 
between animals species (26, 78, 108, 197, 198, 203) and among healthy humans (148) 
have been recorded. However, the effect of exercise before and after ligation on 
angio/inflammogenic responses due to hypoxia and shear stress in intrinsic aerobic 
capacity phenotype, can predict the presence of differential angio/arteriogenesis that stem 
from the different phenotype backgrounds.  
       
 Angiogenesis:  
 Angiogenesis is the growth of blood vessels from the existing vasculature. It 
occurs throughout life in both health and disease, beginning in utero and continuing on 
through old age. Vascular endothelial growth factor (Vegf) plays an important role in 
physiological angiogenesis, such as during exercise, in pathological conditions such as in 
PAD, and during development (96). Vegfa can produce its signal through Fms-like 
tyrosine kinase 1(Flt1),   which is important receptor in angiogenesis during 
development. The other receptor, kinase insert domain-containing receptor (Kdr), 
mediates angiogenesis in the adult. It is important to investigate the impact of exercise-
post ligation on angiogenesis signaling between rats that differ in their intrinsic exercise 
capacity following acute hind limb arterial occlusion. Angiopoietin 1 (Angpt1) stimulates 
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and stabilizes angiogenesis while angiopoietin 2 (Angpt2) prevents vascularization. 
However, when Angpt2 is associated with Vegfa, it stimulates angiogenesis (51). Nuclear 
factor kappa-light-chain-enhancer of activated B cells (Nfkb) is an upstream mediator for 
Vegfa expression in acute arterial ligation in response to hypoxia (241). Intercellular 
adhesion molecule (Icam) and vascular cell adhesion molecule (Vcam) are well-known 
markers for endothelial activation and dysfunction (220). Their elevated levels indicate 
leukocyte recruitment from injured endothelial layers to ischemic tissue (127,173). 
Platelets derived growth factor alpha (Pdgfa) plays an important role in early 
development and in adult. During development, Pdgfa drives the proliferation of 
undifferentiated mesenchymal cells, but in the adult, it also plays a fundamental role in 
tissue remodeling, mesenchymal differentiation, and migration (84). Additionally, Pdgfa 
stimulates fibroblast proliferation for tissue remodeling by recruiting macrophage and 
fibroblast cells and stimulating their gene expression toward proliferation. Thus, it is 
responsible for the induction of an inflammatory environment to expedite the healing 
process (178). Bone morphogen protein receptor 2 (Bmpr2) is a receptor for BMPs, 
ligands which are members of the TGF-β superfamily, and is involved in several process 
of embryonic development and differentiation (29, 109, 242). Its reduced expressions in 
pulmonary artery hypertension has been associated with increased perivascular 
macrophages, muscularized distal arteries (195), and endothelial apoptosis (155). The 
influence of exercise before and after ligation on the vascular adaptive response in 
intrinsic exercise capacity phenotypes has not been studied. 
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The Dosage of Exercise: 
Dosage is critical in clinical medicine, and drugs need data supporting their safety 
and efficacy (122). Vina et al. have reported that every organism needs a minimum 
amount of exercise and performing an amount below which will not be beneficial to their 
health (227). The advantages accumulating from physical activities increases from an 
accompanying rise in the amount of physical activities. However, beyond a particular 
threshold, the negative impacts due to exercise become apparent and begin to replace the 
advantages. On the other hand, unlike medical drugs, the minimal dose, maximal safe 
dose, and dose response of exercise vary greatly from one organism to another, and thus 
the standard of each is unclear (122). This variation has since elicited a non-stop debate 
on how much, how often, what type, the duration, and with what intensity exercise should 
be observed (122) due to the different methods in measuring exercise intensity, different 
classification of dose schemes (122), and different phenotypes within similar species. 
According to Warburton et al. (232), the levels of intensity of physical training can be 
measured based on oxygen consumption (VO2) or heart rate. For instance, moderate-
intensity exercise is when both heart and respiratory rates are increased without 
interfering with one’s ability to talk, as is observed with brisk walking at a speed of 3.0 
mph (80.4 m/min). However, vigorous-intensity exercise is when the heart and 
respiratory rates are increased to the point of causing difficulty in conversing, as is 
observed during and after running. 
In order to determine the minimal effective dose of exercise for each individual, 
the exercise dose should be handled clinically, as a pharmacological dose. A physician
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begins administrating a drug at its minimal effective dose, and if the patient dose not 
respond effectively, then the physician begins titrating the dose upwards, towards the 
maximal effective dose. Exercise should be treated the same way, starting with minimal 
effort and then titrated towards the maximal effort the individual can tolerate, depending 
on the current condition (122). That means those who are untrained may require the 
minimal effective dose of exercise while athletic individuals would requires the maximal 
effective dose (202). Thus, a person who has a fitness level as recommended for all 
healthy young to middle-age adults, would be required to train, during a six-month time 
period, for 300 min or more of moderate-intensity aerobic exercise per week, or 150 min 
or greater of vigorous-intensity aerobic exercise per week (121,169).    
Caution is required when adjusting the exercise dose prescribed for specific 
populations such as elderly, children, pregnant women, and patients with comorbidities 
(232). For example, elderly men over 60 do not require vigorous exercise to prevent 
cardiovascular risks. Instead, regular active exercise is sufficient to significantly decrease 
mortality rate in this age group (227). For type 2 diabetic patients, they might benefit 
initially from the training levels that are recommended for healthy adults, followed by a 
gradual increased toward the recommended doses for specific condition of each 
individual (169). Overall, according to Wen et al. (235), 15 minutes per day or 90 
minutes per week of moderate-intensity physical activity is valuable to an individual’s 
health and life expectancy, and even for persons with high cardiovascular risks (122). 
This suggests that exercise might be harmful if used in wrong dose in specific condition.  
Role of Androgen in Cardiovascular Protection: 
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Clinical and basic experimental studies provided huge evidences about the 
atheroprotective effect of estrogen and testosterone on blood vessels. While studies 
regarding androgen’s role on vasculature have been controversial for a long time, in 
recent years a great amount of work has suggested that androgens exert protective effects 
against the development of atherosclerosis in both genders in human and in animals. 
Among the female population, cardiovascular diseases have been known to be more 
detrimental than in the male population (9, 74, 240, 252). Although the effect of 
testosterone on cardiovascular events and mortality in women has not yet been evaluated 
in large cohort studies, a prospective cohort study in more than 2000 women, that were 
followed up after more than four years from the start of the study, found that women with 
the lowest levels of testosterone had the greatest risk of a cardiovascular event 
independent of traditional risk factors (148). In men, several studies showed the inverse 
relationship between testosterone levels and cardiovascular events (200, 152, 104). In 
animal model, studies on hind limb occlusive model found androgen receptors are 
essential for revascularization response in ischemia in both male and female mice (103). 
Moreover, the testosterone hormone also has been found to increase numerical density of 
capillaries in left ventricle after injection into aging male rats for 4 months (64). The 
mechanisms underlying the associations of low testosterone with CVD are complex and 
poorly understood. However, estradiol and dihydrotestosterone administration in 
gonadectomized male mice has been reported to increase angiogenesis through increasing 
vascular branching and vascular diameter, respectively (213).  
CVD incidence among women is low before menopause, but progressively 
elevates upon beginning menopause. This increase is thought to result partially from the 
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loss of endogenous estrogen. (149) However, androgens also decrease with increasing 
age (35). Whether the ratio of sex hormone receptors is playing a protective role in 
preventing the onset of CVD in the female population, and whether it is phenotypically 
dependent, has yet to be known. 
 
HCR Rats and Possibility of Androgen Oriented-Phenotype:  
HCR rats are characterized as having a higher maximum oxygen uptake and 
resting metabolic rate, lean body mass, increased longevity, and resistance to developing 
dyslipidemia, peripheral insulin resistance, diet induced-liver steatosis, depression, and 
metabolic syndrome in comparison with LCR. These differences are possibly due to 
different underlying endocrine hormonal profile between these phenotypes. Several 
studies on testosterone prove the relationship between these biological characters and 
testosterone levels in human and animals. Studies in humans showed that men who had 
prostatic cancer and who were under androgen deprivation therapy for more than 3 
months, developed lower VO2max and lower resting metabolic rate when compared to 
the group that received the therapy for less than three months (228).  Moreover, studies 
have showed that testosterone decreased visceral fat mass (143), improved insulin 
resistance (143), and increase lean body mass (99).  Additionally, studies revealed that 
long-term testosterone replacement therapy in men with late onset hypogonadism had 
decreased obesity parameters and improved metabolic syndrome and health-related 
quality of life (143). Testosterone replacement therapy for hypogonadal and aging men 
caused decrease in total cholesterol and LDL levels with no change in HDL levels (250).  
Testosterone has also been linked to the onset of depression in old men. A low free 
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testosterone level in elderly men over 70 years of age was associated with a higher 
prevalence of depression (3).  Hormonal replacement therapy has been found to increase 
the longevity in both genders. Testosterone replacement therapy for men with late onset 
hypogonadism increased their survival rate by 9-10% in 5 years, which is similar to that 
of eugonadal men with normal endogenous testosterone level (32). Also, in menopausal 
women with estrogen replacement therapy, their survival rate increased by 2.6% in 5 
years (32). Fatty liver is also associated with low testosterone concentration in both 
human and animal studies. In 495 men diagnosed with non-alcoholic fatty liver disease, 
251 were observed to have a low serum testosterone level with absence of an alternative 
cause (76). In animal studies, mice with a liver-specific androgen receptor deletion have 
higher liver steatosis than obese controls (134). On the other hand, estrogen signaling has 
been shown to be associated with metabolic syndrome and its risk factors (106). It is also 
reported that LCR is known as a genetic model of metabolic syndrome (183). Whether 
LCR rats, as compared to HCR rats, have a different activation of sex hormone receptors 
that are responsible for the differential expression of receptor genes, and whether that 
difference plays a role in remodeling skeletal muscle injury following ischemic stress 
response, is not clear.  
Some epidemiological studies provide strong evidence that hormone replacement 
therapy contributes toward cardioprotection in postmenopausal women (100), while other 
studies do not (91). It has been suggested that the inconsistency in these results is due to 
the heterogeneity of responses to hormonal replacement therapy. LCR and HCR rats are 
generated from heterogeneous N:NIH founder population. Whether AR/ERα ratio in 
gastrocnemius muscle is differentially associated with acute hind limb ischemia between
17 
 the female HCR and LCR rats, and whether AR differentially regulates skeletal muscle 
repair during ischemia has yet to be studied.         
 
Skeletal Muscle Satellite Cells and Ischemia: 
Satellite cells are the myogenic precursor cells and are responsible for the repair 
and regeneration of muscle fiber in adult tissue, either by fusing together or by 
integration into injured myocytes and their nuclei (75). During ischemia, these cells play 
a critical role in muscle preconditioning, remodeling, and repairing of damaged muscle 
fibers. This process involves several inflammatory cells, cytokines, growth factors, 
neurotransmitters, and hormones that play synergistically to activate quiescent satellite 
cells, see (Figure 1.1) (75).    Activation of cells was reported at around 6 hr post-injury 
and within 24 hr the cells display significant growth (75). It remains unclear whether 
intrinsic exercise capacity phenotypes differentially activate the cells at these time points 
in response to the interaction between androgen and dopamine receptor D3R signaling 
pathways.   
HCR Phenotype and Possible Association with D3R Activation: 
HCR and LCR rats are animals models generated to examine the mechanism by 
which their phenotypes influence the development of metabolic disease and life span 
(111-112). Several studies were conducted using this unique model, one of them was to 
















Figure 1.1: Multiple factors are responsible for satellite cells activation during muscle 
injury, including cells, growth factors, hormones, and neurotransmitters. Insulin-like 
growth factor, IGF; mechano growth factors, MGF; tissue growth factors, TGF; platelets 
derived growth factors, PDGF; hepatocyte growth factor, HGF; fibroblast growth factor, 






















Skeletal Muscle Satellite Cells  
19 
monoamine adaptation by active exercise (53). Interestingly, they found that 
dopaminergic neuroplasticity was influenced by intrinsic exercise capacity phenotype, 
and HCR have prolonged dopamine availability compared to LCR (53). They reported 
that HCR phenotype was associated with increased gene expression of D2R, but not 
D1R.  D2R is an inhibitory while D1R is a stimulatory receptors. Although D3R is 
another inhibitory dopaminergic receptor, to date no study has reported an association 
between D3R stimulation and high intrinsic aerobic capacity phenotype. It could be 
possible to show the association of D3R gene expression in this study to understand the 
mechanisms by which high intrinsic aerobic capacity phenotype regulate pathological and 
physiological stresses. Nevertheless, D3R has higher possibility to be associate with the 
high capacity runner phenotype. It has been reported that D3R was associated with the 
reduction in dopamine reuptake in the brain during prolonged administration of 
Pramipexole (D3R Agonist) (24). In addition to the central role, D3R stimulation was 
associated with renal function following renal ischemia reperfusion injury (230). Our lab 
also showed that D3R knockout mice have low life span and associated with adverse 
remodeling in cardiac tissue compared to wild type mice. We also shown that HCR has 
more recovery following hind limb ischemia as compared to LCR. Thus, association of 
D3R stimulation with prolonged dopamine bioavailability, longer life span, and 
protection from cardiovascular disease will open a question to explore the association of 
HCR phenotype, which shows similar biological findings of D3R stimulation, with D3R 
stimulation in ischemic repair such as in PAD model is novel.  
Dopamine and androgen physiologically and pathologically was shown modifying 
each other centrally (1, 49,116).  It is unclear whether HCR phenotype, in response to 
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active exercise with hind limb ischemia, is associated with differential AR and D3R 
expressions as compared to LCR, and whether the interaction between the D3R and AR 
in skeletal muscle satellite cells explains the mechanism of that association is novel.  
                                                                                                         
Role of Dopamine Receptor in Cardiovascular Protection: 
Dopamine receptors are members of the G-protein-coupled receptor family. The 
primary endogenous ligand of theses receptors is the neurotransmitter dopamine. 
Dopamine receptor D1 (D1R) and D5R are stimulatory receptors responsible for the 
synthesis, storage, and release of dopamine, and the activation of the production of the 
second messenger cAMP (165). On the other hand, D2R, D3R and D4R are inhibitory 
receptors that directly inhibit formation of cAMP by inhibiting adenylyl cyclase (166).  
D1R has been reported to be expressed in the pulmonary artery and thought to cause 
vasodilation (189). It is also found in the epicardium, myocardium, and endocardium of 
the heart (25), and in vascular smooth muscle of major organs (92). D1R dysfunction was 
associated with hypertension in animal models of hypertension and in humans with 
essential hypertension (92, 99).    
 
Dopamine Receptor and Ischemia:  
Several studies have showed that dopamine receptors play a role in ischemia. An 
In vivo study Araki et al. found that D1R and dopamine uptake sites, 7 days after the 
initial 10 minutes of cerebral ischemia, are susceptible to ischemia while D2R are 
resistant (4). In cultured neonatal rat cardiomyocytes, activation of D2R inhibited the 
release of cytochrome C, accumulation of intracellular Ca+2 ion concentration and 
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apoptosis, while inhibition of D2R did not significantly affect apoptosis of cardiomyocyte 
(128). A similar study was conducted to determine the role of D1R in ischemia-mimetic 
solution for 2 hours. It was found that activation of D1R induces apoptosis by 
ischemia/reperfusion, and its inhibition has no effect on apoptotic myocytes during 
ischemia reperfusion injury (129).  The role of D3R in ischemia was also recorded. Its 
activation was found to improve the neurological function, learning, and memory of rats 
after global cerebral ischemia/reperfusion (229).  
In peripheral arterial ligation, D2R was found to prolong the post-ischemia 
recovery. In a mouse model of D2 knockout, a unilateral hind limb ischemia showed 
faster recovery rate and stimulation of angiogenesis in the D2 knockout mice compared 
to the wild-type (194). For more roles of dopamine receptors in ischemia refer to (Table 
1.A). This data lead to questions about whether intrinsic differences in endurance 
capacity could be due to differences in dopamine/receptors systems that modulate 
ischemic remodeling in femoral arterial ligation, the answer of which is unknown.                                                                                                                                                  
Dopamine and Exercise: 
Several studies have linked the role of the central nervous system in skeletal 
muscle fatigue. This is referred to central fatigue (105). Dopamine is one of the 
neurotransmitters that has been focused on regarding the mechanisms of exercise-induced 
fatigue, such as the motivational state during physical activity (36). Studies on human 
and animals showed that increases in the dopamine concentration delay the onset of 
fatigue (12, 33, 61, 236). However, reducing dopamine activity accelerated the time to 
fatigue (37, 40, 80, 101).  An important question arose to Teresa E. Foley et al. regarding 
whether intrinsic differences in endurance capacity could be due to differences in the
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Table 1.A: Summary of Some Roles of Different Dopamine Receptors in Ischemia 
 
Dopamine 1 (D1); dopamine 2 (D2); dopamine 3 (D3); dopamine 5 (D5); 
ischemia/reperfusion   (I/R); stimulation (S); inhibition (I). 
 
dopamine system (53). Using high capacity (HCR) and low capacity runners (LCR), they 
hypothesized that HCR have prolonged dopamine availability compared to LCR. So, 
upon studying various brain areas involved in movement, motivation, and fatigue, they 
found that D2R (and not D1R) in HCR was higher than LCR. These data direct to explore 
more about the intrinsic differences in endurance capacity and especially the role of 
dopamine peripherally at the level of skeletal muscle. This data is important in order to 






D1 S Gut ischemia Attenuate vasoconstrictive response to 
 Gut ischemia (Favorable effect). 
(70) 
D1/D5 S Femoral arterial 
ligation 
Enhanced bone marrow-derived cell  
mobilization & post-ischemic angiogenesis 
(187)  
D1 S Vascular  
hypertension 
Smooth muscle cell relaxation  
and vasodilation 
(204)  
D1/D2 S Coronary artery  
occlusion 
Reduce ischemia severity canine  (226)  
D2/D3 S Global cerebral  
I/R 
Improve neurological function, learning 
 and memory 
(229)  
D3 S Renal I/R Attenuates renal I/R injury (230)  
D1 I Global cerebral  
ischemia 
Neuroprotective effect (71)  
D2/D3 S Brain I/R 
 
Neuroprotective effect (71)  
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level of the skeletal muscle than LCR, and if that difference is responsible for hind limb 
ischemia remodeling.  
 
Dopamine and its Relationship with Androgen and Estrogen Receptors: 
Sex steroid receptors commonly function as initiators of transcription genes and 
subsequent synthesis of several proteins to regulate cell function during physiological and 
pathological responses. In regard to the synthesis of dopamine, the rate limiting enzyme 
is tyrosine hydroxylase. A study has explored the androgen responsive element in the 
tyrosine hydroxylase region, base pairs 1562 to 1328, upstream of the promotor (98). 
Studies have shown that testosterone treatment increased or maintained tyrosine 
hydroxylase activity, which decreases after castration (1). Moreover, sex hormones such 
as testosterone and estrogen have been shown to regulate tyrosine hydroxylase gene 
expression (1, 73, 207, 217). Another study done by Ely D. et al. showed that androgen 
alters brain catecholamine content and blood pressure in the testicular feminized male 
rats. They found testosterone manipulation increases blood pressure and correlates with 
dopamine content in the different brain regions through non-genomic or non-classic 
androgen receptor signaling (49). An additional study recorded that the ability of 
nandrolone (anabolic androgen steroid) to modulate motivation and reward-related 
effects of psychostimulant drugs, such as amphetamine, is dependent on the activation of 
androgen or estrogen receptors (116). However, since this research has mostly been 
performed in the brain, we do not know whether androgen and estrogen receptors can 
modulate dopamine receptor signaling in skeletal muscle, and whether intrinsic 
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phenotype differences in endurance capacity differentially modulate dopamine receptors 
by sex steroid receptors in a model of hind limb ischemia.     
                                                                                                                                                              
Thesis Overview: 
 The purpose of this project is to gain a better understanding about the differential 
changes in vascular adaptive response in ischemic skeletal muscle following exercise 
training between HCR and LCR. Our previous studies in this model without exercise 
showed that LCR rats have an attenuated and less effective angiogenic response 
compared to HCR rats. We predict that exercise will also deteriorate vascular adaptive 
response in LCR as compare with HCR.  Previous studies have found that the LCR 
phenotype is a genetic model of metabolic syndrome (183) and presence of diabetes 
attenuates the improvement in walking performance in PAD patients who received 
exercise therapy (137). Studies also have showed that testosterone decreased visceral fat 
mass (143), improved insulin resistance (143), and increased lean body mass (144). This 
suggests that the LCR phenotype will have a decreased tolerance to a peripheral ischemic 
injury and demonstrate maladaptive responses from exercise during vascular ischemia. It 
also suggests that this can be due to the low androgen receptor activation in LCR as 
compared to HCR.   The overall hypothesis is that intrinsic exercise capacity regulates 
sex steroid receptor expression, which affects the remodeling response to PAD with or 
without exercise. In chapter two we describe how exercise before peripheral artery 
ligation in LCR rats protects against vascular adaptive response to ischemia due to 
sufficient angio/inflammogenic response as compared to HCR rats. In chapter three we 
investigate how exercise after peripheral artery ligation in LCR exacerbates vascular 
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adaptive response to ischemia due to an insufficient angio/inflammogenic response as 
compared to HCR rats. Lastly, in chapter four we examine how the intrinsic aerobic 
capacity phenotype modifies the dopamine receptors through the androgen receptor 

























CHAPTER 2: INTRINSIC AEROBIC CAPACITY INFLUENCES THE 
VASCULAR ADAPTIVE RESPONSE TO ACTIVE EXERCISE FOLLOWING 
LOWER LIMB ISCHEMIA 
Abstract: 
The genotype associated with an inducible response to dynamic exercise is 
different from the genotype associated with the intrinsic capacity for aerobic exercise. 
The inducible response is an established component of rehab protocols after ischemic 
events, but the influence of the intrinsic capacity for exercise on the vascular response to 
active exercise following ischemic injury is unknown. Method: HCR and LCR, Female 
rats, 40 weeks, n = 16 each, treated with unilateral femoral artery ligation. Three days 
after the occlusion, half of the animals began treadmill running protocol for 10 days. The 
2nd half served as sedentary post-ischemic controls. Skeletal muscle was harvested from 
both hind limbs. Samples from the non-occluded contralateral limb were used as internal 
controls. Samples were assessed histologically for capillarization using Rosenblatt 
staining, and genetically using PCR. Significant results were then supported by protein 
expression using ELISA to identify the difference in vascular adaptive response between 
the phenotypes following ischemia with/without exercise. Results: LCR rats were about 
80g heavier while HCR had about 500% greater intrinsic running capacity (both p < 
0.01). HCR rats showed 26% better preservation of muscle fiber area in the post-ischemic 
limb, but LCR rats showed at least a 2 fold increase in fiber area in response to active 
exercise (p < 0.05). HCR samples showed a greater increase (80%) in capillary density 
and perfusion exchange ratio (40%) in response to exercise. PCR and ELISA assays for 
multiple angiogenic factors showed expression levels that were consistently higher in the 
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LCR samples, consistent with increased ongoing ischemic stress. Conclusion: 
Combining occlusion with exercise after occlusion in LCR appeared to overwhelm the 
early angiogenic remodeling responses.  
NEW & NOTEWORTHY: Exercise is commonly used as a treatment for those with 
peripheral arterial disease. This paper shows that the intrinsic aerobic capacity phenotype 
is an important internal factor that influences the outcomes from active exercise in lower 
limb ischemia remodeling. We demonstrated that combining occlusion with exercise after 
occlusion in LCR appeared to overwhelm the early angiogenic remodeling responses due 
to imbalanced muscle-capillary relationship and attenuated the vasculogenic adaptive 
response to ischemia. 
Key words: Ischemia, HCR, LCR, exercise, PAD, intrinsic aerobic capacity. 
 
INTRODUCTION 
 Peripheral arterial disease (PAD) is a common disease in the elderly, usually 
resulting from atherosclerosis and associated thrombosis that prevent blood supply to the 
lower limbs (176). It affects 8.5 million people in the US and around 202 million people 
worldwide (174). If left untreated, this disease can cause critical limb ischemia. It is 
responsible for more than 150,000 lower limb amputations per year in the United States 
alone (196). Patients’ intolerance to treatments such as exercise due to pain, or patients 
not suitable for surgery due to comorbidity causes advanced progressions of the disease 
and increased mortality. PAD has various treatment options due to different body 
responses. These options include: exercise therapy, medical therapy, endovascular 
therapy, and surgical intervention (136). However, exercise therapy is more cost 
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effective, safer, and associated with improved walking distance, claudication symptoms, 
and most importantly quality of life (243). The mechanisms underlying the beneficial 
effects of exercise include: vasodilation of the collateral vessels or arterial remodeling, 
improved glucose and fat metabolism of ischemic muscles, improved energy production, 
decreased oxidative stress, stimulation of angiogenesis, improved peripheral nerve 
conductance, and improved pain threshold (212). A meta-analysis study (2) showed that 
exercise has better outcomes compared with revascularization alone in intermittent 
claudication. This is because revascularization and reversal arterial occlusion doesn’t 
reverse muscle function impairment as it improves blood flow. On the other hand, 
supervised exercise has the ability to improve muscle functional performance and 
stimulate the shear stress responses and angiogenesis, therefore improving quality of life 
(72, 81,146). Although it has robust outcomes and is applicable to a majority of PAD 
patients, exercise as a treatment modality is not adaptable to some patients, for example 
patients with asymptomatic PAD. Therefore, it is not surprising to not be adaptable if 
they don’t have symptoms! Even studies on exercise have different effects in subjects 
which could be due to differences in protocols or differences in individual intrinsic 
aerobic phenotype. It has been clear that endurance exercise is mainly genetic in origin. It 
accounts for 70% of variations in exercise capacity (57). Thus, studying the differential 
effects of exercise after hind limb ischemia between the intrinsic aerobic phenotype rats 
bred for low and high aerobic running capacity would provide a better platform for 
understanding the differences in the effects of exercise post-ligation on vascular adaptive 
response in these phenotypes.
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 Arteriogenesis, or arterial remodeling, occurs when acute arterial occlusion causes 
a sudden pressure gradient between proximal arteries (within non-ischemic region) and 
distal arteries (within ischemic region). This pressure gradient increases blood flow 
through the collateral circulation and activates shear stress in these collaterals, causing 
alterations in the gene expression in both calf (ischemic) and thigh (non-ischemic) 
muscles through shear stress response elements (59, 219), and leading to collateral 
remodeling to ensure sufficient blood flow to ischemic tissue. During acute ischemia, 
inflammatory cytokines produced from injured cells causes infiltration of inflammatory 
cells in ischemic tissue to remove debris of necrotic tissue. Monocytes and macrophages 
also play a crucial role in angio/arteriogenesis through the release of Ccl2/MCP-1 
cytokines (5, 22, 77, 223, 224). Also, invading endothelial progenitor cells, which 
originate from bone marrow mononuclear progenitor cells have been shown to be 
involved in arteriogenesis and blood flow recovery (107) in animal models of peripheral 
arterial occlusive disease (246). Variations of collateral arteries between animal species 
(26, 77, 108, 197, 198, 203) and among healthy humans (148) have been recorded. 
However, the effect of exercise post-ligation on angio/inflammogenic responses due to 
hypoxia and shear stress in intrinsic aerobic capacity phenotype can predict the presence 
of differential angio/arteriogenesis that stem from the different phenotype background.  
  Vascular endothelial growth factor (Vegf) plays an important role in 
physiological angiogenesis, such as during exercise, in pathological conditions such as 
PAD, and during development (96). Vegfa can produce its signaling through Fms-like 
tyrosine kinase 1(Flt1), which is important in angiogenesis during development. The 
other receptor, kinase insert domain-containing receptor (Kdr), mediates angiogenesis in 
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the adult. It is important to investigate the impact of exercise post-ligation on 
angiogenesis signaling between rats that differ in their intrinsic exercise capacity 
following acute hind limb arterial occlusion. Angiopoietin 1 (Angpt1) stimulates and 
stabilizes angiogenesis while angiopoietin 2 (Angpt2) prevents vascularization. However, 
when Angpt2 is associated with Vegfa, it stimulates angiogenesis (51). Nuclear factor 
kappa-light-chain-enhancer of activated B cells (Nfkb) is an upstream mediator for 
Vegfa expression in acute arterial ligation due to hypoxia (241). Intercellular adhesion 
molecule (Icam) and vascular cell adhesion molecule (Vcam) are well-known markers 
for endothelial activation and dysfunction (220). Their elevated levels indicate leukocyte 
recruitment from injured endothelial layers to ischemic tissue (127,173). Platelet derived 
growth factor alpha (Pdgfa) plays an important role in early development and in adult 
physiology. During development, Pdgfa drives the proliferation of undifferentiated 
mesenchymal cells, while in adults it plays a fundamental role in tissue remodeling, 
mesenchymal differentiation, and migration (84). Pdgfa also stimulates fibroblast 
proliferation for tissue remodeling by recruiting macrophage and fibroblast cells and 
stimulating the expression of genes necessary for proliferation. Thus, it is responsible for 
the induction of an inflammatory environment for faster healing (178). Bone morphogen 
protein receptor 2 (Bmpr2) is a receptor for BMP ligands which are members of the 
TGF-β superfamily and are involved in several process of embryonic development and 
differentiation (29, 109, 242). The expression of Bmpr2 is reduced in pulmonary artery 
hypertension is associated with increased perivascular macrophages, mascularized distal 
arteries (195), and endothelial apoptosis (155). The influence of exercise post-ligation on 
the vascular adaptive response in intrinsic exercise capacity phenotypes has not been 
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studied. Using a rat model to determine how intrinsic aerobic exercise capacity responds 
and adapts to several diseases has been developed by Koch and Britton (20). The low 
aerobic capacity rats are a genetic model for metabolic syndrome that contribute to an 
increased risk of diabetes and cardiovascular disease. A study has been shown that 
exercise for PAD patients with diabetes attenuates the improvement in walking 
performance while it improves the walking performance of PAD patients without 
diabetes (137). These studies suggest genetic susceptibility might responsible for the 
negative outcomes from exercise training after the development of peripheral arterial 
obstructive disease in diabetic patients, and demonstrate that different intrinsic aerobic 
capacity phenotypic background might be an important factor in shaping the response to 
exercise therapy in PAD patients. Using this animal model is essential in studying the 
link between intrinsic aerobic capacity and active exercise after arterial occlusive disease. 
 We are interested in understanding differential changes in vascular adaptive 
response in ischemic skeletal muscle following exercise training between HCR and LCR. 
Our hypothesis is that LCR rat’s vascular adaptive response is deteriorated by exercise 
post-ligation due to an insufficient angio/inflammogenic response compared to the HCR 
rats. Our model utilizes a unilateral hind limb femoral artery ligation followed by a mild 
intensity of progressive treadmill exercise. Our previous studies in this model without 
exercise showed that LCR rats have an attenuated and less effective angiogenic response 
compared to HCR rats. We predict that exercise will also deteriorate vascular adaptive 




MATERIAL AND METHODS 
Animal Strains and Experimental Groups. HCR and LCR, female rats, 40 
weeks, n= 16 each, generation 32. Eight HCR and eight LCR rats were exercised post-
ligation for 10 days, beginning at day 3 post-ligation. The remaining 16 animals served as 
sedentary post-ischemic control. These animals were obtained from Drs. Lauren Koch 
and Steven Britton at the University of Michigan.  They have previously described the 
artificial selection used for the generation of the HCR and LCR strains (111-112,22).  
Briefly, each sex was selected from the founder population (N: NIH stock). Two-way 
artificial selective breeding was used to create low capacity runner (LCR) and high 
capacity runner (HCR) strains that were divergent for treadmill running capacity (run 
time until exhaustion on a graded treadmill exercise test).  The 13 lowest and 13 highest 
running capacity rats of each sex were randomly paired for mating.   This pattern was 
repeated over subsequent generations to produce the divergent strains using a rotational 
breeding scheme.  In the present study animals from generation 32 were used.   All the 
animals were exposed to treadmill exercise for the 5 days at 11 weeks of age when the 
animals were phenotyped for treadmill running capacity.  Upon verifying the phenotypes 
of the animals, animals were prepared for shipping at 14 weeks of age, or soon after as 
weather conditions (airport tarmac temperatures < 85F) permitted.  Once received by the 
Department of Comparative Medicine at ECU, the animals were maintained under 
mandatory quarantine for 10 weeks before they were released for study. Rats were 
provided standard rat chow and water ad libitum and were kept on a 12 h light/ 12 h dark 
time schedule until sacrifice.  Animal procedures were conducted in accordance with 
American Physiological Society guidelines for the humane and safe use of animals, and 
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all protocols involving animals used for these experiments were approved by the East 
Carolina University Animal Care and Use Committee. 
Exercise Training.  Motorized treadmill running exercise was used for Ex-post 
ligation groups as a type of mild intensity supervised exercise training. Animals were 
subjected to 5 days on the treadmill at a very low speed (10 m/min) to condition them to 
the treadmill environment.  Animals that were not running on the treadmill were removed 
and returned to their cages.  Significant attention was devoted to minimizing exposure to 
the shock grid by using blasts of air or gentle prodding with a brush.  Animals began 
exercising for 5 minutes at 14-16 m/min for 5 days a week for two weeks; the duration of 
exercise was gradually increased 5 min per day, until they were training for 60 minutes. 
Ex post-ligation protocol was generally 2 weeks in duration, beginning on post-op day 3 
(8 events). The Total number of sessions was: 5 conditioning + 8 protocol = 12 
events/animal (174).  
Hind Limb Femoral Artery Occlusion. Femoral artery occlusion was produced as 
outlined by others (135, 136,184).  Briefly, rats were anesthetized with ketamine xylazine 
(0.1ml/100g body weight IP).  The fur was shaved from the inner thigh and the surgical 
sight was cleaned with Betadine and 70% alcohol.  Utilizing a small incision, the left 
femoral artery was isolated and three ligatures of 6-0 surgical silk were placed to cause 
an ischemic condition in the downstream tissue.  One ligature was placed 5-6mm distal to 
the inguinal ligament, a second was placed on a collateral artery, and the third was placed 
5-6 mm distal to the first ligature.  When all three ligatures were in place, the incision 
was closed, and the animal was given a Buprenex injection (0.1ml/100g body weight IP) 
and placed in its cage to recover.  Animals were allowed to wake up and have unlimited 
34 
access to food and water.  Animals were sacrificed at day 14 following placement of the 
ligature. This procedure produces a uniform occlusion of the femoral arteries that reduces 
blood flow reserve capacity to 10–20% of normal, but also remains sufficient to meet 
resting blood flow requirements (243, 244, 245). 
Skeletal Muscle Morphology: Rosenblatt Staining and Analysis.  
Gastrocnemius muscle for each animal was excised and quickly frozen by placing them 
in optimal cutting temperature (O.C.T.) compound.  The muscle in the OCT was cut into 
transverse sections (thickness 8µm) and then was underwent capillary staining as 
originally defined by Rosenblatt et al (26, 60). Briefly, Rosenblatt staining allows 
visualization of capillaries for subsequent photographs under 20 X magnification.  
Capillaries were quantified manually from the image on individual fibers. The following 
six indexes were measured: 1. Share factor (SF), 2. Average cross-sectional myofiber 
perimeter (AP), 3. Average cross-sectional myofiber area  (AA),. 4. Capillary per fiber 
perimeter exchange (CFPE), 5. Number of capillary attached per fiber (NCAF), 6. 
Capillary density (CD). Fiber cross-sectional average area and perimeter were measured 
with the ImageJ-analysis system calibrated to transform the number of pixels (viewed on 
a computer monitor) into micrometers from an image of the myosin ATPase stain.  
RNA Isolation, Reverse Transcriptase-PCR, and Real-Time PCR.  Total RNA was 
extracted from harvested gastrocnemius muscle using TRIzol reagents (Invitrogen) and 
cDNA was generated using the High-Capacity cDNA Reverse Transcription kit from 
Applied Biosystems (Thermofisher) following the manufacturer’s protocol. qReal-time 
PCR was  performed using 5̀ fluorescent labeled primers for Vegfa, Angpt1, Angpt2, 
Hif1a, Icam, Vcam, Pdgfa, Kdr, Flt1, Nfkb, Ccl2, Il6, and Bmpr2 with TaqMan Fast 
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Advanced Master Mix (Life Technology) following the manufacturer’s protocol. 
Actin β was used as the reference gene since CT values for this gene did not change with 
treatment. The qReal-Time PCR detection system used was the ABI Prism 7900 
sequence detection system (Applied Biosystems, Foster City, CA). LCR and HCR 
internal legs samples were used for all data to be normalized with treated samples of 
other legs using the ratio of 2-∆ CT of treated sample/2-∆ CT of controlled sample 
method. 
ELISA. The levels of several cytokines were detected by ELISA kits from 
harvested gastrocnemius muscle using 1x phosphate buffered saline (PBS 1X, pH 7.4) 
(Thermofisher) containing 2% Triton X-100 (Sigma) and an electronic homogenizer.  
Vegfa and Mcp-1 ELISA kits (Abcam), Nfkb and Angiop 2 ELISA kits (Aviva System 
Biology); and Pdgfa and Bmpr2 ELISA kits (LSBio) were utilized according to the 
manufacturer’s instruction. The tissue lysate was diluted with the sample dilution buffer 
at a ratio of 1:5. Results were calculated using computer software to generate a four-
parameter logistic (4-PL) curve fit.  
Statistics.  Statistical analysis was performed using data analysis software in 
Microsoft Excel worksheet (Windows 10).  Data is expressed as means ± SEM, and a p 
value <0.05 was considered statistically significant.  Single factor ANOVA tests were 
used to compare between HCR and LCR to determine statistical significance among the 
groups (two groups at a time) comparing three different ways: internal control data of 
HCR with the counterpart of LCR group, ischemic limb data of HCR with its counterpart 
of LCR, and finally the ratio of ischemic/non-ischemic limb of HCR with the LCR 
counterpart.  Similarly, relative gene expression levels were calculated by comparing q-
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RT PCR data (after normalizing them to the internal standard housekeeping gene, 
Actin-β) of non-ischemic limb of HCR with its counterpart of LCR and comparing 
ischemic limb and the ratio of ischemic to non-ischemic limb of HCR with LCR 
counterpart groups as explained above.  Linear regression was used to analyze the 
interrelationship between the mean muscle fiber cross-sectional area and capillary density 
in exercised post-ligation groups. Significant differences were accepted in all 
circumstances where p < 0.05. 
 
RESULTS 
The Differential Changes in Muscle-Capillary Relationship in the Calf 
Gastrocnemius Muscle 14 Days Following the Ligation Without EX between LCR 
and HCR:  
In the ratio of ischemic over non-ischemic limb: The ratio of capillaries to average 
muscle fiber area or CD did not significantly increase (p≥0.05) between the phenotypes 
(figure 2.1A).   The amount of capillary surface available for exchange per muscle fiber 
surface area, or capillary-to-fiber perimeter exchange (CFPE), is an accurate indicator of 
muscle capillary interference. CFPE was not significantly changed between the 
phenotypes (p≥0.05) (figure 2.1B).  The number of capillaries attached per fiber (NCAF) 
is another important parameter in muscle-capillary relationship and is affected by 
ischemia and exercise. NCAF was 26% higher in the HCR than in LCR group (p<0.05) 
(figure 2.1C).  The number of fibers sharing a single capillary, or the share factor (SF), 
was also significantly (p<0.05) altered in HCR compared to LCR, as it was 27% higher in 
HCR than LCR (figure 2.1D). The average area of muscle fiber (AA) is a very important 
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parameter in measuring muscle functionality and a good indicator of CD state in the 
skeletal myocyte. HCR muscle fiber average area was 110% higher as compared to LCR 
(p<0.05) after ischemia without exercise (figure 2.1E). The average perimeter of muscle 
fiber also followed the similar change of AA. Ligation without exercise affected the 
average perimeter of muscles, and it was not significantly (p>0.05) higher in HCR than 
LCR due to the increased muscle fiber average area at that point in time (figure 2.1F).  
 
 
     FIGURE 2.1.   The effect of intrinsic aerobic capacity phenotype on gastrocnemius 
muscle-capillary relationship following 14 days of left femoral artery ligation. Capillary 
density, CD (A), capillary-to-fiber perimeter exchange, CFPE (B), number of capillaries 
attached to fiber, NCAF (C), sharing factor, SF (D), and muscle fiber average area (E), 
muscle fiber average perimeter (F). Data is expressed by LCR and HCR left leg to right 
leg ratio, LCRL/r and HCRL/r, respectively, n=15. Single factor ANOVA test was used 
to analyze the data, * indicates p<0.05. The error bars represent standard error. 
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In the non-ischemic (right) limb, only the average area (AA) of muscle fiber was 
significantly higher (~30%) in the LCR right limb (LCRr) than HCRr, while the other 
muscle-capillary parameters were not statistically significant (figure 2.2A-F).   
 
 
  FIGURE 2.2.  The effect of intrinsic aerobic capacity phenotype on non-ischemic (right leg) 
gastrocnemius muscle-capillary relationship following 14 days of left femoral artery ligation. 
Capillary density, CD (A), capillary-to-fiber perimeter exchange, CFPE (B), number of capillaries 
attached to fiber, NCAF (C), sharing factor, SF (D), muscle fiber average area (E), and muscle fiber 
average perimeter (F). Data is expressed by LCR and HCR right leg, LCRr and HCRr, respectively, 





The Differential Changes in Muscle-Capillary Relationship in the Calf 
Gastrocnemius Muscle Between LCR and HCR Following Exercise Post-Ligation: 
In the ratio of ischemic over non-ischemic limb:  CD was approximately 0.8-fold higher 
in HCR as compared to LCR (p<0.05) after 14 days of treadmill exercise starting at day 3 
of the ligation (figure 2.3A).  It was approximately 0.4-fold higher in HCR as compared 
to LCR (p<0.05) at day 14 when the animals exercised post ligation (figure 2.3B). 
Exercise did not significantly affect (p≥0.05) NCAF between phenotypes (figure 2.3C).  
However, there was no significant difference (p≥0.05) in SF between the phenotypes 
after training (figure 2.3D). AA was significantly higher (~8 fold) in LCR than HCR 
when ligation was followed by exercise (figure 2.3E). The average perimeter was 
significantly (p<0.05) greater (16%) in LCR as compared to HCR after the training 
(figure 2.3F). 
In the non-ischemic (right) limb, The CD was significantly lower (33%) in the 
HCRr due to an approximately 37% larger average area (AA) as compared with LCRr. 
However, the other muscle-capillary parameters were not statistically significant (figure 
2.4A-F).  




FIGURE 2.3. The effect of active exercise following left femoral artery ligation, exercise began 
on day 3 until day 14, on gastrocnemius muscle-capillary relationship in high and low aerobic 
capacity phenotype rats (HCR and LCR ) respectively. Capillary density, CD (A), capillary-to-
fiber perimeter exchange, CFPE (B), number of capillaries attached to fiber, NCAF (C), sharing 
factor, SF (D), muscle fiber average area (E), and muscle fiber average perimeter (F). Data is 
expressed by LCR and HCR left leg (ischemic) over right leg (non-ischemic) ratio, LCRL/r and 
HCRL/r, respectively, n=15. Single factor ANOVA test was used to analyze the data, * indicates 





FIGURE 2.4.  The effect of active exercise following left femoral artery ligation, 
exercise began on day 3 until day 14, on gastrocnemius muscle-capillary relationship in 
the non-ischemic right leg of high aerobic capacity rat (HCRr) and low aerobic capacity 
rats (LCRr), n=15. Capillary density, CD (A), capillary-to-fiber perimeter exchange, 
CFPE (B), number of capillaries attached to fiber, NCAF (C), sharing factor, SF (D), 
muscle fiber average area (E), and muscle fiber average perimeter (F). Single factor 





FIGURE 2.5. A histological representation of Gastrocnemius muscle cross-section 
following left femoral artery ligation in trained and untrained groups, using 8 micron 
sectioning and the myosin ATPase staining “Rosenblatt staining”, showing cross section of 
the muscle fiber and capillaries. In all animals, the left leg (LCR-L and HCR-L) was 
ischemic, and the right leg (LCR-R and HCR-R).  Images A-D show the effects of occlusion 
without any exercise after ligation.  Images E-H show sections from the corresponding limb 
muscle with an exercise regimen after occlusion.   As noted elsewhere LCR = low intrinsic 
aerobic capacity rat; HCR = high intrinsic aerobic capacity rat.  Fiber cross-sectional average 
area and perimeter were measured using NIH imageJ software calibrated to transform the 
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FIGURE 2.6. The relationship between capillary densities (CD) and mean muscle fiber 
cross-sectional area of the gastrocnemius muscle in trained HCR rats. Linear regression test 
was used to analyze the data, n=10. 
 
 
The Differential Changes in Gene Expression in the Calf Gastrocnemius Muscle 
Following Exercise Post-Ligation in HCR vs. LCR:  
The patterns in expression of multiple genes are known to be essential for the understanding 
of the vascular adaptive response of the hind limb to arterial occlusion. These patterns were 
significantly different after exercise post-ligation in ischemic, nonischemic, and the ratio of 
ischemic to the non-ischemic hind limbs (I/N). 
Vegfa is a strong indicator of angiogenesis in response to physiological and 
pathological hypoxia. Its mRNA expressions were doubled in both non-ischemic and 
ischemic muscle of untrained LCR as compared to HCR, although the trend was only 
r=-0.8  




significant in the non-ischemic side (p=0.003 in the non-ischemic side and p=0.1 in ischemic 
side). However, there was no change in Vegfa expression in I/N ratio between the 
phenotypes (Table 2.A; 1, 14 and 27). The expression of Vegfa receptors, Kdr and Flt1, were 
not significantly changed (p>0.05) in untrained groups, although they were generally higher 
in LCR than HCR (Table 2.A; 2-3, 15-16, and 28-29). Vegfa levels were almost doubled on 
the ischemic side of LCR as compared to HCR (p=0.02 after exercise), and I/N ratio was also 
higher (32%) in LCR, but the trend was near significant (p=0.07). There was no change of 
Vegfa expression in non-ischemic sides of both phenotypes after exercise (Table 2.B; 1, 11, 
and 21). The expression of Kdr and Flt1 were not altered significantly between the 
phenotypes. Although, the Flt1 in I/N ratio was near to significantly higher (p=0.07) in HCR 
than LCR (Table 2.B; 2-3, 12-13, and 22-23).  
Hif1a is the sensitive mediator for hypoxia that mediates the activity of Vegf for 
angiogenesis. The mRNA expression in untrained and trained phenotypes was not 
significantly elevated at the 14th day after femoral artery ligation. However, mRNA 
expression was higher (p>0.05) in LCR than the HCR (Table 2.A; 4, 17, and 30; & Table 
2.B; 4, 14, and 24). The expression of other hypoxia-related transcription factors include 
Nfkb, Angpt1, and Angpt2. Although the gene expression of Nfkb and Angpt1 did not reach 
significant difference (p>0.05), they were higher in untrained LCR than HCR (Table 2.A; 6-
7, 19-20, and 32-33). Angpt2 in untrained groups was 4-fold higher in the non-ischemic side 
of LCR rats as compared to HCR (P=0.001) (Table 2.A; 8). The ischemic side of LCR 
(Table 2.A; 21) also had higher Angpt2 but the difference was not statistically significant 
(p=0.1). The I/N ratio of Angpt2 gene expression was not changed (p>0.05) (Table 2.A; 34).  
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Table 2.A. Gene Expression in Gastrocnemius Muscle of Non-Exercised HCR and LCR 
Rats Following Two Weeks of Abrupt Left Femoral Artery Ligation  
No. Genes LCR HCR 
Non-Ischemic Gastrocnemius Muscle (right leg (r)) 
1 Vegfa 0.38± 0.02* 0.20 ± 0.04 
2 Flt1 0.02 ± 0.003 0.03 ± 0.01 
3 Kdr 0.04 ± 0.004 0.03 ± 0.01 
4 Hif1a 0.02 ± 0.003 0.03 ± 0.01 
5 Il6 8.8x10-5 ± 1.5x10-5 8.6x10-5 ± 1.6x10-5 
6 Nfkb 0.02 ±  0.001 0.03 ± 0.002 
7 Angpt1 0.01 ± 0.001 0.009 ± 0.001 
8 Angpt2 0.01 ± 0.001* 0.002 ±   0.001 
9 Ccl2 0.003 ± 0.0005 0.004 ± 0.004 
10 Vcam 0.0033 ± 0.001   0.003 ± 0.001 
11 Icam 0.01 ± 0.001  0.005 ± 0.001 
12 Bmpr2 0.035 ± 0.003 0.03 ± 0.003 
13 Pdgfa 0.02 ± 0.001 0.023 ± 0.002 
Ischemic Gastrocnemius Muscle (Left leg (L)) 
14 Vegfa 0.383 ± 0.1 0.20 ± 0.1 
15 Flt1 0.03 ± 0.01 0.02 ± 0.01 
16 Kdr 0.043 ± 0.01 0.021 ± 0.01 
17 Hif1a 0.03 ± 0.01  0.02 ± 0.01 
18 Il6    0.0001 ± 3.7x10-5  9.9x10-5 ± 3x10-5 
19 Nfkb 0.02 ± 0.006 0.02 ± 0.003 
20 Angpt1 0.013 ± 0.005 0.004 ± 0.001 
21 Angpt2 0.01 ± 0.002 0.004 ± 0.001 
22 Ccl2 0.007 ± 0.004 0.009 ± 0.001 
23 Vcam 0.04 ± 0.001 0.004 ± 0.001 
24 Icam 0.01 ± 0.002 0.004 ± 0.001 
25 Bmpr2 0.04 ± 0.02 0.03 ± 0.003 
26 Pdgfa 0.22 ± 0.003 0.025 ± 0.003 
Ratio of Ischemic Over Non-Ischemic Muscle (L/r) 
27 Vegfa 1.03 ± 0.2 1.05 ± 0.3 
28 Flt1 1.13 ± 0.2 0.8 ± 0.3 
29 Kdr 1.2 ± 0.3 0.8 ± 0.2  
30 Hif1a 1.13 ± 0.2 0.8 ± 0.3 
31 Il6 1.5 ± 0.3 1.2 ± 0.2 
32 Nfkb 1.2 ± 0.5 0.8 ± 0.13 
33 Angpt1 1.9 ± 1.05 1.1 ± 0.2 
34 Angpt2 1.2 ± 0.43 1.4 ± 0.5 
35 Ccl2 2.45 ± 1.13 0.91 ± 0.11 
36 Vcam 1.45 ± 0.4 1.1 ± 0.2 
37 Icam 1.004 ± 0.3 0.84 ± 0.1 
38 Bmpr2 0.8 ± 0.1 0.9 ± 0.1 
39 Pdgfa 0.97 ± 0.2 1.03 ± 0.1 
*Significant differences between phenotypes at corresponding side.
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Table 2.B. Gene Expression in Gastrocnemius Muscle of Two Weeks Exercise 
Following Day 3 Post-Abrupt Left Femoral Artery Ligation in HCR and LCR Rats 
No. Genes LCR HCR 
Exercised-Non-Ischemic Gastrocnemius Muscle (right leg (r)) 
1 Vegfa 0.07± 0.01 0.073 ± 0.01 
2 Flt1 0.02 ± 0.001 0.02 ± 0.003 
3 Kdr 0.03 ± 0.002 0.022 ± 0.01 
4 Hif1a 0.005 ± 0.0004 0.006 ± 0.0005 
5 Nfkb 0.022 ±  0.002* 0.031 ± 0.002 
6 Angpt1 0.014 ± 0.001 0.02 ± 0.004 
7 Angpt2 0.01 ± 0.001* 0.004 ± 0.0004 
8 Ccl2 0.001 ± 9.1x10-5 0.003 ± 0.001* 
9 Bmpr2 0.18 ± 0.011* 0.24 ± 0.02 
10 Pdgfa 0.02 ± 0.002 0.03 ± 0.004* 
Exercised-Ischemic Gastrocnemius Muscle (Left leg (L)) 
11 Vegfa 0.09 ± 0.01* 0.05 ± 0.01 
12 Flt1 0.02 ± 0.003 0.015 ± 0.003 
13 Kdr 0.024 ± 0.01 0.02 ± 0.003 
14 Hif1a 0.006 ± 0.001  0.007 ± 0.001 
15 Nfkb 0.02 ± 0.002 0.028 ± 0.002 
16 Angpt1 0.023 ± 0.01 0.02 ± 0.002 
17 Angpt2 0.01 ± 0.0011* 0.005 ± 0.001 
18 Ccl2 0.001 ± 0.0002 0.003 ± 0.001* 
19 Bmpr2 0.221  ± 0.02 0.211 ± 0.010 
20 Pdgfa 0.022 ± 0.002 0.03 ± 0.001 
Ratio of Ex-Ischemic Over Ex-Non-Ischemic Muscle (L/r) 
21 Vegfa 1.09 ± 0.12 0.77  ± 0.1 
22 Flt1 0.6 ± 0.12 0.9 ± 0.1 
23 Kdr 0.92 ± 0.2 1.1 ± 0.2  
24 Hif1a 1.3 ± 0.2 1.14 ± 0.14 
25 Nfkb 1.24 ± 0.12 0.96 ± 0.11 
26 Angpt1 1.71 ± 0.55 1.4 ± 0.5 
27 Angpt2 1.42 ± 0.3 1.4 ± 0.2 
28 Ccl2 1.32 ± 0.3 1.24 ± 0.4 
29 Bmpr2 1.3 ± 0.12* 0.9 ± 0.08 
30 Pdgfa 1.3 ± 0.2 1.1 ± 0.2 
*Significant differences between phenotypes at corresponding side. 
 
After exercise post-ligation, Nfkb was only significantly higher (33%) in the non-
ischemic side of HCR as compared to LCR (p<0.05) (Table 2.B; 5, 15, and 25). Angpt2 
gene expression significantly was higher (25-30%) at the phenotypic baseline of LCR 
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than HCR, which does not make the I/N ratio statistically significant (Table 2.B; 7, 17, 
and 27). Angpt1 in trained animals followed the similar pattern as in untrained animals 
(Table 2.B; 6, 16, and 26). 
Other genes related to an inflammatory response such as Ccl2, Icam, Vcam, Il6, 
Bmpr2, and Pdgfa showed distinct patterns in the HCR compared to LCR. The phenotype 
did not show any significant increase (p>0.05) for Ccl2 (Table 2.A; 9, 22, and 35), Vcam 
(Table 2.A; 10, 23, and 36), Icam (Table 2.A; 11, 24, and 37), Il6 (Table 2.A; 5, 18, and 
31), Bmpr2 (Table 2.A; 12, 25, 38), and Pdgfa (Table 2.A; 13, 26, 39) under the influence 
of ischemia alone without exercise. However, the pattern of expression was different 
between the phenotypes under the influence of exercise post-ligation. Ccl2 gene 
expression was significantly greater (p<0.05) in non-ischemic and ischemic sides of HCR 
(60% and 55%, respectively) as compared to LCR (Table 2.B; 8 and 18), but no 
difference in I/N ratio (p>0.05) (Table 2.B; 28).  Similarly, in Pdgfa, the expression was 
approximately 48% and 24% higher in non-ischemic and ischemic sides of HCR rats, 
respectively, as compared to LCR rats (Table 2.B; 10 and 20), but no changes were 
observed in I/N ratio between the phenotypes (Table 2.B; 30). Bmpr2 gene expression 
between the phenotypes under the influence of exercise post-ligation was very 
interesting. The non-ischemic side of HCR had significantly (p=0.01) higher levels of 
Bmpr2 (26%) compared to the non-ischemic side of LCR (Table 2.B; 9). However, these 
levels were not significantly higher in LCR (p= 0.6) in ischemic limb (Table 2.B; 19). 
The final percentage change of I/N limbs was 28% higher in LCR than HCR (P=0.03) 
(Table 2.B; 29). Il6, Vcam, and Icam were not significantly altered (p>0.05) among the 




Table 2.C. List of the genes in Gastrocnemius muscle that didn’t show significant 
differences between the HCR and LCR rats following two weeks exercise beginning 
day 3 post-left femoral artery ligation. 
Genes LCR HCR 
Exercised-Non-Ischemic 
Gastrocnemius Muscle (right leg (r)) 
  
Il6 6.41x10-5 ± 4.6x10-6 0.0002 ± 5.5x10-5 
Vcam 0.001 ± 9.5x10-5   0.0011 ± 0.0003 
Icam 0.01 ± 0.001  0.005 ± 0.001 
Exercised-Ischemic Gastrocnemius 
Muscle 
(Left leg (L)) 
  
Il6 4.5x10-5 ± 1.25x10-5  6.1x10-5 ± 6.2x10-6 
Vcam 0.001 ± 0.0002 0.0007 ± 8.6x10-5 
Icam 0.006 ± 0.0005 0.005 ± 0.001 
Ratio of Ex-ischemic over Ex-non-
ischemic muscle (L/r) 
  
Il6 0.7 ± 0.2 0.5 ± 0.1 
Vcam 1.1 ± 0.234 0.81 ± 0.2 
Icam 0.93 ± 0.14 0.89 ± 0.1 
 
The Differential Changes in Protein Expression in the Calf Gastrocnemius Muscle 
Following Exercise Post-Ligation in HCR vs. LCR:  
 Since protein levels in a particular cell dictate its function, here we conducted 
experiments to measure the concentrations of cytokines that were significantly expressed 
at the genetic levels in the non-ischemic and ischemic gastrocnemius muscles of both 
untrained and EX post-ligation groups between the phenotypes.  
 Vegfa protein levels were almost doubled in both non-ischemic and ischemic legs 
of untrained LCR as compared to HCR (P=0.03) (Figure 2.7 A and B). After exercise, 
Vegfa levels were doubled in non-ischemic legs of LCR (Figure 2.7C), but did not differ 




FIGURE 2.7.   Protein expression in calf muscle 2 weeks after acute femoral arterial 
lygation in non-ischemic (LCRr/HCRr) LCR/HCR limbs and ischemic limbs 
(LCRL/HCRL) of LCR and HCR rats in untrained and EX-post ligation groups, n=10. 
ELISA was used to determine the protein expression level of mediators that showed 
already statistical difference in their genes expressions including Vegfa in untrained (A 
and B) and trained (C and D), Nfkb in untrained (E and F) and trained (G and H), MCP-1 
in untrained (I and J) and trained (K and L). Single factor ANOVA test was used to 
analyze the data, * indicates p<0.05. The error bars represent standard error.
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The protein levels of Nfkb and Ccl2 (MCP-1) were higher in non-ischemic limb 
of LCR as compared to HCR in untrained groups. The levels of Nfkb and Ccl2 in non-
ischemic untrained LCR (34% and 66%, respectively) were significantly higher in LCR 
as compared to HCR (Figure 2.7E and 2.7I). In the ischemic limbs, Nfkb levels were near 
significantly higher in LCR (25%) as compared to HCR (P=0.05) (Figure 2.7F), whereas 
there was no significant change in Ccl2 levels in ischemic limbs between the phenotypes 
(Figure 2.7J). In exercise post-ligation, only non-ischemic limbs showed significant 
difference between the phenotypes. Nfkb and Ccl2 were 40% and 50% higher, 
respectively, in LCR as compared to HCR (Figure 2.7G and 2.7K), while no significant 
changes occurred in ischemic limbs after the exercise training between the phenotypes 
(Figure 2.7H and 2.7L). 
The protein levels of Angiop2 did not significantly change between the untrained 
phenotypes. However, after exercise training they were significantly altered (P=0.0009), 
as non-ischemic limb of LCR was ~70% higher than HCR. In the ischemic limbs, 
Angiop2 was 50% higher and near significant in LCR than HCR.  
 BMPR2 protein levels in untrained and trained groups were higher in LCR than 
HCR. In non-ischemic limb of untrained LCR, BMPR2 was 90% higher and near 
significant in LCR as compared to HCR, while in ischemic limb of trained LCR the trend 
was ~90% higher in LCR as compared to HCR. However, in EX post-ligation groups 
Bmpr2 levels were 85% higher in non-ischemic limb of LCR as compared to HCR, but 
there is no significant difference between the phenotypes in the Bmpr2 levels after the 
exercise post-ligation.  Interestingly, Pdgfa protein levels were not significantly different 





The most common symptom of PAD is the painful cramping of muscle, which 
commonly occurs in the calf muscle during walking. This pain is a major interference in 
the quality of life (145, 150, 211, 225, 233) because it limits the ability to exercise and 
perform many activities of daily living, such as walking. Exercise therapy increase pain 
threshold, improve exercise capacity and avoid surgical revascularization and other 
invasive therapies (212, 150, 225). Most studies focused on the mechanisms of how 
exercise can produce its beneficial effects on vasculature and blood flow to the ischemic 
limb (47, 96, 136).  However, the inability of some asymptomatic PAD patients to 
exercise may be due to their intrinsic aerobic capacity phenotype background. Therefore, 
it is not surprising if those patients can not finish their exercise therapy after developing 
symptomatic disease. The underlying genetic susceptibility for aerobic endurance 
capacity might mechanistically affect the genes that are responsible for developing the 
intrinsic risk factors for PAD and cardiovascular diseases. This could include developing 
metabolic syndrome or other conditions that would affect the genes responsible for 
vascular adaptation after arterial occlusion. It suggests that exercise post-peripheral 
arterial occlusion might not always be beneficial due to different vascular adaptive 
responses at the cellular or molecular levels to exercise after acute arterial occlusion 
between responsive and unresponsive patients. 
The model of intrinsic aerobic endurance capacity helped to better understand the 
differential effect of exercise post-ligation. This model infers that genetic susceptibility is 
an effect of active exercise post-ligation on vascular remodeling in response to femoral 
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arterial ligation and helps to better understand the benefit from the exercise therapy for 
patients with PAD. This is especially relevant for those who require exercise therapy 
because of their medication intolerance, asymptomatic PAD, they would be at a high risk 
for complications during surgical interventions. This study also may provide more 
mechanistic insights for developing a novel molecular therapy for patients who cannot 
perform the active exercise therapy. The goal of this study was to determine the 
differential vascular adaptive responses between rats with low intrinsic running capacity 
and rats with high intrinsic running capacity. The results of this study showed that rats 
selectively bred for high endurance running capacity (HCR) and low endurance running 
capacity (LCR) have different responses to exercise post-ligation in a model of peripheral 
arterial obstructive disease. The results also provide a distinct corroboration that the low 
endurance running capacity phenotype has a higher risk for developing exercise post-
ligation injury due to an insufficient priming in the anatomical structure for adapting to 
ischemic stress. 
 
Differential Changes After Acute Ligation Without Exercise 
The muscle-capillary relationship after acute arterial ligation was distinctly 
different between the two phenotypes. HCR rats’ muscle-capillary relationship was not 
affected by acute arterial ligation. The number of capillaries attached per muscle fiber 
(NCAF) and share factor (SF) did not change from the non-ischemic side, whereas these 
parameters in LCR rats prominently decreased (Figure 2.1, C and D). The average muscle 
fiber cross-sectional area was higher in HCR, while it was decreased in LCR. The 
changes in mean muscle fiber area indicate the severity of ischemic muscle injury in LCR
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rather than HCR. Additionally, capillary density (CD) changes are negatively correlated 
with muscle fiber area. Therefore, CD was lower in HCR rats due to increase in their 
muscle fiber area, while CD increased in LCR rats due to the reduction in their muscle 
fiber area. These results indicate that HCR rats have an underlying intrinsic resistance 
mechanism against acute arterial ligation while the vascular response of LCR rats is less 
primed to adapt to arterial occlusion. One possible mechanism behind the different 
adaptations to ischemia is that HCR muscle fiber area is inherently and significantly 
lower than muscle fiber area in LCR rats (Figure 2.2E). This difference is very important 
in maintaining the muscle capillary relationship intact and in resisting a reduction in 
blood flow. Our linear regression data, which is consistent with other studies (191, 205), 
showed that mean muscle cross-sectional area is negatively, and significantly, correlated 
with the CD (Figure 2.6). It suggests that having a smaller muscle cross-sectional area, 
before the development of acute arterial occlusion, is protective against severe injury of 
ischemic muscle by decreasing diffusion surface area between capillary and muscle fiber. 
These results are consistent with our previous (unpublished data) and others who also 
found that cross-sectional area of HCR muscle fiber was 35% smaller as compared to 
LCR (88), and consistent with those who reported that lower muscle cross-sectional area 
in HCR rats contributes to higher intrinsic capillary density (87). In this study, only mean 
muscle cross-sectional area was significantly different in non-ischemic sides between the 
phenotypes. The capillary density was not significantly higher in HCR when compared to 
LCR, which was possibly due to low sample size (figure 2.2A). However, our previous 
study (unpublished data) and others (89) showed significantly higher CD in non-ischemic 
control HCR vs. LCR. The significant increase of mean 
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muscle cross-sectional area in HCR as compared to LCR after acute arterial ligation 
indicates the severity of the injury was less in HCR, and we infer that their physical 
activity was not affected. This is consistent with a human study which showed resistance 
training at low intensity leads to an increase in muscle size and strength when combined 
with blood flow restriction, and that without muscle training hypertrophic promoting 
factors, muscle cannot be hypertrophied (139). Although HCR rats in this case did not 
receive exercise training except for their spontaneous cage activity, their cage activity 
may resemble mild aerobic exercise in its effect.  In LCR rats, mean muscle fiber area 
significantly decreased after arterial ligation, with a related increase in CD. This suggests 
a different vascular adaptive response to ischemia by increasing both capillary surface 
area and muscle atrophy to compensate with low blood supply to the ischemic tissue, 
therefore, decreasing muscle necrosis.  
HCR rats at this time point did not show a significant increase in any angiogenic 
and inflammatory gene expression. This suggests that HCR rats resist the arterial ligation 
injury by possibly depending on native collateral circulation, which conducts few blood 
flow under normal circumstances, as the influence of share stress stimulus was below the 
threshold. However, LCR rats showed an increase in both Vegfa and Angiop2 mRNA, 
but only in Vegfa protein expression at this time point. Protein levels of Vegfa has been 
reported by Brandao et al. to be increased in muscle biopsy of patients with critical limb 
ischemia, and they suggested effective angiogenic drive (18). Increasing Nfkb, Ccl2, and 
Bmpr2 protein expressions in non-ischemic limbs of LCR as compared to HCR indicate 
an ongoing stress response to ischemia. The increase in the protein levels without an 
increase in their gene expressions might suggest a decreased rate of protein degradation 
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and/or an increase mRNAs degradation, which mediate these proteins, degradation (209). 
Nfkb was found to play a crucial role in Ccl2 expression in pancreatic beta cells (117). 
Ccl2 expression in cardiovascular system during hypoxia has also been reported. Rat 
Ccl2 was found to be expressed in chronic intermittent hypoxia in the carotid body (118). 
Increased protein levels in LCR could be due to their higher weight versus HCR. Only 
Bmpr2 protein expression was higher in both limbs after ischemia without exercise in 
LCR than HCR. Low protein expression of Bmpr2 has been reported to recruit 
macrophages in pulmonary hypertension (203) and has a role in endothelial injury (210). 
Here, the high level of Bmpr2 might suggest negative feedback inhibition of macrophage 
infiltration as indicated by high Ccl2 levels in LCR versus HCR. However, whether 
Bmpr2 is regulating Ccl2, or vice versa, is not clear. On the other hand, HCR rats seemed 
reacted differently from the LCR pathway, with more resistant phenotype. These results 
indicate that LCR rats respond to acute arterial ligation by initial muscle fiber atrophy, 
functional gene expression of Vegfa, and lately, by angiogenesis. Since the number of 
capillaries did not increase here, this confirms that active angiogenesis or vascular 
sprouting will take place later on to bring closer muscle-capillary relationship. Taken 
together, these results clearly show the presence of differential baseline phenotypic 
changes in muscle-capillary relationship that further regulate differential vascular 
adaptive response under the influence of arterial ligation.   
 
Differential Changes After Exercise Post-Ligation                    
HCR and LCR intrinsically differ in their muscle-capillary relationship which is 
regulated, to some extent, by genes controlling systemic and local metabolism. For 
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example, in a human study by Lillioja et al., CD in skeletal muscle has been found to 
negatively correlate with fasting plasma glucose and insulin concentrations (133). This 
report also found improvement in muscle-capillary relationship in HCR due to the effect 
of exercise post-ligation. HCR skeletal muscle is strong, genetically well primed, and 
resistant to exercise post-ligation stress. However, this relationship in LCR rats seems to 
be deteriorated. 
CD in the HCR rats was higher than the LCR rats due to a decrease in mean 
muscle cross-sectional area regulated by muscle atrophy, indicating less muscle necrosis 
and adequate blood flow. Other researchers also reported that CD is increased following 
acute arterial occlusion in a mouse model (246). On the other hand, CD in LCR was 25% 
lower than CD of the non-ischemic side. This decrease in CD was associated with around 
an 8-fold increase in their mean muscle cross-sectional area (Figure 2.3A), suggesting the 
presence of a large necrotic area and blood flow restriction. Another study also reported 
there is an association of occlusive exercise with muscle hypertrophy of the occlusive leg 
(139). Occlusive exercise is a type of resistance exercise training with moderate blood 
flow restriction in human using a thigh compressor elastic belt. The absence of muscle 
necrosis suggests that LCR muscle hypertrophy may be due to a compensation of live 
muscle fibers in replacement of necrotic cells in order to maintain body support during 
exercise. The non-ischemic side of LCR had significantly lower mean muscle cross-
sectional area than HCR. This is not consistent with the same human study (139), as they 
found that the cross-sectional area of trained arm muscles of an individual with occlusive 
exercise in the leg was increased due to strong systemic endocrine activation. However, 
the study is consistent with the development of non-ischemic muscle hypertrophy in HCR
                                                                                     57 
rats, suggesting an activation of systemic neuroendocrine mediators. The results are in 
line with our findings of increased gene expressions of androgen and androgen/estrogen 
ratio, in both ischemic and non-ischemic gastrocnemius muscles of HCR rats as compare 
to LCR (see chapter 4). These results suggest HCR and LCR have different underlying 
baseline phenotypic and ischemic responses to the same stimulus.  
Huge muscle hypertrophy in the ischemic side of LCR also had a negative impact 
on the other muscle-capillary parameters, such as CFPE and NCAF. CFPE was lower in 
LCR due to decrease in both CD and number of fibers, which in turn may be due to 
necrosis and increased mean muscle cross-sectional area. NCAF also decreased in LCR 
compared to HCR, and also compared to the non-ischemic side of LCR. CFPE was 
higher in HCR due to higher CD and better perfusion of atrophic muscle, despite lower 
Vegfa gene expression. However, protein levels in the ischemic HCR were higher than 
non-ischemic HCR, although there was no significant difference at the protein levels in 
ischemic limbs between the HCR and LCR phenotypes at that time point. This may 
suggest that collateral artery engagement is the initial vascular adaptive response or 
fasting angiogenic response. Taken together, these results show that HCR responds to 
exercise post-ligation by their intrinsic CD, muscle atrophy and collateral artery 
involvement, or faster angiogenic response. Therefore, it is expected to have accelerated 
muscle regeneration and normotrophy. In this study, since the model was not observed at 
additional extended time points, the data showed no increase in angiogenic gene 
expression, it is not known yet when angiogenesis was stimulated in this phenotype. In 
contrast, LCR may have responded to exercise post-ligation by early muscle necrosis 
with compensatory hypertrophy, increased expression of angiogenic factors, late capillary
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formation, and insufficient early collateral artery involvement, as explained by the 
inflammatory and angiogenic genes and proteins expressions studied in this phenotype 
(see below).  
The screening of angiogenic and inflammatory genes and proteins in the 
gastrocnemius muscle was done to obtain a complete picture of the differential molecular 
mechanisms and functions between the LCR and HCR phenotypes, as well as to support 
the histological results. Vegfa gene expression was higher in the ischemic limb of LCR 
while HCR showed lower Vegfa. Interestingly, the protein levels did not match gene 
expression. In ischemic limbs, the protein levels of Vegfa were similar between the 
phenotypes (P>0.05). Decreased levels of Vegfa gene expressions were consistent with 
another study on rats (215), which showed decreased Vegfa gene expression in ischemic 
muscle after acute arterial occlusion, but not in mice (246), which showed increased 
Vegfa expression. The difference between our study and their study is that our animals 
were exposed to exercise post-ligation. Similar results in exercised human with restricted 
leg has been recorded, showing increased gene expression and protein levels of Vegfa, 
which has been suggested to be due to short mRNA bursts induced by exercise bout (69). 
These data indicate that HCR requires both ischemia and exercise to induce functional 
Vegfa gene expression, while in LCR each of these stimuli separately is able to induce 
Vegfa protein expression effectively. The data also suggests that our exercise protocol 
was not the effective dose for HCR and therefor, a dose titration required for each 
phenotype is recommended in order to reach optimal effective dose of exercise response. 
However, Hif1a, Kdr, and Flt1 were not significantly changed in LCR, which is not in 
line with the findings of others who reported increased Hif1a with Vegfa expression to 
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stimulate angiogenesis (246). This is due to a difference in time points where Hif1a 
expression increased after in 6 hours, and then decreased 24 hours after of the occlusion 
(246). Therefore, it is possible that Hif1a, after inducing Vegfa gene expression, returned 
to normal levels at this time point in LCR.  However, this expression was not associated 
with capillary development or angiogenesis, which these rats depended on to resupply 
blood flow to their ischemic fibers, and was consistent with decreased CFPE, NCAF, and 
CD. In HCR, the pattern of Hif1a mRNA expression followed the low expression of 
Vegfa, which suggests either HCR did not depend on angiogenesis in increasing capillary 
parameters in non-ischemic conditions, or the angiogenesis took place prior to 2 weeks, 
as is seen by the increased protein expression in ischemic limb. Angiogenic genes such as 
Angpt1 and Angpt2 are known to play roles in angiogenesis, but only Angpt2 gene 
expression and protein levels were increased in both ischemic and nonischemic limbs of 
LCR. These findings suggest the underlying differential phenotypic responses to 
ischemia alone, or with exercise, between HCR and LCR.  
 As angiogenic gene expression did not support the idea of their playing a role in 
capillary formation in the HCR, we hypothesized that, in addition to possible 
angiogenesis occurrence, there might be early collateral artery involvement that senses 
the large pressure gradient between the collateral arteries in the thigh and the arteries in 
the ischemic hind limb after exercise-post ligation, activating inflammatory gene 
expression in gastrocnemius muscle as compared to LCR. It is well known that acute 
shear stress, both in vitro (246) and in vivo (8) elicits rapid endothelial cytoskeletal 
remodeling that activates transduction signaling, through the acute release of NO in the
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proximal non-ischemic region, of several transcription factors, such as AP-1, Nfkb, Egr-
1, SP1, and serum responsive elements. These transcription factors and responsive 
elements in turn regulate the transcription of genes such as Icam, Vcam, Ccl2, Pdgfa, 
Pdgfb, TGF-β, and Egr-1 (17). Egr-1and nitric oxide are known in the regulation of shear 
stress-mediated induction of Pdgfa (30), Ccl2 /MCP-1 (7), and Icam (163).Therefore, we 
investigated the genes, Nfkb, Pdgfa, Ccl2, Icam, and Vcam in non-ischemic, ischemic, 
and the ratio of ischemic/non-ischemic in trained and untrained phenotypes. We also 
looked at the Bmpr2 gene expression to understand its differential regulation after 
exercise post-ligation between the phenotypes.     
Nfkb is the upstream mediator to Ccl2/MCP-1 (17). The gene expression of Nfkb 
was higher in the non-ischemic limb of HCR when compared to LCR, However, the 
protein level of Nfkb was opposite to that which was observed in its gene expression, i.e. 
it was significantly higher in LCR than HCR. However, there was no difference in the 
gene expression and protein levels between the phenotypes in ischemic limb. This was 
possibly due to the upregulation of Nfkb in the early few hours after acute arterial 
ligation, followed by its subsequent return to baseline levels within 24 hours of the 
ligation (246). Additionally, increased Nfkb gene expression in HCR was associated with 
an increased trend of Il6, but did not reach statistical difference (p=0.1) when compared 
to LCR. This finding might also interpret the early muscle hypertrophy of non-ischemic 
side in the HCR due to the cross-transfer effect that was reported by Haruhiko et al. 
(139), since Nfkb is also an upstream mediator of Il6. Il6 is secreted locally by skeletal 
muscle during exercise-induce muscle hypertrophy (159). Expression of Il6 was observed 
to be greater in the ischemic side of HCR, but the result did not achieve statistical 
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significance (Table 2.C). Another study (215) that also used a rat model of acute arterial 
occlusion reported nonsignificant changes in Il6 as well.  
 
Although the Ccl2 gene expression in ischemic and non-ischemic limbs of HCR 
gastrocnemius muscle was higher in HCR than LCR. The protein level was significantly 
higher in the non-ischemic limb of LCR than HCR. However, the protein level increased 
in the ischemic limb of HCR while it decreased in LCR. There was no statistical 
difference at the protein level in the ischemic limb between the phenotypes. Ccl2/MCP-1 
in ischemic limb plays a role in monocyte and macrophage recruitment, which is 
expressed mainly by these cells to induce an inflammatory environment in the ischemic 
muscle. Macrophages play crucial roles in acute ischemic injury. They are phagocytic 
cells for necrotic debris and stimulate arteriogenesis (26, 77, 223, 224). Ccl2 is 
considered pro-arteriogenic because it increases collateral blood flow in acute arterial 
ligation (184) through the upregulation of monocyte adhesion molecules. This suggests 
that the possible reason of increased capillarization parameters in the HCR histology is 
due to increase blood flow in the collateral arteries and not due to angiogenesis. Although 
we did not measure blood flow in this study, we had measured it in the previous study, 
where it was shown that blood flow was decreased slightly in HCR after 1 hour and 7 
days of acute ligation without exercise, while greater reduction was found in the LCR 
(unpublished data). 
Low Ccl2 expression in LCR rats in this study also suggests that the LCR 
phenotype either has an insufficiency in activation of the collateral artery and small 
pressure gradients developed between the collateral arteries and arteries in ischemic limb 
                                                                                     62 
(51, 164, 220), or a low number of collateral arteries is not sufficient to adapt to ischemia.  
An increase in Ccl2 expression in the non-ischemic limb of HCR, but not LCR rats, may 
suggest that the non-ischemic limb was the dominant limb used by the HCR rats during 
daily spontaneous activity in the cage, which is consistent with the hypertrophy. It has 
been reported that an increase Ccl2 expression after exercise was suggested to be due to 
the influence of exercise intensity rather than the presence of exercise induced-muscle 
damage, but its role was not clear in exercise condition (67). In LCR, lower levels of 
Ccl2 with decreased mean muscle cross-sectional area in non-ischemic muscle as 
compared to HCR suggested that LCR rats were more sedentary between the exercise 
regimens than HCR. These results suggested differential inflammatory phenotypic 
background between HCR and LCR. 
Pdgfa and Icam are the inflammatory mediators that play positive roles in the 
shear stress response (17). Pdgfa gene expression was significantly higher in ischemic 
and non-ischemic limbs of HCR than LCR. Although the protein levels did not 
significantly differ between the phenotypes. Both phenotypes showed a slight increase in 
the Pdgfa protein level in ischemic limbs. Pdgfa plays an important role in tissue 
remodeling and cellular differentiation (84) either in the non-ischemic limb of HCR or 
ischemic limb of LCR where there was muscle hypertrophy, but still non-significantly 
lower than HCR (Table 2.B; 20).  These data were consistent with Yang et al. (246) who 
reported increased Pdgfa gene expression in ischemic gastrocnemius muscle after acute 
arterial occlusion. Pdgfa also has the ability to remodel the tissues by stimulating 
fibroblast proliferation and macrophage recruitment (178). Although there was no 
significant increase in the Icam and Vcam gene expressions between phenotypes, their 
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expression levels were higher in LCR. It has been reported that increased shear stress 
response in acute arterial ligation causes a decrease in Vcam (17). In chronic arterial 
occlusion, Vcam increased more than in acute ligation (246). Increased Vcam and Icam 
are associated with endothelial dysfunction. However, increased Icam was also associated 
with increase shear stress (17). 
Although higher gene expression of Bmpr2 was found in non-ischemic limb of 
HCR and in ischemic limb of LCR, but lower expression was found in ischemic limb of 
HCR and in non-ischemic limb of LCR (opposite response between the phenotype!), the 
protein level was higher in the LCR ischemic and non-ischemic limbs as compared to 
HCR. Low protein expression of Bmpr2 has been reported to recruit macrophage in 
pulmonary hypertension (174). Bmps, Bmpr ligands, have been shown to prevent 
mesenchymal stem cell infiltration in the myogenic lineage (62). Thus, these results 
suggest the role of Bmpr2 in preventing macrophage and mesenchymal stem cell 
infiltrations on the ischemic and non-ischemic limbs of LCR, and to a lesser extent in the 
ischemic limb of HCR. They also suggest an activation of non-ischemic muscle 
hyperplasia due to muscle hypertrophy during exercise, which is consistent with the 
lower CFPE and Ccl2 opposite to LCR. Lower protein levels of Bmpr2 after exercise was 
seen only in HCR non-ischemic-exercised limbs, but not in LCR rats, suggesting there is 
a phenotypic influence (LCR vs. HCR) on Bmpr2 protein expression after exercise 
training.   
These data suggest that the vascular system of HCR rats is primed to adapt to 
exercise post-ligation through previously existent and newly activated internal collaterals. 
This is through the increased effective expression of shear stress-related genes that is 
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seen in response to exercise post-ligation than in response to ligation without exercise as 
compared to LCR. In LCR, the vascular adaptive response to exercise post-ligation is 
directed mainly by angiogenesis and insufficient inflammatory protein expression. 
However, this can also make LCR ischemic muscle more prone to chronic ischemic 
stress, because delayed muscle-capillary remodeling, increase the incidence of 
developing atherosclerosis, and increase the susceptibility to develop recurrent arterial 
thrombosis because their endothelial cells are prone to increase expression of abnormal 
adhesion molecules such as Vcam and Icam. Clinically, this is relevant especially after 
revascularization of arterial occlusion when some patients develop recurring thrombosis.  
 
CONCLUSION                                                                                                                              
This study showed that mild exercise intensity after arterial occlusion in LCR rats 
produces chronic ischemia-like vascular adaptive response, with more hypoxia-induced 
angiogenesis than inflammogenic-induced vasculogenesis. This is possibly due to less 
toleration to the same temporal and spatial effect of two stimuli on their physiological 
and pathological responses coming from exercise post-ligation and acute arterial 
occlusion, respectively. Therefore, exercise post-ligation outcomes depend on the type of 
intrinsic aerobic phenotype an individual has, with favorable outcomes appearing in 
individuals with a high intrinsic aerobic capacity phenotype. Those with low intrinsic 
aerobic capacity phenotype might respond better to exercise pre-conditioning than 
exercise post-ligation to first allow their body to adapt to the physiological stimulus 





CHAPTER 3: INTRINSIC AEROBIC CAPACITY INFLUENCES THE 
VASCULAR ADAPTIVE RESPONSE TO EXERCISE PRECONDITIONING 
AGAINST LOWER LIMB ISCHEMIA 
 
Abstract: 
  Peripheral arterial disease (PAD) is a common disease affecting the elderly. It 
affects one in every 20 Americans who are over the age of 50. This causes an increase in 
the clinical and economic burdens on patients and the government, respectively. Exercise 
preconditioning has extensively been used to protect heart and skeletal muscle from 
ischemia reperfusion injury. However, there are heterogeneous responses as effects to 
exercise in animals and humans. The relationship between exercise preconditioning and 
its effect on peripheral arterial ligation in low and high intrinsic aerobic running capacity 
phenotypes (LCR and HCR, respectively) is novel, and will give a clear picture about the 
mechanistic effect of preventive exercise on PAD in both phenotypes. Our previous work 
with this model has shown that both untrained and exercised post-ligation LCR rats have 
impaired vascular adaptive response compared to HCR following peripheral arterial 
ligation. In this study, we examined the effect of exercise preconditioning on muscle-
capillary relationship as well as the levels of angiogenic/inflammogenic factors including 
Vegfa, Kdr, Flt-1, Angp 1, Angp 2, Hif-1a, Il-6, Pdgfa, Pdgfrb, Icam, and Vcam. These 
factors were examined 14 days following unilateral hind limb femoral artery occlusion 
using mild treadmill exercise training for two weeks or without exercise. Trained LCR 
rats showed closed relationship in the muscle-capillary interface.  The number of 
capillaries attached per fiber increased with decreasing average muscle fiber area in the 
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ischemic muscle and showed an increase in angiogenic gene expression. On the other 
hand, the muscle-capillary relationship in HCR rats was neither deteriorated nor 
improved in the ischemic muscle that was preconditioned for two weeks by treadmill 
exercise. However, the effect of exercise on the non-ischemic limb of HCR was more 
favorable than what was found in the ischemic limb. Interestingly, exercise pre-ligation 
did not decrease adhesion molecules in LCR as it did in HCR. Therefore, it appears that a 
mild exercise intensity can precondition hind limb occlusive disease in low intrinsic 
aerobic exercise capacity phenotype through remodeling the musculovascular adaptive 
response. These findings will help protect the elderly with a high risk of PAD from 
developing the disease.  
NEW & NOTEWORTHY: The protective effect of exercise preconditioning has been 
reported in several diseases, including peripheral arterial diseases. However, the PAD 
model that has been used in exercise preconditioning has only been studied in the context 
of ischemia reperfusion injury. This study reported for the first time the effect of exercise 
preconditioning on the prevention of peripheral arterial occlusive disease in a model of 
low intrinsic aerobic capacity rats, or LCR. This paper shows that exercise pre-ligation in 
LCR encourages musculovascular remodeling in response to ischemia.  




 Peripheral arterial disease (PAD) is a common but serious disease. The National 
Heart, Lung, & Blood Institute reported that one in every 20 Americans over the age of 
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50 has PAD. Those with PAD have an increased risk for developing myocardial 
infarction and stroke. PAD develops when the arterial vasculature is exposed over time to 
fatty deposits, causing plaque formations that narrow the lumen and limit blood flow to 
the legs. 
 Commonly, this disease is asymptomatic and can be discovered suddenly in the 
clinic by ankle-brachial index during screening for PAD in elderly people, or it is 
diagnosed when the patient complains of painful walking that either disappears during 
rest (intermittent claudication), or less commonly, progresses into severe pain that 
persists at rest (critical limb ischemia). When the disease gradually increases in its 
severity, it is diagnosed by ankle-brachial index and is treated by several plans, each of 
which depends on the disease severity, patient tolerance, and body response. PAD 
therapies include: exercise therapy, medical therapy, endovascular and surgical therapy, 
and as a last resort, amputation of the affected leg (136). 
 PAD is associated with increased morbidity and mortality due to comorbidities 
with conditions/diseases such as obesity, diabetes, and hypertension; all of which that are 
also expected to increase significantly with aging of the population (10, 83). 
Additionally, the current clinical interventions can increase the burden on PAD patients 
due to recurring hospitalizations and repeated re-vascular surgery. Moreover, this burden 
extends into the economic domain. It has been estimated that the US total annual costs of 
hospitalizations for PAD patients in 2004 was more than $21 billion (140), indicating that 





 Compared to other therapies, exercise therapy is considered cheap, safe, 
convenient, non-invasive, and more importantly, it improves the quality of life (243). 
Several mechanisms have been found to be impacted from exercise therapy in PAD such 
as angiogenesis, arteriogenesis, improved muscle metabolism, decreased oxidative stress, 
and increase pain threshold (212). Accumulating evidence indicates the protective effect 
of exercise preconditioning against diverse cardiovascular diseases by decreasing risk 
factors (216) and promoting muscular metabolic and morphological adaptations to 
several types of stress (28,31). It has been documented in a mouse model that exercise 
preconditioning caused resistance to acute myocardial infarction (216). However, since 
70% of aerobic exercise capacity is determined by genetic factors, this explains the 
possible heterogeneous response to active exercise and opens the question: What is the 
differential effect of exercise preconditioning on protecting peripheral arterial disease 
between low intrinsic aerobic capacity and high intrinsic aerobic capacity phenotypes? 
Since the role of exercise preconditioning against peripheral arterial ligation has not yet 
been studied, it is important to investigate how intrinsic aerobic phenotypes respond to 
active treadmill exercise preconditioning to promote muscle-capillary adaptive response, 
both morphologically and genetically, to ischemic and remodeling stressors. 
 A rat model of intrinsic aerobic exercise capacity has been generated by Koch and 
Britton at Michigan University. Through the use of artificial selection and based on the 
endurance treadmill running phenotype, they were able to generate low capacity running 
rats (LCR) and high capacity running rats (HCR). LCR rats are characterized as having 
multiple risk factors for cardiovascular diseases including hypertension, insulin 
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resistance, hyperlipidemia, high levels of fasting blood glucose, obesity, and a decreased 
exercise running capacity (239). This study could potentially aid the elderly by providing 
insight into the prevention of PAD, of which there is an increased risk of acquiring during 
aging, by using a rat model to study the intrinsic aerobic capacity backgrounds and 
whether or not exercise can act as a preconditioning modality against PAD in both 
phenotypes.      
 
MATERIALS AND METHODS 
Animal Strains and Experimental Groups. HCR and LCR, female rats, 40 weeks, 
n= 16 each, generation 32. Eight HCR and eight LCR rats were exercised pre-ligation for 
10 days, beginning at day -14 before the occlusion. The remaining 16 animals served as 
sedentary ischemic control. These animals were obtained from Drs. Lauren Koch and 
Steven Britton at the University of Michigan. They have previously described the 
artificial selection used for the generation of the HCR and LCR strains (111, 112, 10). 
Briefly, each sex was selected from the founder population (N:NIH stock). Two-way 
artificial selective breeding was used to create low capacity runner (LCR) and high 
capacity runner (HCR) strains that were divergent for treadmill running capacity (run 
time to exhaustion on a graded treadmill exercise test). The 13 lowest and 13 highest 
running capacity rats of each sex were randomly paired for mating. This pattern was 
repeated over subsequent generations, using a rotational breeding scheme, to produce the 
divergent strains. In the present study animals from generation 32 were used. All animals 
were exposed to treadmill exercise for 5 days at 11 weeks of age when the animals were 
phenotyped for treadmill running capacity. Upon verifying the phenotypes of the animals, 
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they were prepared for shipping at 14 weeks of age, or as soon after as weather 
conditions (airport tarmac temperatures < 85F) permitted. Once received by the 
Department of Comparative Medicine at ECU, the animals were maintained under 
mandatory quarantine for 10 weeks before they were released for study. Rats were 
provided standard rat chow and water ad libitum and were kept on a 12 h light/ 12 h dark 
time schedule until sacrifice. Animal procedures were conducted in accordance with the 
American Physiology Society guidelines for the humane and safe use of animals. 
Additionally, all protocols involving animals were approved by the East Carolina 
University Animal Care and Use Committee.
Exercise Training.  Motorized treadmill running exercise was used for exercise 
pre-ligation groups as a type of mild intensity supervised graded exercise training. 
Animals were subjected to 5 days on the treadmill at a very low speed (10 m/min) to 
condition them to the treadmill environment. Animals that were not running on the 
treadmill were removed and returned to their cages. Significant attention was devoted to 
minimizing exposure to the shock grid by using blasts of air or gentle prodding with a 
brush. Animals began exercising for 5 minutes, at a rate of 14-16 m/min, for 5 days a 
week for two weeks. The duration of exercise was gradually increased by 5 min per day, 
until the training sessions lasted 60 minutes at a time. Exercise pre-ligation protocol was 
generally 2 weeks in duration (10 events). The total number of sessions was: 5 
conditioning + 10 protocol = 15 events/animal (174).  
Hind Limb Femoral Artery Occlusion. Femoral artery occlusion was produced as 
outlined by others (136,135,184). Briefly, rats were anesthetized with ketamine xylazine 
(0.1ml/100g body weight IP). The fur was shaved from the inner thigh and the surgical 
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sight was cleaned with Betadine and 70% alcohol. Utilizing a small incision, the left 
femoral artery was isolated and three ligatures of 6-0 surgical silk were placed to cause 
an ischemic condition in the downstream tissue. One ligature was placed 5-6mm distal to 
the inguinal ligament, a second was placed on a collateral artery, and the third was placed 
5-6 mm distal to the first ligature. When all three ligatures were in place and the incision 
was closed, the animal was given a Buprenex injection (0.1ml/100g body weight IP) and 
placed in its cage to recover. Animals were allowed to arouse to consciousness on their 
own and have unlimited access to food and water. Finally, animals were sacrificed at day 
14 following placement of the ligature. This procedure produces a uniform occlusion of 
the femoral arteries that reduces blood flow reserve capacity to 10–20% of normal levels, 
while remaining sufficient to meet resting blood flow requirements (243, 244, 245).  
Skeletal Muscle Morphology: Rosenblatt Staining and Analysis. Gastrocnemius 
muscle for each animal was excised and quickly frozen by placing the tissue into an 
optimal cutting temperature (O.C.T.) compound. The muscle in the OCT was cut into 
transverse sections (thickness 8um) and underwent capillary staining as originally defined 
by Rosenblatt et al. (21, 60). Briefly, Rosenblatt staining allows for capillary visualization 
for subsequent photographs under 20X magnification. Capillaries were quantified 
manually from the image on individual fibers. The following six indexes were measured: 
1. SF; 2. Average perimeter (AP); 3. Fiber cross-sectional average area (AA); 4. CFPE; 5. 
NCAF; 6. CD. Fiber cross-sectional average area and perimeter measurements were 
calculated with the ImageJ-analysis system, which was calibrated to transform the 




RNA Isolation, Reverse Transcriptase-PCR, and Real-Time PCR. Total RNA was 
extracted from harvested gastrocnemius muscle using TRIzol reagents (Invitrogen), and 
cDNA was generated using the High-Capacity cDNA Reverse Transcription kit from 
Applied Biosystems (Thermofisher) following the manufacturer’s protocol. qReal-time 
PCR was performed using 5̀ fluorescent labeled primers for Vegfa, Angpt1, Angpt2, 
Hif1a, Icam, Vcam, Pdgfa, Kdr, Flt1, Nfkb, Ccl2, Il6, and Pdgfrb utilizing TaqMan Fast 
Advanced Master Mix (Life Technology) and following the manufacturer’s protocol. 
Actinb was used as the reference gene since CT values for this gene did not change with 
treatment. The qReal-Time PCR detection system used was the ABI Prism 7900 
sequence detection system (Applied Biosystems, Foster City, CA). LCR and HCR 
internal control right leg samples were used for the normalization of all data points with 
treated samples of other legs using the ratio of 2-∆ CT of treated sample / 2-∆ CT of 
controlled sample.
Statistics. Statistical analysis was performed using the data analysis software in 
the Microsoft Excel worksheet (Windows 10). Data is expressed as mean values ± SEM, 
and a p value < 0.05 was considered statistically significant. Single factor ANOVA tests 
were used to compare between LCR and HCR to determine statistical significance among 
the groups (two groups at a time). Data was compared three different ways: internal 
control data of LCR with the counterpart of HCR group, ischemic limb data of LCR with 
its counterpart of HCR, and finally the ratio of Lt ischemic/non-ischemic Rt limb (Lt/Rt) 
of LCR with the HCR counterpart. Similarly, relative gene expression levels were 
calculated by comparing q-RT PCR data, after normalizing them to the internal standard 
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housekeeping gene (Actinb), of non-ischemic Rt limb of LCR with its counterpart of 
HCR, and comparing ischemic Lt limb and the Lt/Rt ratio of LCR with HCR counterpart 




The Differential Changes in Muscle-Capillary Relationship in The Calf 
Gastrocnemius Muscle 14 Days Following The Ligation Between Untrained LCR 
and HCR: 
Ratio of Ischemic Over Non-Ischemic Limb: The ratio of capillaries to average muscle 
fiber area, or CD, did not significantly increase (p≥0.05) between the phenotypes (figure 
3.1A). The amount of capillary surface available for exchange per muscle fiber surface 
area, or capillary-to-fiber perimeter exchange (CFPE), is an accurate indicator of muscle 
capillary interference. CFPE was not significantly altered between the phenotypes 
(p≥0.05) (figure 3.1B).  The number of capillaries attached per fiber (NCAF) is also 
another important parameter in muscle-capillary relationship and is affected by ischemia 
and exercise. NCAF was 26% higher in HCR than in LCR group (p<0.05) (figure 3.1C).  
The number of fibers sharing a single capillary, or the share factor (SF), was also 
significantly (p<0.05) altered in HCR compared to LCR, as it was 27% higher in HCR 
(figure 3.1D).  The average area of muscle fiber (AA) is an important parameter in 
measuring muscle functionality and is a good indicator of CD state in the skeletal 
myocyte. HCR muscle fiber average area was 110% higher, after ischemia and without 
exercise, as compared to LCR (p < 0.05) (figure 3.1E). The average perimeter of muscle 
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fiber also followed the similar change in AA. Ligation without exercise affected the 
average perimeter of muscles, and it was not found to be significantly (p > 0.05) higher in 




FIGURE 3.1. The effect of intrinsic aerobic capacity phenotype on gastrocnemius 
muscle-capillary relationship following 14 days of left femoral artery ligation. Capillary 
density, CD (A), capillary-to-fiber perimeter exchange, CFPE (B), number of capillaries 
attached to fiber, NCAF (C), sharing factor, SF (D), muscle fiber average area (E), 
muscle fiber average perimeter (F) are shown. Data is expressed by LCR and HCR left 
leg to right leg ratio (LCRL/r and HCRL/r) respectively, n=15. Single factor ANOVA 
test was used to analyze the data, * indicates p<0.05. The error bars represent standard 
error. 
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In the non-ischemic (right) limb, only the average area (AA) of muscle fiber was found to 
be significantly higher, by approximately 30%, in the LCR right limb (LCRr) than HCRr. 
The other muscle-capillary parameters were not statistically significant (figure 3.2A-F).  
 
FIGURE 3.2. The effect of intrinsic aerobic capacity phenotype on non-ischemic (right 
leg) gastrocnemius muscle-capillary relationship following 14 days of left femoral artery 
ligation. Capillary density, CD (A), capillary-to-fiber perimeter exchange, CFPE (B), 
number of capillaries attached to fiber, NCAF (C), sharing factor, SF (D), muscle fiber 
average area (E), and muscle fiber average perimeter (F) are shown. Data is expressed by 
LCR and HCR right leg. LCRr and HCRr, respectively, n=15. Single factor ANOVA test 
was used to analyze the data, * indicates p<0.05. The error bars represent standard error. 
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The Differential Changes in Muscle-Capillary Relationship in the Calf 
Gastrocnemius Muscle Following Exercise Pre-Ligation Between LCR and HCR:
Ratio of Ischemic Over Non-Ischemic Limb: CD in the Lt/Rt ratio decreased 
slightly, but insignificantly, in both phenotypes to an almost comparable level after 14 
days of left femoral artery ligation, which was preceded by 2 weeks of treadmill exercise 
(figure 3.3A). CFPE was 24% higher in LCR than HCR at day 14 of the ligation when 
the animals exercised before ligation, but the increase was non-significant (p>0.05) 
(figure 3.3B). However, exercise caused a 14% increase (p<0.05) in NCAF in LCR while 
HCR did not show much change in the Lt leg (figure 3.3C). Although there was no 
significant difference (p>0.05) in SF between the phenotypes in training before ligation, 
LCR showed a 7% increase in SF than HCR while HCR did not show much change in the 
Lt Leg (figure 3.3D). AA was increased in both phenotypes, but LCR showed a 48% 
higher (~2 fold) level as compared with HCR when exercise was preceded by ligation 
(figure 3.3E). In the average perimeter, both phenotypes showed ~20% increase without 
statistical significance in the difference (p>0.05) (figure 3.3F).  
Non-Ischemic Limb:  In the non-ischemic (right) limb, the CD was 40% lower, 
but non-significant, in the HCRr due to a ~30% increased (p<0.05) average area (AA) as 
compared with LCRr. Additionally, NCAF and SF were 15% higher in HCRr as 
compared with LCRr (p<0.05) (Figure 3.4A and C-E). The other muscle-capillary 
parameters (CFPE and average perimeter) were not statistically significant (figure 3.4B 





FIGURE 3.3. The effect of exercise preconditioning on gastrocnemius muscle-capillary 
relationship in high and low aerobic capacity phenotype rats, HCR and LCR, 
respectively. Rats were exercised for two weeks, followed by left femoral artery ligation 
for another two weeks before sacrifice. Capillary density, CD (A), capillary-to-fiber 
perimeter exchange, CFPE (B), number of capillaries attached to fiber, NCAF (C), 
sharing factor, SF (D), muscle fiber average area (E), and muscle fiber average perimeter 
(F) are shown. Data is expressed by LCR and HCR left leg (ischemic) over right leg 
(non-ischemic) ratio, LCRL/r and HCRL/r, respectively, n=15. Single factor ANOVA 





FIGURE 3.4. The effect of exercise preconditioning on gastrocnemius muscle-capillary 
relationship (Rt non-ischemic limb) in high and low aerobic capacity phenotype rats, 
HCR and LCR, respectively. Rats were exercised for two weeks, followed by left femoral 
artery ligation for another two weeks before sacrifice. Capillary density, CD (A), 
capillary-to-fiber perimeter exchange, CFPE (B), number of capillaries attached to fiber, 
NCAF (C), sharing factor, SF (D), muscle fiber average area (E), and muscle fiber 
average perimeter (F) are shown. Data is expressed by LCR and HCR non-ischemic right 
leg, LCRr and HCRr, respectively, n=15. Single factor ANOVA test was used to analyze 





FIGURE 3.5.  A histological representation of Gastrocnemius muscle cross-section following 
left femoral artery ligation in trained and untrained groups, using 8 micron sectioning and the 
myosin ATPase staining “Rosenblatt staining”, showing cross section of the muscle fiber and 
capillaries. In all animals, the left leg (LCR-L and HCR-L) was ischemic, and the right leg (LCR-
R and HCR-R).  Images A-D show the effects of occlusion without any exercise before ligation.  
Images E-H show sections from the corresponding limb muscle with an exercise regimen before 
occlusion.   As noted elsewhere LCR = low intrinsic aerobic capacity rat; HCR = high intrinsic 
aerobic capacity rat.  Fiber cross-sectional average area and perimeter were measured using NIH 
imageJ software calibrated to transform the number of pixels (viewed on a computer monitor) 
into micrometers from an image of the myosin ATPase stain.
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The Differential Changes in Gene Expression in the Calf Gastrocnemius Muscle 
Following Ligation in Trained and Untrained HCR Rat vs. LCR Counterpart:
  The patterns of expression of multiple genes are known to be essential for the 
understanding of the vascular adaptive response of the hind limb to arterial occlusion. 
These patterns were significantly different when the ligation followed 2 weeks of 
treadmill exercise in ischemic (Lt), nonischemic (Rt), and the ratio of ischemic to the 
non-ischemic hind limbs (Lt/Rt). 
  Vegfa is a strong indicator of angiogenesis in response to physiological and 
pathological hypoxia. Its mRNA expression in the control limb (Rt leg) of untrained LCR 
as compared to HCR was significantly higher, by approximately 47%, than HCR (Table 
3.A; 1). Similarly, in the Lt ligated limb, Vegfa mRNA expression was found to be 
increased in the LCR, but the trend was not significant (p=0.1) (Table 3.A; 14). The ratio 
of Lt/Rt was increased slightly in the same level (3%) in these phenotypes (Table 3.A; 
27).   
      The expression of Vegfa receptors, Flt1 and Kdr, were not altered significantly 
(p>0.05) in Rt (Table 3.A; 2-3), Lt (Table 3.A; 15-16), or even Lt/Rt ratio (Table 3.A; 28-
29) between the phenotypes in untrained groups. However, the overall expressions were 
higher in LCR than HCR. Vegfa expression in the exercise pre-ligation group was 
distinct. The control limb (Rt leg) showed no significant difference (P>0.05) in Vegfa 
expression in gastrocnemius muscle between the phenotypes (Table 3.B; 1), while the Lt 
leg showed a significant 55% increase in Vegfa levels in LCR as compared with HCR 
(Table 3.B; 14). The ratio of Lt/Rt wassignificantly higher, by 48%, in LCR as compared 
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with HCR, but its trend showed a reduction in the Vegfa expression when compared with 
its Rt leg (Table 3.B; 27).  
       Flt-1 expression in the Rt leg was not significantly different between the trained 
phenotypes (Table 3.B; 2), but in the Lt leg of LCR it was 50% higher than HCR (Table 
3.B; 15). The Lt/Rt ratio was ~50% higher in LCR than HCR, but was not statistically 
significant (P=0.09) (Table 3.B; 28). The expression of Kdr followed Flt-1 expression 
with no significant difference in Rt leg between the trained phenotypes (Table 3.B; 3). 
However, the Lt leg showed an approximate 58% increase, bordering statistical 
significance (p=0.05), in LCR as compared with HCR (Table 3.B; 16). The Lt/Rt ratio 
was significantly higher by about 64% in LCR than HCR. (Table 3.B; 29).    
      Hif1a is the sensitive mediator for hypoxia that mediates the activity of Vegf for 
angiogenesis. However, its mRNA expression in untrained, either in the Rt (Table 3.A; 
4), Lt (Table 3.A; 17), or Lt/Rt ratio (Table 3.A; 30), and trained phenotypes, Rt (Table 
3.B; 4), Lt (Table 3.B; 17), or Lt/Rt ratio (Table 3.B; 30) were not significantly elevated 
at the 14th day after femoral artery ligation. Although, overall Hif1a mRNA expression 
was higher (p>0.05) in LCR than the HCR.   
     The expression of other hypoxia-related transcription factors includes Nfkb, 
Angpt1, and Angpt2. The gene expressions of Nfkb and Angpt1 were not significant 
(p>0.05) in either untrained Rt (Table 3.A; 6-7), Lt (Table 3.A; 19-20), and Lt/Rt ratio 
(Table 3.A; 32-33) or in trained Rt (Table 3.B; 5-6), Lt (Table 3.B; 18-19), and Lt/Rt 
ratio (Table 3.B; 31-32) between the phenotypes. However, they were generally higher in 
LCR than HCR. 
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  Angpt2 expression in the untrained LCR group at the phenotypic baseline was 
significantly higher, by approximately 70%, than HCR (Table 3.A; 8). In the Lt leg, 
Angpt2 expression was 54% higher, but not statistically significant, in LCR than HCR 
(Table 3.A; 21). The Lt/Rt ratio was lower in LCR than HCR (P>0.05) (Table 3.A; 34) 
because Angpt2 expression decreased in the ligated leg of LCR while it increased in 
HCR. In exercise pre-ligation, Angpt2 expression in Rt (Table 3.B; 7) and Lt leg (Table 
3.B; 20) were 50% and 54% higher, respectively, in LCR than HCR. However, the Lt/Rt 
ratio was increased in HCR to a level similar (~15%) to LCR (p>0.05) (Table 3.B; 33).  
   Other genes related to an inflammatory response such as Ccl2, Icam, Vcam, Il6, 
Pdgfrb, and Pdgfa showed distinct patterns in the LCR compared to HCR. Under the 
influence of ischemia alone without exercise, the phenotypes did not show any significant 
increase (p>0.05) for Ccl2 (Table 3.A; 9, 22, and 35), Vcam (Table 3.A; 10, 23, and 36), 
Icam (Table 3.A; 11, 24, and 37), Il6 (Table 3.A; 5, 18, and 31), Pdgfrb (Table 3.A; 12, 
25, 38), and Pdgfa (Table 3.A; 13, 26, 39). However, the patterns of expression were 
different between the phenotypes under the influence of exercise pre-ligation.   
   Vcam gene expression in the Rt leg was nearly comparable in these phenotypes 
(p>0.05) (Table 3.B; 11). However, in the Lt leg, the Vcam expression was significantly 
higher, by 63%, in LCR than HCR (Table 3.B; 24) with a Lt/Rt ratio reaching a 65% 
increase in LCR compared with HCR (Table 3.B; 37).  
   Icam gene expression was the same between the phenotypes in Rt leg (Table 3.B; 
12). In the Lt leg, the Icam gene expression in LCR was 35% higher than HCR, but not 
significant (P=0.1) (Table 3.B; 25). However, the level of significance increased when 
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the Lt/Rt ratio was calculated to show that the percentage change of Icam expression in 
LCR was about 35% higher (p<0.05) than HCR (Table 3.B; 38).  
   Pdgfa gene expression, after 2 weeks of treadmill exercise followed by 14 days of 
Lt femoral artery ligation, was higher in HCR than LCR in the Rt leg without reaching a 
significant difference (p>0.05) (Table 3.B; 10). However, in the Lt leg, the Pdgfa 
expression increased significantly, by 24%, as compared with LCR (Table 3.B; 23). The 
Lt/Rt ratio was also higher in HCR than LCR, but was not significant (p=0.2) (Table 3.B; 
36). Pdgfrb gene expression in the Rt limb showed a 40% significant increase in HCR 
than LCR (Table 3.B; 9).  
   Unlike Pdgfa, Pdgfrb expression in the Lt leg was not significantly (p>0.05) 
higher in LCR than HCR, with HCR showing a reduction in its Pdgfrb gene expression 
(Table 3.B; 22). When we took a look at how much the percentage change differed 
between the phenotypes, we found a 62% (P<0.05) increased change in the Lt leg/Rt leg 
of LCR as compared with HCR (Table 3.B; 35). Ccl2 gene expression did not change 
much between the phenotypes, either in Rt (Table 3.B; 8), Lt (Table 3.B; 21), or in the 
ratio of Lt/Rt (Table 3.B; 34).  
   Il6 gene expression was 52% higher in the Rt leg of HCR than LCR, but was not 
statistically significant (p=0.1) (Table 3.B; 13). Additionally, the Lt legs between the 
phenotypes showed almost similar level of Il6 expression (Table 3.B; 26) and the Lt/Rt 
ratio was non-significantly (P=0.2) ~43% higher in LCR than HCR (Table 3.B; 39).    
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Table 3.A. Gene Expression in Gastrocnemius Muscle of Non-Exercised HCR and 
LCR Rats Following Two Weeks of Abrupt Left Femoral Artery Ligation  
No. Genes LCR HCR 
Non-Ischemic Gastrocnemius Muscle (right leg (r)) 
1 Vegfa 0.38± 0.02* 0.20 ± 0.04 
2 Flt1 0.02 ± 0.003 0.03 ± 0.01 
3 Kdr 0.04 ± 0.004 0.03 ± 0.01 
4 Hif1a 0.02 ± 0.003 0.03 ± 0.01 
5 Il6 8.8x10-5 ± 1.5x10-5 8.6x10-5 ±1.6x10-5 
6 Nfkb 0.02 ±  0.001 0.03 ± 0.002 
7 Angpt1 0.01 ± 0.001 0.009 ± 0.001 
8 Angpt2 0.01 ± 0.001* 0.002 ±   0.001 
9 Ccl2 0.003 ± 0.0005 0.004 ± 0.004 
10 Vcam 0.0033 ± 0.001   0.003 ± 0.001 
11 Icam 0.01 ± 0.001  0.005 ± 0.001 
12 Pdgfrb 0.038 ± 0.003 0.043 ± 0.004 
13 Pdgfa 0.02 ± 0.001 0.023 ± 0.002 
Ischemic Gastrocnemius Muscle (Left leg (L)) 
14 Vegfa 0.383 ± 0.1 0.20 ± 0.1 
15 Flt1 0.03 ± 0.01 0.02 ± 0.01 
16 Kdr 0.043 ± 0.01 0.021 ± 0.01 
17 Hif1a 0.03 ± 0.01  0.02 ± 0.01 
18 Il6    0.0001 ± 3.7x10-5  9.9x10-5 ± 3x10-5 
19 Nfkb 0.02 ± 0.006 0.02 ± 0.003 
20 Angpt1 0.013 ± 0.005 0.004 ± 0.001 
21 Angpt2 0.01 ± 0.002 0.004 ± 0.001 
22 Ccl2 0.007 ± 0.004 0.009 ± 0.001 
23 Vcam 0.05 ± 0.001 0.004 ± 0.001 
24 Icam 0.02 ± 0.002 0.004 ± 0.001 
25 Pdgfrb 0.032± 0.011 0.036 ± 0.006 
26 Pdgfa 0.23 ± 0.003 0.025 ± 0.003 
Ratio of Ischemic Over Non-Ischemic Muscle (L/r) 
27 Vegfa 1.03 ± 0.2 1.05 ± 0.3 
28 Flt1 1.13 ± 0.2 0.8 ± 0.3 
29 Kdr 1.2 ± 0.3 0.8 ± 0.2  
30 Hif1a 1.13 ± 0.2 0.8 ± 0.3 
31 Il6 1.5 ± 0.3 1.2 ± 0.2 
32 Nfkb 1.2 ± 0.5 0.8 ± 0.13 
33 Angpt1 1.9 ± 1.05 1.1 ± 0.2 
34 Angpt2 1.2 ± 0.43 1.4 ± 0.5 
35 Ccl2 2.45 ± 1.13 0.91 ± 0.11 
36 Vcam 1.45 ± 0.4 1.1 ± 0.2 
37 Icam 1.004 ± 0.3 0.84 ± 0.1 
38 Pdgfrb 0.764 ± 0.233 0.774 ± 0.078 
39 Pdgfa 0.97 ± 0.2 1.03 ± 0.1 
*Significant differences between phenotypes at corresponding side.
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Table 3.B Gene Expression in Gastrocnemius Muscle Following Exercise 
preconditioning For Left Femoral Artery Ligation in HCR and LCR Rats.  
No. Genes LCR HCR 
Exercised-Non-Ischemic Gastrocnemius Muscle (Right Leg (r)) 
1 Vegfa 0.29± 0.032 0.25 ± 0.035 
2 Flt1 0.037 ± 0.008 0.034 ± 0.008 
3 Kdr 0.038 ± 0.004 0.0503 ± 0.009 
4 Hif1a 0.021 ± 0.002 0.023 ± 0.004 
5 Nfkb 0.023 ±  0.001 0.028 ± 0.003 
6 Angpt1 0.014 ± 0.002 0.013 ± 0.002 
7 Angpt2 0.008 ± 0.001* 0.004 ± 0.0005 
8 Ccl2 0.004 ± 0.001 0.004 ± 0.002 
9 Pdgfrb 0.038 ± 0.007 0.063 ± 0.007* 
10 Pdgfa 0.019 ± 0.001 0.021 ± 0.002 
11 Vcam 0.0001± 2.4x10-5   0.003 ± 0.001 
12 Icam 0.003 ± 0.0003 0.002 ± 0.0004 
13 Il6 0.0001± 2.4x10-5 0.0002 ± 6.6x10-5 
Exercised-Ischemic Gastrocnemius Muscle (Left Leg (L)) 
14 Vegfa 0.328 ± 0.046* 0.148 ± 0.024 
15 Flt1 0.033 ± 0.006* 0.017 ± 0.003 
16 Kdr 0.052 ± 0.013 0.023 ± 0.003 
17 Hif1a 0.037 ± 0.008  0.0199 ± 0.004 
18 Nfkb 0.026 ± 0.003 0.024 ± 0.001 
19 Angpt1 0.017 ± 0.002 0.012 ± 0.002 
20 Angpt2 0.009 ± 0.002 0.004 ± 0.001 
21 Ccl2 0.002 ± 0.0004 0.001 ± 0.0004 
22 Pdgfrb     0.051 ± 0.007 0.04 ± 0.009 
23 Pdgfa     0.018 ± 0.001 0.024 ± 0.002 
24 Vcam      0.006 ± 0.001* 0.002 ± 0.0004 
25 Icam      0.003 ± 0.001 0.002 ± 0.0004 
26 Il6  0.0001 ± 4.5x10-5 0.0001 ± 4.7x10-5 
Ratio of Ex-Ischemic Over Ex-Non-Ischemic Muscle (L/r) 
27 Vegfa 1.149 ± 0.106* 0.594  ± 0.048 
28 Flt1 1.319 ± 0.332 0.6481 ± 0.14 
29 Kdr 1.396 ± 0.338* 0.507 ± 0.082  
30 Hif1a 1.767 ± 0.367 1.001 ± 0.224 
31 Nfkb 1.143 ± 0.106 0.888 ± 0.077 
32 Angpt1 1.42 ± 0.279 1.01 ± 0.303 
33 Angpt2 1.185 ± 0.222 1.174 ± 0.231 
34 Ccl2 0.459 ± 0.37 0.478 ± 0.074 
35 Pdgfrb 1.711 ± 0.31* 0.644 ± 0.095 
36 Pdgfa 1.03 ± 0.104 1.237 ± 0.111 
37 Vcam 1.923 ± 0.411* 0.657 ± 0.119 
38 Icam 1.398 ± 0.196* 0.917 ± 0.09 
39 Il6 1.484 ± 0.398 0.848 ± 0.335 
*Significant differences between phenotypes at corresponding side.
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DISCUSSION 
Peripheral arterial disease (PAD) is an ischemic injury of the lower limbs 
which commonly causes intermittent claudication. It affects patient mobility and quality 
of life, leading to a sedentary status. This advances the deterioration of the patient’s 
condition both locally, by developing critical limb ischemia and increasing the likelihood 
of amputation, and systemically, by increasing the risk of developing coronary artery and 
cerebrovascular atherosclerosis. Preventing PAD by a simple, safe, and cheap modality 
such as exercise will prolong a good quality of life by promoting systemic and local 
skeletal muscle health. It is well established that increased levels of physical activity, 
exercise, and fitness decrease cardiovascular mortality (21-22) by modifying the 
expression of genes that are linked to vascular health, function, and structure (167). Some 
of the health benefits and adaptations of aerobic exercise on skeletal muscle morphology 
and exercise performance include increased capillarization, increased mitochondrial 
density (proteins, oxidation, and function), increased aerobic and anaerobic capacities, 
and improved neural adaptations (48). The model of intrinsic aerobic capacity will help to 
better understand which phenotype will better adapt to lower limb ischemia following 2 
weeks of gradually increased mild intensity treadmill exercise. This model infers there is 
genetic susceptibility to the effect of active exercise pre-ligation on vascular remodeling 
in response to femoral arterial ligation. This model also helps to understand the benefit of 
the exercise in preventing PAD in the elderly who have higher risk to develop PAD and 
may not be willing to perform exercise therapy after developing PAD due to the severity 
of the condition and the presence of comorbidities. 
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The goal of this study was to determine how the vascular adaptive response 
between rats bred for low intrinsic aerobic capacity and high intrinsic aerobic capacity 
are different through the use of arterial ligation following 2 weeks of mild intensity 
graded treadmill exercise. The results of this study showed that rats with low endurance 
running capacity phenotype (LCR) have a better vascular adaptive response to ligation 
following mild intensity treadmill exercise in a model of peripheral arterial obstructive 
disease. The results also provide a distinct corroboration that the high endurance running 
capacity phenotype has an unchanged vascular adaptive response to ligation following 
the type and intensity of this exercise. This can be explained due to the low exercise 
threshold received by the rats, as their system is usually stimulated and adapted to higher 
intensity exercise than what they received in this study. 
  
Differential Changes After Two Weeks of Ligation Without Exercise 
  The muscle-capillary interaction following permanent arterial ligation was 
obviously distinct between the phenotypes. LCR rats’ muscle-capillary interaction 
was altered by the arterial ligation. The number of capillaries attached per muscle 
fiber (NCAF) and share factor (SF) prominently decreased in the LCR phenotype, 
whereas in HCR rats these parameters were unchanged from the non-ischemic leg by 
acute arterial ligation (figure 3.1C and D). The mean muscle fiber cross-sectional area 
was quite low in LCR but was increased in HCR. The changes in mean muscle fiber 
area indicate the severity of ischemic muscle injury in LCR than HCR. The capillary 
density changes were negatively correlated to muscle fiber area. Therefore, CD was 
increased in LCR rats due to the reduction in their muscle fiber area while CD was 
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lower in HCR rats the increase in their muscle fiber area. These results indicate that 
the vascular response of LCR rats is less primed to adapt to the arterial occlusion, 
while HCR rats have an underlying intrinsic resistant mechanism against the arterial 
ligation. One possible mechanism behind the differential adaptation to ischemia is that 
HCR mean muscle fiber area is genetically and significantly lower than LCR rats 
(figure 3.2E). This inherent difference is crucial both in maintaining the close muscle-
capillary relationship and in resisting the obstruction in blood flow. Our linear 
regression data, which is consistent with others (191, 205), shows that mean muscle 
cross-sectional area was negatively, and significantly, correlated with CD (figure 2.6). 
It suggests that having a smaller muscle cross-sectional area, prior to the development 
of acute arterial occlusion, might protect against mild injury of ischemic muscle 
through reducing diffusion distance or surface area between capillary and myofiber. 
These results are reliable with our previous data (unpublished) and others who also 
found that the cross-sectional area of HCR muscle fiber was 35% smaller than LCR 
(88), and corresponds with those who found that lower muscle cross-sectional area in 
HCR rats was due to higher intrinsic capillary density (87). In this study, only mean 
muscle cross-sectional area was significantly different in the non-ischemic leg 
between the phenotypes. The capillary density was higher, but did not reach statistical 
difference in HCR as compared with LCR, which is possibly due to the low sample 
size (figure 3.2A). However, our previous study (unpublished data) and others (89) 
found a significant greater CD in the control leg of HCR than LCR. The significant 
decrease in mean muscle cross-sectional area in LCR as compared to HCR after acute 
arterial ligation indicates that the injury was more severe in LCR, and leads us to infer 
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that their physical activity was significantly affected. This is reliable with a human 
study that found resistance training at a low intensity leads to an increase in muscle 
size and strength when combined with blood flow restriction, and that without muscle 
training hypertrophic promoting factors, muscle cannot be hypertrophied (139). 
Although, HCR rats in this trial did not receive exercise training except for their 
spontaneous cage activity, which may resemble mild aerobic exercise in its effect. In 
LCR rats, mean muscle fiber area significantly decreased after arterial ligation with a 
related increase in CD. This suggests there is a different vascular adaptive response to 
ischemia by increasing capillary surface area with an increase in muscle atrophy. The 
possible mechanism is as follows: through decreasing the physical activity of the 
ischemic limb and shifting dependence on the other limb, a state of intermittent 
claudication is presented to compensate for the low blood supply to the ischemic 
tissue, therefore controlling muscle necrosis.  
  LCR rats at this time point did not show a significant increase in any angiogenic or 
inflammatory genes expression except for an increase in Vegfa mRNA expression. This 
indicates that LCR rats respond to two weeks of arterial ligation through initial muscle 
fiber atrophy and expression of Vegfa. Additionally, another possible late response to 
arterial ligation is initiation of angiogenesis, since the number of capillaries did not 
increase in this period of time, confirming that either vascular sprouting will take place 
later on to present a closer muscle-capillary relationship or the process might be 
attenuated intrinsically. 
  However, HCR rats did not show a significant change in any angiogenic or 
inflammatory gene expression. This suggests that HCR rats resisted the arterial ligation 
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injury by possibly depending on intrinsic collateral circulation that already conducted 
blood flow under normal circumstances without exercise, and that the influence of the 
share stress stimulus was below the threshold or needed a stronger stimulus to propagate 
its response. The overall observation from these results clearly showed there are 
differential baseline changes in the muscle-capillary relationship that are responsible for 
the differential musculovascular adaptive responses between the phenotypes, at least 
under the influence of arterial ligation.   
 
Differential Changes in Exercise Pre-Ligation           
  LCR and HCR intrinsically differ in their muscle-capillary interference, which is 
regulated by an intrinsic aerobic capacity phenotype that reversibly interacts with 
systemic and local metabolism. For example, skeletal muscle mass, CD, and fiber 
composition have been found to play roles in the pathogenesis of insulin resistance (97). 
Our study is a unique, in that we found the skeletal muscle-capillary relationship was 
strengthened by exercise pre-ligation in LCR rats. If LCR skeletal muscle is not 
inherently strong to face unilateral arterial ligation, exercise pre-ligation modality 
significantly improved it genetically and morphologically while this relationship in HCR 
rats remained steady. 
  Muscle-capillary relationship in the LCR Rt leg of exercise pre-ligation showed a 
deterioration in some parameters. Mean cross-sectional area, number of capillaries 
attached per fiber (NCAF), and share factor (SF) were deteriorated in LCR Rt leg as 
compared with HCR Rt leg. The possible reason why these parameters were negatively 
affected in exercise pre-ligation is likely due to its low intrinsic aerobic capacity 
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phenotype. When the muscle that intrinsically has low aerobic capacity begins to exercise 
for two weeks, this leads to physiological changes in the muscle, such as increased 
myofiber size or hypertrophy and increased capillary number as an adaptive response. 
   However, when that bout of exercise is followed by two weeks of a sedentary 
state, the hind limb muscle will atrophy at a rate more rapid than the process of 
hypertrophy, and capillaries will be degenerated (Guyton physiology). This might suggest 
that when a muscle remains unused for two weeks after bouts of exercise, the muscle will 
no longer be able to preserve the physiological adaptation. In other words, the effect of 
long-term exercise on the muscle-capillary interface is less than fourteen days. Lennon et 
al. reported that exercise-induced cardio-protection against myocardial stunning persisted 
for 9 days, but was absent 18 days after the cessation of exercise training (125). These 
parameter changes (decreased mean cross-sectional area, number of capillaries attached 
per fiber (NCAF), share factor (SF), and CFPE) were similar to what have been seen in 
the ischemic limb after ligation without exercise in the same LCR phenotype.  
  Although the causes are different, the results are the same. That is until we 
combined the two factors together (i.e. exercising the animals for two weeks and 
followed by ligation for another two weeks) and found a favorable effect on these 
parameters in the left leg: increased mean cross-sectional area, number of capillaries 
attached per fiber (NCAF), share factor (SF), and CFPE). This data is similar to the study 
that showed when exercise was followed by intermittent occlusion of the lower limb, 
muscle function and structure improved; with a difference between this study and ours in 
that we used a permanent occlusion instead of intermittent (172). This suggests that not 
only intermittent occlusion can be preconditioned against muscle damage through the use 
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of exercise, but that permanent occlusion can also strengthen the muscle structure if 
preceded by tread mill exercise in low intrinsic aerobic runner capacity phenotype.  
  In HCR Rt leg, exercise pre-ligation caused increases in the mean muscle cross-
sectional area, NCAF, and SF with a slight increase in CFPE. It is not surprising that CD 
decreased, as it is negatively correlated with mean muscle cross-sectional area (191, 205). 
These same parameters were oppositely higher in HCR Rt leg than LCR Rt leg, 
suggesting that the high aerobic capacity phenotype is well-primed to adapt to exercise as 
compared with LCR phenotype. However, when we exercised HCR rats for two weeks 
before the unilateral ligation of the Lt femoral artery, we found no effect on the muscle-
capillary interaction, as the Lt (ischemic) over the Rt (non-ischemic) ratio of almost all 
parameters have a ratio ~ 1. These results infer that exercise pre-ligation in HCR 
phenotype is not as significant as in the LCR phenotype; the possibility of this being due 
to the effect of mild ischemia is negligible in front of primed intrinsic collaterals that 
already preconditioned the muscle against ischemia or the sedentary effect during the 
period of ischemia. Our previous study showed that when HCR rats started treadmill 
exercise three days post Lt femoral artery ligation, the parameters were favorably 
increased, creating a close muscle-capillary relationship. However, these same 
parameters were deteriorated in LCR.    
  Angiogenic gene expression supports the relationship between muscle and its 
capillarity and can be observed histologically in the LCR. In the LCR Rt leg, Vegfa 
expression decreased by 25% as a result of exercise (was 0.38 in the non-ligated non-
exercised limb and became 0.29 in exercised non-ligated limb). This change is consistent 
with the low mean muscle cross-sectional area and low NCAF previously shown. LCR 
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still had higher Vegfa expression than HCR in the Rt limb, although it slightly decreased 
in HCR Rt leg from the baseline control leg. The Lt leg of LCR had increased expression 
of Vegfa under the effect of exercise and ligation, while HCR Lt leg showed further 
reduction of Vegfa expression. Although the difference between HCR and LCR was not 
significant, the trend was near significant (p=0.1). The ratio of Lt/Rt was 50% higher in 
LCR than HCR. These results suggest that exercise pre-ligation has an influence on 
Vegfa expression; more so than the effect of ligation alone in these phenotypes. They 
also suggest that exercise pre-ligation acts as a synergistic single factor for increasing 
Vegfa expression in LCR rats only.  
  The Flt1 and Kdr expressions were 50% higher in the LCR Lt leg than HCR, which 
is consistent with the vegfa expression in each phenotype. This data shows that Vegfa 
and its receptors are phenotypically expressed during exercise preconditioning and 
ischemia, with higher levels present in LCR than HCR. This is consistent with 
histological data which indicates ongoing angiogenesis more in LCR than HCR.  
  Similar to Vegfa expression, Angpt2 levels were higher in LCR Rt leg than HCR 
under the influence of exercise preconditioning. A further increase was observed with a 
comparable percentage change in both phenotypes in Lt/Rt ratio under the influence of 
both exercise preconditioning and ischemia. Unlike Angpt2, Angpt1and Hif1a were only 
elevated in LCR Lt leg under the influence of exercise pre-ligation and there was no 
effect of exercise pre-ligation on Angpt1 and Hif1a in HCR. Additionally, there was no 
phenotypic differential response in its expression under exercise preconditioning alone. 
Presence of phenotypic differential responses in Angpt2 expression (higher in LCR than 
HCR), either under the influence of exercise preconditioning alone or under the influence 
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of exercise pre-ligation with a comparable percentage change between the phenotypes, 
suggests there is a different mechanism regulating baseline Angpt2 levels and therefore, 
different angiogenic mechanisms between HCR and LCR.  
  Nfkb was oppositely expressed between the phenotypes. Expression of Nfkb, 
under the influence of exercise preconditioning, was higher in HCR Rt leg than LCR, 
while after exercise pre-ligation (Lt leg), Nfkb expression was increased in the LCR 
phenotype and decreased in the HCR phenotype. However, this was not a significant 
change between the phenotypes, suggesting there is no phenotypic difference in Nfkb 
expression under the effect of exercise pre-ligation. The increase in Nfkb expression 
in each phenotype was not associated with muscle atrophy since the results from 
histology showed an increase in the mean muscle fiber area, indicating that the role of 
Nfkb in this model is toward regulating inflammatory, cell survival, and proliferation 
responses (158). Ccl2/Mcp1 is the downstream target of Nfkb signaling (43) and its 
expression mirrored that of Nfkb expression, in that there was an increased expression 
in the hypertrophic muscle of Rt HCR due to exercise and Lt LCR due to exercise 
pre-ligation.  
  This data is complementary with the possible role of Nfkb in skeletal muscle 
under physiological stress alone, or both physiological and pathological stress 
combined. Il-6 is also affected down-stream of Nfkb signaling. The level of Il-6 
expression was increased in both HCR Rt leg, where there was an increase in mean 
muscle fiber area due to exercise, and in LCR Lt limb, due to the combination of 
exercise pre-ligation; although its level was lower than its HCR counterpart. 
Expression of Nfkb also lead to the expression of adhesion molecules. Our data 
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showed an increase in Vcam and Icam expressions in the Lt leg of LCR as compared 
with HCR under the influence of exercise pre-ligation. There was no differential 
response in these genes under the influence of exercise between the phenotypes. This 
data suggests that low intrinsic aerobic capacity phenotype has a higher risk of 
endothelial dysfunction, with a possibility of increased risk of atherosclerosis and 
atherothrombosis, and that exercise pre-ligation will not protect from endothelial 
dysfunction. Furthermore, this data is comparable to what has been reported regarding 
the concept that atherosclerosis is a diffuse disease that increases the likelihood of 
PAD patients developing stroke and acute myocardial infarction (56), although we 
looked only below the level of ligation (hind limb). Nfkb has also been reported to 
possibly participate in the expression of Pdgfa-inducible genes (170).  
   Pdgfa showed higher gene expression in HCR but showed no change in LCR, 
likely due to the effect of exercise pre-conditioning or ischemia following the 
exercise. On the other hand, Pdgfrb expression decreased in HCR and increased in 
LCR in exercise pre-ligation leg. This may indicate that HCR rats are more reliant on 
Pdgfa than Pdgfb, since Pdgfa only binds to Pdgfra, while LCR rats are more reliant 
on Pdgfb/pdgfd than Pdgfa, since Pdgfb/pdgfd have high affinities for Pdgfrb (23). 
Pdgfa plays an important role in myocyte formation and differentiation. 
Histologically, mean muscle fiber size was consistent with Pdgfa expression in HCR. 
In the HCR Rt leg (under the effect of exercise without ligation) and Lt leg (under the 
effect of exercise followed by ligation), the muscle fiber hypertrophied and Pdgfa 
expression was elevated. However, this mechanism seems phenotypically dependent. 
In LCR Rt leg, there was muscle atrophy with a decrease in Pdgfrb expression and no 
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change in Pdgfa expression. Similarly, when there was muscle hypertrophy in the Lt 
leg of LCR, following exercise pre-ligation, Pdgfrb expression increased while Pdgfa 
expression did not change, indicating different myogenesis mechanism between the 
phenotypes in response to exercise and ischemic stress. It is important to understand 
that each case in PAD needs to be treated separately from other cases. This data will 
add more to our current knowledge of PAD and help in sorting PAD patients into 
LCR and HCR phenotypes. Additionally, this data shows that rats of LCR and HCR 
phenotypes are convenient models to conduct further experiments and generate 
information that may be successfully translated to clinical applications.    
  Exercise preconditioning (EXP) activates cellular stress to protect against 
oxidative, mechanical, and metabolic stressors that might lead to pathological effects 
(119). EXP has been used clinically to protect against ischemia-reperfusion injury, 
type 2 diabetes, and muscle atrophy (42, 46, 54). EXP has been associated with an 
increase in capillary density (CD), leading to low stroke damage in ischemic rats (41). 
It has also been shown to prevent acute myocardial infarction and AMI-induced acute 
cardiac injury (216). EXP also has been found to decrease neonatal incision surgery-
induced enhanced hyperalgesia (65). Moreover, EXP has been shown to prevent right 
ventricular diastolic dysfunction induced by monocrotaline-induced pulmonary 
arterial hypertension (168). In addition, EXP has been found to facilitate a decreased 
recovery time for patients, through improved functionality and a reduction in pain 
when performing activities of daily living, after joint surgery (182, 192, 214), and 
protects against acute doxorubicin cardiotoxicity for up to 10 days (94). Lastly, in a 
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rat model, EXP has been recorded to facilitate functional recovery from a localized 
injury to the spinal cord (27). 
 
CONCLUSION                                                                                                                                       
This study showed that two weeks of treadmill exercise can precondition hind limb 
occlusive disease in low intrinsic aerobic running capacity phenotype through 
remodeling the musculovascular adaptive response. This finding will help the elderly 
with high risks of developing PAD to be protective against the development of the 
disease and therefore, will decrease the clinical and economic burdens placed on PAD 









CHAPTER 4: THE DIFFERENCIATIL IMPACT OF ANDROGEN AND 




Peripheral arterial disease among the female is detrimental than in the male population. 
Estrogen, androgen and dopamine receptors have been reported as participating in the 
cardiovascular disease protection. High intrinsic aerobic capacity rats are protected 
against cardiovascular risk factors. We studied, in vivo, hind limb ischemia to elucidate 
the differential association and function of AR, ERα, and D3R between HCR and LCR in 
response to ischemia. We also explored in vitro, how the phenotypes differentially affect 
AR/D3R signaling interaction on satellite cell growth at early and late time points. HCR 
and LCR, Female rats, 40 weeks, n = 16 each, and dopamine treated with unilateral 
femoral artery ligation. Skeletal muscle was harvested from both hind limbs. We also 
used D3KO female mice (B6.129S4-DrD3tm1Dac/J) and their associated wild types 
(C57BL/6 mice), 22 weeks, n= 6. Samples were assessed in rats and mice by 
immunofluorescent for AR, ERα, and D3R protein expressions, and in rats for AR/ERα 
gene expression ratio.  We found there is an increase AR/Eα gene expression ratio in 
HCR ischemic and non-ischemic limb as compared to LCR (P=0.005). However, protein 
expressions were not significant in the rats and mice. In vitro, we found that that LCR 
satellite cells have different AR/D3R signaling interaction between early growth and late 
growth time points while HCR cells have similar receptors interactions between early and 
late time points, which involved activation of both receptors signaling pathways. 
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INTRODUCTION 
 We mentioned in chapters 1, 2, and 3 the evidence regarding the tremendous 
effect of aerobic phenotype on angio-inflammatory gene expressions and skeletal muscle-
capillary relationship. Here, we will provide additional evidence about the role of 
estrogen, androgen, and dopamine in vascular function and disease, as well as the 
biological characteristics of HCR and LCR that differentiate them from each other, 
suggesting a potential presence of neuroendocrine differences between these phenotypes.   
 HCR rats are characterized as having higher maximum oxygen uptake and resting 
metabolic rate, a leaner body mass, increased longevity, and are resistant to developing 
dyslipidemia, peripheral insulin resistance, diet induced-liver steatosis, depression, and 
metabolic syndrome in comparison with LCR. These differences are possibly due to a 
different underlying neuroendocrine profile between these phenotypes. 
 Several studies on testosterone prove the relationship between these biological 
characters and testosterone levels in human and animals. Studies in humans showed 
that men who had prostatic cancer and who were under androgen deprivation therapy 
for more than 3 months developed lower VO2max and lower resting metabolic rate 
compared to the group that received the therapy for less than three months (228).   
 Moreover, studies have shown that testosterone decreases visceral fat mass 
(143), improves insulin resistance (143), and increases lean body mass (144).  
Furthermore, studies have revealed that long-term testosterone replacement therapy in 
men with late onset hypogonadism have decreased obesity parameters and improved 
metabolic syndrome and health-related quality of life (143). Testosterone replacement 
therapy for hypogonadal and aging men caused decreases in total cholesterol and LDL 
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levels and no change in HDL (250).  Testosterone has also been linked with depression 
in old men. A low free testosterone level in elderly men over 70 years of age was 
associated with a higher prevalence of depression (3).  Hormonal replacement therapy 
has been found to increase life expectancy in both genders. Testosterone replacement 
therapy for men with late onset hypogonadism increased the survival rate by 9-10% in 
5 years, which is similar to that of eugonadal men with normal endogenous 
testosterone level.  
 Likewise, menopausal women who have undergone estrogen replacement 
therapy have an increased survival rate of 2.6% within 5 years (32). Fatty liver is also 
associated with low testosterone concentration in both human and animal studies. In 
495 men diagnosed with non-alcoholic fatty liver disease, 251 of them had low serum 
testosterone levels with the absence of an alternative cause (76). In animal studies, 
mice with a liver-specific androgen receptor deletion have higher liver steatosis than 
obese controls (134).  
Clinical and basic experimental studies have provided evidence about the 
atheroprotective effect of estrogen, testosterone, and dopamine on blood vessels. 
While studies regarding the role of androgen on vasculature have been controversial 
for a long time, in recent years a great work has suggested that androgens exert 
protective effects against the development of atherosclerosis in both genders, and in 
both humans and animals. Although the effect of testosterone on cardiovascular 
events and mortality in women has not yet been evaluated in large cohort studies, a 
prospective cohort study that followed up on more than 2000 women after more than 
a 4-year period found that women with the lowest levels of testosterone had the 
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greatest risk of developing a cardiovascular event, independent of traditional risk 
factors (68). Studies on the hind limb occlusive model in animals found that androgen 
receptors are essential for the revascularization response in ischemia in both male and 
female mice (103). Moreover, the hormone testosterone has also been found to 
increase numerical density of capillaries in the left ventricle after injecting aging male 
rats with testosterone for 4 months (64). The mechanisms underlying the associations 
of low testosterone with CVD are complex and poorly understood.  
However, estradiol and dihydrotestosterone administration in gonadectomized 
male mice have been reported to increase angiogenesis through increasing vascular 
branching and diameter, respectively (213). CVD incidence among women is low 
before menopause, but progressively elevates after the beginning of menopause. This 
increase is thought to result partially from the loss of endogenous estrogen (149). 
However, androgens also decrease with respect to increasing age (35). 
Epidemiological studies provided strong evidence that hormone replacement therapy 
provides cardioprotection in postmenopausal women (100), while other studies do not 
(91). It has been suggested that the inconsistency in these results is due to the 
diversity of responses to hormonal replacement therapy. LCR and HCR rats are 
generated from heterogeneous N:NIH founder population. Whether AR/ERα ratio in 
gastrocnemius muscle is differentially associated with acute hind limb ischemia 
between the female HCR and LCR rats, and whether AR differentially regulates 
skeletal muscle repair during ischemia has yet to be studied.                                                                                                                                      
Sex steroid receptors commonly function as transcription initiators of genes, 
followed by the subsequent synthesis of several proteins, so as to regulate cell 
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function during physiological and pathological responses. In regard to the synthesis of 
dopamine, the rate limiting enzyme is tyrosine hydroxylase. A study has explored the 
androgen responsive element in the tyrosine hydroxylase region, base pairs 1562 to 
1328, upstream of the promotor (98). Studies have shown that testosterone treatment 
increased or maintained tyrosine hydroxylase activity, which decreases after 
castration (1). HCR and LCR also differ in their dopamine systems in the brain. A 
study, using various brain areas involved in movement, motivation, and fatigue in 
HCR and LCR, found that HCR have prolonged dopamine availability compared to 
LCR. They found that D2R (and not D1R) in HCR was higher than in LCR. This data 
directs toward exploring additional determinants regarding the intrinsic differences in 
endurance capacity, and especially toward exploring the role of dopamine, 
peripherally, at the level of skeletal muscle.                                                                                      
In peripheral arterial ligation, dopamine was found to play a role in 
remodeling the vasculature. D2R was found to prolong the post-ischemia recovery. In 
a mouse model, D2 knockout mice showed a faster recovery rate and stimulation of 
angiogenesis in response to unilateral hind limb ischemia compared to wild-type 
(194). D3R was also found to play a role in ischemia. Its activation was found to 
improve the neurological function, learning, and memory of rats after global cerebral 
ischemia/reperfusion (229). This data is important in order to find whether the HCR 
phenotype also has a higher dopamine D3 receptor expression at the level of the 
skeletal muscle than LCR, and if that difference is responsible for skeletal muscle 
repair after ischemia. 
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MATERIALS AND METHODS 
Animal Strains and Experimental Groups   
HCR and LCR, female rats, 40 weeks, n= 16 each, generation 32. Eight HCR 
and eight LCR rats were received left femoral artery ligation while right limb served 
as internal control and at day 14 animals were sacrificed. These animals were 
obtained originally from Drs. Lauren Koch and Steven Britton at the University of 
Michigan.  They have previously described the artificial selection used for the 
generation of the HCR and LCR strains (10, 111-112). Briefly, each sex was selected 
from the founder population (N: NIH stock). Two-way artificial selective breeding 
was used to create low capacity runner (LCR) and high capacity runner (HCR) strains 
that were divergent for treadmill running capacity (run time until exhaustion on a 
graded treadmill exercise test).  The 13 lowest and 13 highest running capacity rats of 
each sex were randomly paired for mating.   This pattern was repeated over 
subsequent generations to produce the divergent strains using a rotational breeding 
scheme.  In the present study, animals from generation 32 were used.   All the animals 
were exposed to treadmill exercise for 5 days at 11 weeks of age when the animals 
were phenotyped for treadmill running capacity.  Upon verifying the phenotypes of 
the animals, animals were prepared for shipping at 14 weeks of age, or as soon after 
as weather conditions (airport tarmac temperatures < 85F) permitted.   
Once received by the Department of Comparative Medicine at ECU, the 
animals were maintained under mandatory quarantine for 10 weeks before they were 
released for study. Rats were provided standard rat chow and water ad libitum, and 
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were kept on a 12 h light/ 12 h dark time schedule until sacrifice.  We also used D3KO 
female mice (B6.129S4-DrD3tm1Dac/J; kind gift from Dr. Clemens Stefan) and their 
associated wild types (C57BL/6 mice), 22 weeks, n= 3 each were anesthetized by 
inhalation of isoflurane in a sealed jar and decapitated. Animal procedures were 
conducted in accordance with American Physiological Society guidelines for the 
humane and safe use of animals, and all protocols involving animals used for these 
experiments were approved by the East Carolina University Animal Care and Use 
Committee. 
Hind Limb Femoral Artery Occlusion. Femoral artery occlusion was produced 
as outlined by others (135, 136, 184).  Briefly, rats were anesthetized with ketamine 
xylazine (0.1ml/100g body weight ip).  The fur was shaved from the inner thigh and 
the surgical sight was cleaned with Betadine and 70% alcohol.  Utilizing a small 
incision, the left femoral artery was isolated and three ligatures of 6-0 surgical silk 
was placed to cause an ischemic condition in the downstream tissue.  One ligature 
was placed 5-6mm distal to the inguinal ligament, a second was placed on a collateral 
artery, and the third was placed 5-6 mm distal to the first ligature. When all three 
ligatures were in place, the incision was closed and the animal was given a Buprenex 
injection (0.1ml/100g body weight IP) and placed in its cage to recover.  Animals 
were allowed to wake up and have unlimited access to food and water.  Animals were 
sacrificed at day 14 following placement of the ligature. This procedure produces a 
uniform occlusion of the femoral arteries that reduces blood flow reserve capacity to 




Quantitative Distribution Immunofluorescence. We used standard protocol for dual 
labeling immunofluorescence in skeletal muscle as described elsewhere (55), but we 
used TBS instead of PBS. Briefly, right (Rt) and left (Lt) gastrocnemius muscles for 
each animal were excised and flash-frozen in isopropanol, which then was cooled in 
liquid nitrogen. The samples were stored at -80°C until cut. The muscle in the OCT 
were cut into serial transverse muscle sections (thickness 8um) were slice at -20°C 
using cryostat and immediately post-fixed in 4%paraformaldehyde (sc-281692; Santa 
Cruz Biotechnology Inc.) on super-frosted plus microscopic slides (VWR 
International, LLC, Suwanee, GA) and then blocked for 2 hours with 10% normal 
goat serum (ab 7481, Abcam) in Tris buffered saline containing 0.2 % Tween-
20(TBST). After overnight incubation with the dual labeled primary antibody 
(recommended dilution for D1R and D3R is 1:260) or unlabeled primary antibody, 
which were based on concentration titration (recommended dilution for AR antibody 
2µg/ml, and for ER antibody is 10ug/ml), the sections were washed 3X with TBS, 
then incubated with the secondary antibody (1:200 recommended by the company) for 
2 hours and washed 1X with TBS containing 0.1 Triton-X. In conjugated primary 
antibodies, the second wash was skipped and coverslips were applied with vectashield 
mounting medium with DAPI (Vector Laboratories, Inc., Burlingame, CA). The 
following primary antibodies were used; rabbit anti-AR antibody (sc-816; Santa Cruz 
Biotechnology Inc.), mouse anti-ER-alpha (MA1-310, Invitrogen). The myocyte 
specific mouse anti-α-Actin (sarcomeric) antibody (Sigma Aldrich, St Louis, MO) 
was used to verify that the sections analyzed were skeletal muscle cells. The
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 secondary antibodies were: FITC-conjugated goat anti-rabbit IgG (ab97079, Abcam) 
and cy3-conjugated goat anti-mouse (ab97035, Abcam). The conjugated primary 
antibodies used were: D1R antibody [Alexa Fluor 488] (NB110-60017AF488, Novus) 
and D3R polyclonal antibody, Cy5 conjugated (bs-1743R-cy5, Bioss).   In indirect 
staining, control sections were incubated with only secondary antibodies to determine 
non-specific binding. A random sample of images across the skeletal muscle section 
were acquired at wavelength 639 and 488 nm, analyzed by laser-based confocal 
microscopy using relative reading of mean intensity per field area, keeping parameters 
constant throughout the acquisition process. Data were presented as mean 
intensity/field area.  
RNA Isolation, Reverse Tanscriptase-PCR, and Real-Time PCR.  Total RNA 
was extracted from harvested rat gastrocnemius muscle using TRIzol reagents 
(Invitrogen) and cDNA was generated using the High-Capacity cDNA Reverse 
Transcription kit from Applied Biosystems (Thermofisher) following the 
manufacturer’s protocol. qReal-Time PCR was performed using 5̀ fluorescent labeled 
primers for AR and ERα utilizing TaqMan Fast Advanced Master Mix (Life 
Technology) following the manufacturer’s protocol. Actinb was used as the reference 
gene since CT values for this gene did not change with treatment. The qReal-Time 
PCR detection system used was the ABI Prism 7900 sequence detection system 
(Applied Biosystems, Foster City, CA). LCR and HCR internal control Rt legs 
samples were used for all data to be normalized with treated samples of other legs 
using the ratio of 2-∆ CT of treated sample/2-∆ CT of controlled sample method.                                                                                           
Isolation and Culture of Primary Satellite Skeletal Muscle Cells (SSC).  
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Dopamine and androgen receptors exist in many tissues, including rat skeletal 
muscle tissue. However, the physiological importance of interaction of dopamine with 
androgen receptors in the regulation of skeletal muscle satellite cell function in these 
phenotypes is unclear. In this study, isolation and purification of satellite cells (SSC) 
were modified from the previous description (34). Gastrocnemius muscle tissue from 
both legs were obtained from the two experimental groups D3KO and WT mice (20 
weeks old) or HCR and LCR rats (30 weeks old) rinsed in pre-warmed DMEM 
(Dulbeco’s Modefied Eagle Medium; high glucose, with 4500 mg/L glucose, 4 mM 
L-glutamine, 110 mg/L sodium pyruvate) supplemented with 1% antibiotics (15240-
062, ThermoFisher) and 1% Na-pyruvate (11360070, ThermoFisher). In a petri dish 
containing DMEM and using dissecting forceps, connective and fat tissue was 
removed from the muscle. Muscle was then transferred into a 60-mm petri dish with 
DMEM and cut into 3mm3 fragments. Muscle suspension was then transferred into a 
15-ml conical tube and centrifuged at low speed (~200xg) for 4 minutes. Supernatant 
were aspirated and discarded. DMEM were used to re-suspend fragments up to 2ml 
for muscles from one animal and the whole bulk was transferred into 35-mm. The 
remaining sticky fragments were washed with 700µl of DMEM and added to the dish. 
Next, 300 µl of 1% pronase was added to the dish so as to achieve 3ml of 0.1% 
pronase solution in mice, or 6ml in rats. Using the pronase enzyme instead of 
collagenase may inhibit survival and proliferation of non-myogenic cells and increase 
the purity of isolated satellite cell populations (34).  The dish with the enzymatic 




At the end of the digestion period, the enzyme and muscle fragment solution 
was transferred to a 15 ml conical tube and centrifuged at 400 x g for 5 min. The 
supernatant was removed and the pellet was re-suspended in 5 ml of 10% FBS in pre-
warmed DMEM instead of 10% horse serum because we found changing the serum 
type from horse serum to fetal bovine serum has a similar effect (44,147). After 
enzymatic digestion, mechanical trituration was used to release the still attached 
satellite cells. The muscle trituration occurred by passing the fragments (20 times) 
through a 10-ml glass pipette until the tissue passed easily through the tip of the 
pipette. Then muscle was allowed to settle at room temperature to separate large 
fragments from the supernatant. Separated supernatant was transferred in to a 15 ml 
tube. The process of trituration was repeated by adding 5 ml of 10% FBS into the tube 
contained the remaining large fragments using 9'' cotton-plugged glass pipette until all 
pieces easily passed through it. Supernatant was added to the rest of the previously 
collected supernatant in the 15 ml tube.  
To eliminate residual debris from the suspension, a 40-µm cell strainer in 50 
ml conical tube was used for the collected supernatant and additional 1 ml volume of 
DMED was added for maximum cell recovery. Next, cell suspension was centrifuged 
at ~1000 x g for 10 min, the supernatant was discarded and the pellet was suspended 
in 1ml of standard growth media. After this, cells were purified before plating by 
performing the pre-plating technique, where cell suspension is distributed onto 
uncoated tissue culture plastic for a period of 15-30 minutes to further enrich the 
isolated myogenic cell population (63,186). Fibroblasts or epithelial cell present in the 
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muscle suspension rapidly adhere to the uncoated tissue culture plastic, and the 
satellite cells remaining in suspension (15, 190) can be collected and plated on the 
gelatin-coated 24-well plate. Gelatin is commonly used with satellite cells culture for 
optimal cell proliferation (44). Cells remained in the incubator undisturbed for 3 days. 
After that, the media was removed and the plate was washed two times with 1x DPBS 
and replaced with fresh complete media contained DMEM with 1% antibiotics, 1% 
chicken embryo extract (100356-958, VWR), and 20% Fetal Bovine Serum (10091-
148, ThermoFisher).   
Cell Identification and Purification. Cells after isolation process and before 
plating on coated tissue culture plastic, were purified by a simple technique, which is 
called pre-plating technique. In this technique, cells that in suspension where 
distributed onto uncoated tissue culture plastic for a period of 15-30 minutes to further 
enrich the isolated myogenic cell population (186, 63). Fibroblasts or epithelial cells 
present in the muscle suspension rapidly adhere to the uncoated tissue culture plastic, 
and the satellite cells remaining in suspension (15, 190) can be collected and plated on 
the gelatin-coated 24-well plate.  
For identification of satellite cell markers we used fluorescent 
immunocytochemistry staining protocol to detect Pax7+ marker and MyoD for 
satellite cells progeny as previously described with slight modification (34, 201). 
Briefly, square cover slips (18x18-1, ThermoFisher) were first disinfected by 75% 
ethanol and coated with 2% gelatin by setting them in gelatin-filled 35-petri dish and 
then allowing the slides to dry by placing them onto an irregular surface so as to avoid 
adhesion to the surface. Coated cover slips were then placed in each well of a 6-well 
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plate and kept in the cell culture hood under ultraviolet rays for one hour before 
plating cells. Cells were plated at a density of 2000-4000 cells per well and sat 
undisturbed overnight to allow for cell attachment to the bottom of the wells. Cells 
then were rinsed with serum free media three times. An equal volume of media and 
pre-warmed 4% paraformaldehyde (sc-281692; Santa Cruz Biotechnology Inc.) was 
added on the culture for 10 minutes at room temperature.  Cultures were then rinsed 
three times with Tris-buffered saline (TBS; 0.05 M Tris, 0.15 M NaCl, pH 7.4) and 
permeabilized with 0.5% Triton X-100 in TBS containing 1% goat serum (ab 7481, 
Abcam) for blocking and kept at room temperature for 2 hours. Cultures were then 
rinsed three times with tris-buffer saline containing 0.5% Tween-20 (TBST) followed 
by incubation with primary antibodies for 2 hours at room temperature. Cells were 
then incubated with the primary labeled Alexa Fluor 405 and 467 antibodies (NBP 2-
34706AF647, Novus) at dilution of 1:50, and primary labeled MyoD Alexa Fluor 467 
at dilution of 1:50 (sc-377460 AF647, Santa Cruz) for 2 hours at room temperature, 
and washed 3X with TBST.  Vectashield mounting medium with or without DAPI 
(Vector Laboratories, Inc., Burlingame, CA) was used to avoid masking the nuclear 
marker. Images were captured by confocal microscope at 20x magnification.
Cell Viability Evaluation. By using automated counter (Cellometer Bright 
Field Automated Cell Counter 2000, Nexcelom), the cell viability reagent kit, and the 
trypan blue dye exclusion assay (0.4%, Sigma).  
Cell Culture Experiments. Performed using previously published protocol and 
materials used in satellite cells isolation from mouse gastrocnemius muscle with slight 
adjustment for rat muscle (34, 124,129). Cells from passage 1-2 were grown to 80% 
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confluency in T75 flasks with normal culture media (NCM) containing 20% FBS and 
1% chicken embryo extract in regular standard cell culture incubator. After cells were 
grown to sub-confluence, they were diluted to the required volume of phenol red‐free 
and serum-free DMEM containing 0.2 % FBS, and plated in monolayer at a density of 
less than 60,000 cells per well via 300 μl aliquots into 96‐well (Falcon, Corning, NY 
USA) (pre-coated with 2% gelatin) in triplicate. Experiment was done in two separate 
replicates and the average was calculated. Before treatment, each plate was exposed to 
serum-free media for 2 hr to synchronize cells, followed by incubation in normal 
culture medium for 36-48 hr depend on the experimental type. We conducted 
experiments on Sprague Dawley and HCR/LCR rats for studying cell growth at 
different time points.  
Cell Growth Test. Growth properties of skeletal muscle cell (SSC) were 
detected using an automated cell counter (Cellometer Bright Field Automated Cell 
Counter 2000, Nexcelom). The isolated cells were seeded into 96-well plate at density 
of less than 60,000 cell per well with 300 µl CCM. Cells were then incubated at 37 °C 
with 5% CO2 for 12 hours, followed by incubation in serum free media for 2 hours. 
After 2 hours, the media was changed to normal complete media with drugs added as 
follow: first triplicate were cells without treatment, second triplicate were cells treated 
with D3R antagonist, 10 µM (93) SB 27701A (kind gift from Dr. Clemens Stefan) the 
third triplicate were cells treated with androgen, 10 nM 5α-Androstan-17β-ol-3-one, 
dihydrotestosterone DHT (A8380, Sigma) (142), the 4th triplicate were cells treated 
with androgen antagonist, 50 nM Flutamide (F9397, Sigma) (206), Flutamide, the 5th 
triplicate were cells treated with D3R agonist, 10 µM pramipexole (kind gift from Dr. 
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Stefan Clemens) + androgen, the 6th triplicate were cells treated with D3R antagonist 
+ androgen antagonist, the seventh triplicate were cells treated with D3R antagonist + 
D3R agonist + androgen, the last triplicate were cells treated with D3R antagonist + 
androgen. This test was repeated four times in the same plate for four trials with four 
different time points after replacing the media with addition of drugs as follow: 6 
hour, 12 hour, 24 hour, 36 hour and 48 hours where cells were trypsinized with 1x 
Trypsin-EDTA phenol red-free solution (15400054, ThermoFisher) and incubated for 
2-3 minutes at 37 °C. Cells were then neutralized using similar volume of Trypsin 
Neutralizer Solution (1x) (R002100, ThermoFisher). An equal volume of the cell 
suspension and Trypan blue (15250061, ThermoFisher) were mixed and a Cellometer 
Bright Field Automated Cell Counters for accurate cell counting, total cell 
concentration, and trypan blue viability. Data are presented as (treated group/control x 
100) in each group at 6, 12, 24, 36, and/or 48 hours.  
Statistics.  Statistical analysis was performed using data analysis software in 
Microsoft Excel worksheet (Windows 10).  Data are expressed as means ± SEM, and 
a p value <0.05 was considered statistically significant.  Single factor ANOVA tests 
were used to compare between LCR and HCR to determine statistical significance 
among the groups (two groups at a time) comparing three different ways: internal 
control data of LCR with the counterpart of HCR group, ischemic limb data of LCR 
with its counterpart of HCR, and finally the ratio of Lt ischemic/non-ischemic Rt limb 
(Lt/Rt) of LCR with the HCR counterpart.  Similarly, relative gene expression levels 
were calculated by comparing q-RT PCR data, after normalizing them to the internal 
standard housekeeping gene (Actinb), of non-ischemic Rt limb of LCR with its
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 counterpart of HCR and comparing ischemic Lt limb and the Lt/Rt ratio of LCR with 
HCR counterpart groups as explained above.  For cell culture groups, the statistical 
analysis was based on the comparison among the groups at the same time point using 
single factor ANOFVA and paired t-test to find if there was a statistical difference 
between two groups at a time. Significant differences were accepted in all 
circumstances where p < 0.05. 
 
RESULTS 
The Differential Changes in AR, ERα, AR/ERα Genes and Proteins Expression in 
The Calf Gastrocnemius Muscle 14 Days Following Ligation Between LCR and 
HCR: 
The AR and ERα genes expression in the non-ischemic limb, ischemic limb, and 
the ratio of ischemic over non-ischemic limbs (L/r) did not change significantly (P≥ 0.05) 
between the phenotypes (Figure 4.1 A and B).   However, the AR/ERα gene expression 
ratio was significantly higher (32% and 42%) in the HCR non-ischemic and ischemic 
limbs respectively than LCR groups (P< 0.05), but when we calculated this ratio in the 
ischemic limb/non-ischemic limb (L/r) between the phenotypes, the trend did not reach 





FIGURE 4.1.  AR, ERα, and AR/ERα Gene expression ratio in Gastrocnemius muscle of non-
ischemic, ischemic and the ratio of ischemic to non-ischemic limbs in HCR and LCR rats 
following two weeks of abrupt left femoral artery ligation. AR gene expression (A), ERα gene 
expression (B), and AR/ERα gene expression ratio (C) in non-ischemic (a), ischemic (b), and 
ischemic/non-ischemic (c) limbs between HCR and LCR after acute ligation. AR, androgen 
receptor; ERα, estrogen receptor alpha; AR/ ERα, the ratio of androgen receptor over estrogen 
receptor alpha.  Left limb is the ischemic limb in all animals (HCRL and LCR L), and right limb 
is non-ischemic internal control limb (HCRr and LCRr). N = 10-11, * p < 0.05, mean ± SEM.
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The protein expression of AR, ERα, and their ratio were not significantly changed 
between the phenotypes (P> 0.05) (Figure 4.2).  
 
 
FIGURE 4.2.  Androgen and estrogen receptor α protein expression in gastrocnemius muscle of 
high capacity and low capacity runner rats after 14 days of hind limb ischemia. Shown 
representative confocal microscopy photographs of AR (in green), ERα (in red) and the merged 
of both colors on gastrocnemius muscle frozen section in non-ischemic and ischemic limbs of 
LCR (A) and HCR (B) after acute left femoral arterial ligation.
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Figure 4.3 Quantification of confocal images for AR (A) ERα (B) and AR/ERα (C) protein 
expression in the non-ischemic limb (a), ischemic limb (b), and the ratio of ischemic to 
non-ischemic limb (c) between HCR and LCR after the ischemia; AR, androgen receptor; 
ERα, estrogen receptor alpha; LCRr, right limb of low capacity runner rat; HCRr, right 
limb of high capacity runner rat; LCRL, left limb of low capacity runner rat; HCRL, left 
limb of high capacity runner rat; n=10.  The error bars represent standard error. 
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The Differential Changes in D1R and D3R Proteins Expression in The Gastrocnemius 
Muscle 14 Days Following Ligation Between LCR and HCR: 
There were no differential changes in stimulatory ‘D1R’ and inhibitory ‘D3R due to 
intrinsic differences in endurance capacity after hind limb arterial ligation either in non-
ischemic or ischemic limbs or the ratio of ischemic to non-ischemic limbs (Figure 4.4). 
 
FIGURE 4.4.  Representative confocal microscopy photographs of D1R (in green), D3R (in red) 
and the merged of both colors with neuclei stained with DAPI (in blue) on gastrocnemius muscle 
frozen cross-section in non-ischemic (LCRr & HCRr) and ischemic (LCRL & HCRL) limbs in LCR 
(A) and HCR (B) after acute left femoral arterial ligation;  D1R, dopamine 1 receptor; D3R, 
dopamine 3 receptor.
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Similarly, WT and D3KO mice showed no statistical differences in D1R and D3R protein 
expression in gastrocnemius frozen cross-section under baseline condition (Figure 4.5). 
 
 
Figure 4.5.  Quantification of confocal immunoflourescent images for Dopamine D1 and D3 
receptors protein expression in gastrocnemius muscle of high and low capacity runner rats after 
14 days of hind limb ischemia.  D1R (A) and D3R (B) protein expression in the non-ischemic 
limb (a), ischemic limb (b), and the ratio of ischemic to non-ischemic limb (c) between HCR and 
LCR after the ischemia.  N = 10-11; mean ± SEM.
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FIGURE 4.6. Representative confocal microscopy photographs of D1R (in green), D3R 
(in red) and the merged of both colors with neuclii stained with dapi (in blue) on 
gastrocnemius muscle frozen section in WT and D3KO mice at baseline condition (A).  
Quantification of relative immunoflourescence for Dopamine D1(B) and D3 (C) 
receptors protein expression in gastrocnemius muscle of WT and D3KO mice at baseline 
condition. D1R, dopamine 1 receptor; D3R, dopamine 3 receptor; WT, Wild-Type mice; 
D3KO, dopmine receptor 3 knockout mice; n=6,  Mean ± SEM.
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In Vitro Cell Growth Assessment of Satellite Cells Under The Influence of Androgen 
and Dopamine 3 Receptor Agonists/Antagonists. 
 
We analysed the cell growth of skeletal muscle satellite cells isolated from 
gastrocnemius muscle of Sprague Dawley rats treated with different pharmacological AR 
and D3R agonist/antagonist in order to test their roles in cell physiology at different times 
points (6 hr, 24 hr, 36 hr, and 48 hr). As seen below (Figure 4.7) we found that the D3R 
antagonist (SB 277011A) significantly decreased cell grwoth (~32%) as compared to vehicle 
at 6 hr, but increases cell growth (72%) as compared to the vehicle at 36 hr (P<0.05). 
Howevere, there was no significant change in cellular growth at 24 hr and 48 hr.  
Cells treated with DHT (10 nM) showed no statistical difference at 6 and 24 hr as 
compared to the vehicle. However, DHT at 36 hr increased cell growth (~60%) (P<0.05) as 
compared with cells treated with combination of DHT +D3R agonist and antagonist, and 
decreased cell growth (50%) (P<0.05) as compared with cells treated with D3R antagonist 
alone. At 48 hr, DHT decreased cell growth as compared to 36 hr, but still had higher impact 
on the cell growth at this time point around 50% in comparison with vehicle (P<0.05).  
Cells that received Flutamide (50 nM) showed no significant changes in cellular 
growth in 24 hr and 36 hr while significant decrease (~25%) at 6 hr and (~30% increase) at 
48 hr as compared to the vehicle. The group of cells that co-treated with combination of 
SB277011A and DHT drugs did not showed significant changes at 6, and 24 hr. 
Nevertheless, at 48 hr cells showed doubling in their total numbers as compared with the 
vehicle (P<0.05).   
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FIGURE 4.7. Effects of both androgen and D3R agonist, antagonist, and their combinations on 
Sprague Dawley skeletal muscle cell growth at four different time points (6 hr, 24 hr, 36 hr, and 48 
hr). Nine groups where treated with different drugs or vehicles as shown by colors of the columns. 
Data represented by the percentage of control (treated group/control group x100) ± SEM. DHT, 
dihydrotestosterone; SB, SB277011A; Drugs concentrations as follows: SB 277011A and 
Pramipexole (10µM) each; DHT (10 nM); Flutamide (50 nM). To avoid confusion, we used several 
symbols to mark statistical trends between the groups, where *: as compared to the vehicle; $: as 
compared to SB277011A + Flutamide; &:  as compared to Pramipexole + DHT; #:  as compare to 
DHT; ø:  as compared to SB277011A; n=4. Single factor ANOVA test was used to analyze the data 
between the groups; P<0.05.
 




Cells that received a combination of D3R and AR antagonists (SB277011A + 
Flutamide) increased growth at only 36 hr. At 36 hr, the growth increased ~61% as 
compared with group received (Pramipexole + DHT).  
Treatment with (Pramipexole + DHT) caused a 75% decrease in growth (at 36 hr) 
then ~ 50% increase in cell growth (at 48 hr) (P<0.05). There was no significant difference 
between this group and the other groups at 12 hr and 24 hr.  
The last group of cells that were treated with three drugs (SB + Pramipexole + DHT) 
showed effect at 36 hr with (80%, 55%, 65%) statistical difference in cell growth in 
comparison with the SB277011A, DHT, and SB+ Flutamide, respectively, and 50% increase 
in cell growth as compared to the vehicle.   
 
Early cell growth (at 6 hr), in the presence of DHT: 
The effect of DHT on LCR cell growth pretreated with dopamine antagonist was not 
changed significantly as compared to cells pretreated with dopamine agonist. In HCR, 
satellite cells that pretreated with dopamine agonist, there was (44%) significant decrease in 
cell growth as compared to cells pretreated with dopamine agonist. Between the phenotypes, 
there was (70%) higher growth in LCR cells that pretreated with dopamine antagonist as 




FIGURE 4.8. The effect of Dihydrotestosterone on LCR and HCR satellite cell number 
treated with D3R antagonist/agonist at early time point. Data represented cell growth by 
percentage of control (treated group/untreated control group x100) ± SEM. DHT, 
Dihydrotestosterone (10 nM); D3R antagonist, dopamine D3 receptor antagonist (SB, 
SB277011A 10µM); D3R agonist, dopamine D3 receptor agonist (Pramipexole 10µM); 
LCR, low capacity runner rat; HCR, high capacity runner rat; SEM, standard error of the 
mean; hr, hour. *: represent statistical significant. n=4. Paired t-test was used to compare within 
the groups of LCR or HCR and single factor ANOVA test was used to analyze the data between HCR 




Late cell growth (at 36 hr), in the presence of DHT:
In the presence of DHT, LCR cells that pretreated with dopamine antagonist had (85%) 
significant decrease in their growth as compared to cells pretreated with dopamine agonist 
(P<0.05). However, in HCR satellite cells, there was no significant changes between cells 
pretreated with dopamine antagonist and cells pretreated with dopamine agonist. Similarly, 
there were no significant changes found between the phenotypes (Figure 4.9). Both time 
points for both phenotypes are illustrated in (Figure 4.10) for convenience visualization. 
 
FIGURE 4. 9. The effect of Dihydrotestosterone on LCR and HCR satellite cell growth treated with 
D3R antagonist/agonist at late time point. Data represented cell number by percentage of control 
(treated group/untreated control group x100) ± SEM. DHT, Dihydrotestosterone (10 nM); SB, 
SB277011A (D3R antagonist 10µM); Pramipexole (D3R agonist 10µM); LCR, low capacity runner 
rat; HCR, high capacity runner rat; SEM, standard error of the mean; hr, hour. *: represent statistical 
significant. n=4. Paired t-test was used to compare within the groups of LCR or HCR and single 
factor ANOVA test was used to analyze the data between HCR and LCR groups; P<0.05.
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FIGURE 4.10. The effect of Dihydrotestosterone on LCR and HCR satellite cell number treated with 
D3R antagonist/agonist at both time points. Data represented cell number by percentage of control 
(treated group/untreated control group x100) ± SEM. DHT, Dihydrotestosterone (10 nM); SB, 
SB277011A (D3R antagonist 10µM); Pramipexole (D3R agonist 10µM); LCR, low capacity runner 
rat; HCR, high capacity runner rat; SEM, standard error of the mean; hr, hour. *: represent statistical 
significant within the phenotype. #: represent statistical significant with the corresponding HCR 
group. n=4. Paired t-test was used to compare within the groups of LCR or HCR and single factor 
ANOVA test was used to analyze the data between HCR and LCR groups; P<0.05. 
 
Early cell growth (at 6 hr), in the presence of Pramipexole: 
In LCR, cells that pretreated with AR agonist showed (13.5%) significant decrease in 
cell growth as compared with cells pretreated with AR antagonist (P<0.05). However, in 
HCR, there was no significant difference between cells pretreated with AR agonist and cells 
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pretreated with AR antagonist. There was also no significant difference between the 




FIGURE 4.11. The effect of Pramipexole on LCR and HCR satellite cell number treated with 
AR antagonist/agonist at early time point. Data represented cell growth by percentage of 
control (treated group/untreated control group x100) ± SEM. Prami, Pramipexole (D3R 
agonist 10µM); AR agonist, androgen receptor agonist (Dihydrotestosterone 10 nM); AR 
antagonist, androgen receptor antagonist (Flutamide 50 nM); LCR, low capacity runner rat; 
HCR, high capacity runner rat; SEM, standard error of the mean; hr, hour. *: represent 
statistical significant. n=4. Paired t-test was used to compare within the groups of LCR or 
HCR and single factor ANOVA test was used to analyze the data between HCR and LCR 
groups; P<0.05.
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Late cell growth (at 6 hr), in the presence of Pramipexole: 
In LCR, cells that pretreated with androgen receptor agonist showed (54%) 
significant increase in cell growth as compared with cells pretreated with androgen receptor 
antagonist (P=0.05). However, there was no significant difference between cells pretreated 
with androgen receptor agonist, and cells pretreated with androgen receptor antagonist. 
Between the phenotypes, there was no significant difference in both treatments (Figure 4.12). 
For a complete visualization of the effect at both time points for both phenotypes, see (Figure 
4.13).  
 
FIGURE 4.12. The effect of Pramipexole on LCR and HCR satellite cell number treated with AR 
antagonist/agonist at late time point. Data represented cell umber by percentage of control (treated 
group/untreated control group x100) ± SEM. Prami, Pramipexole (D3R agonist 10µM); AR agonist, 
androgen receptor agonist (Dihydrotestosterone 10 nM); AR antagonist, androgen receptor antagonist 
(Flutamide 50 nM); LCR, low capacity runner rat; HCR, high capacity runner rat; SEM, standard 
error of the mean; hr, hour. *: represent statistical significant. n=4. Paired t-test was used to compare 
within the groups of LCR or HCR and single factor ANOVA test was used to analyze the data 




FIGURE 4.13. The effect of Pramipexole on LCR and HCR satellite cell number treated 
with AR antagonist/agonist at both time points. Data represented cell number by 
percentage of control (treated group/untreated control group x100) ± SEM. Prami, 
Pramipexole (D3R agonist 10µM); AR agonist, androgen receptor agonist 
(Dihydrotestosterone 10 nM); AR antagonist, androgen receptor antagonist (Flutamide 50 nM); 
LCR, low capacity runner rat; HCR, high capacity runner rat; SEM, standard error of the 
mean; hr, hour. *: represent statistical significant. n=4. Paired t-test was used to compare 
within the groups of LCR or HCR and single factor ANOVA test was used to analyze the data 






FIGURE 4.14. Identification of satellite cells from gastrocnemius muscle of both high 
capacity runner (HCR) and low capacity runner (LCR) rats. Shown representative phase 
contrast micrographs depicting the morphology of HCR and LCR myogenic cultures in 
rich growth media at day 3 according to protocols detailed in this chapter (A); confocal 
microscopy photographs of identified satellite cells by nuclear marker Pax7 at day3 (B) 
and by both Pax 7 (in blue), MyoD (in red), and the merged of both colors (in pink) for 
proliferating satellite cell progeny after Day 6 of isolation (C); Pax7, paired box protein-





Peripheral arterial disease (PAD) among the female population has been 
known to be more detrimental than in the male population (9, 74, 240, 255). Sex 
hormones have been reported as participating in the cardiovascular disease protection. 
Not only can low levels of estrogen be risky in relation to cardiovascular disease (old 
concept), but lower levels of androgen has also been found to be associated with the 
onset of cardiovascular disease. Although females also express the androgen receptor 
in cardiovascular system, the study of association of androgen receptor expression 
with the severity of PAD in female individuals is not as extensively studied as in male 
individuals. 
The model of intrinsic aerobic endurance capacity provides a better 
understanding of the differential association of sex steroid receptors with lower limb 
arterial ligation. This model helps answer questions such as how the intrinsic factors 
(genes) play roles in differentially distributing sex steroid receptors (AR and ERα) 
during vascular remodeling in response to arterial ligation. It also helps in better 
understanding the benefit from increase sex steroid receptors in prevention and 
treatment of PAD through developing a novel molecular therapy for PAD patients 
who can’t tolerate exercise therapy.   
The goal of this study was to determine whether there are associations of sex 
steroid receptors (AR and ERα) and dopamine receptors (D1R and D3R) in the 
differential vascular adaptive responses between female rats with low intrinsic 
running capacity and high intrinsic running capacity and if these receptors play role 
in the skeletal muscle cell repair.  The results of this study showed that rats 
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selectively bred for high endurance running capacity (HCR) and low endurance 
running capacity (LCR) have a different AR/ERα gene expression ratio in non-
ischemic and ischemic limbs after 14 days of left femoral artery ligation. The results 
suggest the importance of the AR/ERα genetic ratio in influencing vascular adaptive 
response to peripheral vascular occlusive disease in females with differences in 
intrinsic aerobic capacity.  
 
AR/ERα Differential Changes Between HCR and LCR After Acute Ligation: 
The AR/ ERα gene expression ratio was apparently different between the 
phenotypes. HCR rats’ AR/ERα gene expression ratio was significantly higher than LCR 
groups (32% in non-ischemic limb, P=0.005 and 42% in ischemic limb, P=0.006). 
However, the proteins expression ratios of these receptors were not significantly changed 
between the phenotypes although the protein ratio was lower in HCR than LCR. The 
possible interpretation for non-significant change of the AR/ERα protein ratio between 
the phenotypes could be due to the time period between the initial ligation and tissue 
collection (14 days) very long to cause loss of the acute response of these receptors 
(minutes to hours). As we know sex steroid receptors are part of highly regulated system 
in our body (Endocrine). The mechanism by which these receptors are regulated is very 
complex. When the ligation occurs (stimulus), the receptors are activated (translocated to 
the nucleus), leading to the replacement of these receptors immediately from the stored 
receptors in the cytoplasm. While the active receptors act as transcription factors for 
several genes involved in vascular remodeling, they also transcribe for new sex steroid 
receptors synthesis from previously degraded receptors by ubiquitination process in 
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proteasome. Another possible interpretation for unchanged AR/ERα protein ratio is 
because we obtained the total distribution including the nuclear fraction. It is possible that 
the differences between the phenotypes is at the nuclear level (functional steroid 
receptors). At the level of nuclear AR/ERα gene ratio, higher ratio in the HCR than LCR 
indicates more activation and replenishment of the androgen receptor relative to estrogen 
receptor alpha (acute response within hours), causing low to unchanged protein levels, 
followed by more receptor degradation and synthesis (within days) which causes higher 
mRNA levels. 
 
       The importance of AR/ERα ratio has been reported in cardiovascular 
studies. In 1994, Mosnarova et al. studied the vascular reactivity of male rabbit 
after one month of sex hormone administration (estradiol or testosterone twice per 
week). They reported that hyperestrogenemia and change in the estrogen-
androgen level ratio caused changes in vascular reactivity to several vasoreactive 
compounds. They suggest that a higher level of estrogen to androgen ratio in 
males is a risk factor to several vascular diseases (157). Another study was in 
2010 conducted by Naessen et al. on prevalent cardiovascular disease in 70-year-
old men and women. They found that prevalent cardiovascular disease was 
associated with indication of lower androgen precursors, an increase in aromatase 
activity, and higher estradiol levels in both sexes. This suggests an endogenous 
response to developing atherosclerosis, instead of a causation relationship (162), 
which supports our previous studies on these animals where we found higher 
markers of endothelial dysfunction in LCR as compared to HCR (Chapter 2).
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              In 2012, Naessen et al. studied the endogenous estrogen levels in 70-
year-old women and men and assessed the common carotid arteries’ intima, media 
and their ratio thickness. They found low androgen levels, high aromatase activity 
and high estrogen levels were associated with unhealthier artery wall (thick 
intima, thin media, and high intima to media ratio) in females as well as in males 
(161). Although we did not measure the androgen and estrogen hormones in these 
animals, we conducted these experiments because we strongly believe that HCR 
are considered androgen-oriented phenotype opposite to LCR. HCR rats 
characterized by having higher maximum oxygen uptake and resting metabolic 
rate, lean body mass, longevity, and are resistant to developing dyslipidemia, 
peripheral insulin resistance, diet induced-liver steatosis, depression, and 
metabolic syndrome in comparison with LCR. These differences are possibly due 
to at least different underlying endocrine hormonal profile between these 
phenotypes.   
Several studies on testosterone prove the relationship between these 
biological characters and testosterone levels in human and animals. Studies in 
human showed that men who had prostatic cancer and who were under androgen 
deprivation therapy for more than 3 months developed lower VO2max and lower 
resting metabolic rate compared to the group that received the therapy for less 
than three months (228).  Moreover, studies have showed that testosterone 
decreased visceral fat mass (143), improved insulin resistance (143), and increase 
lean body mass (144).  Also, studies revealed that long-term testosterone 
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replacement therapy in men with late onset hypogonadism decrease obesity 
parameters and improved metabolic syndrome and health-related quality of life 
(143).  
Testosterone replacement therapy for hypogonadal and aging men caused 
decrease in total cholesterol and LDL levels and no change in HDL (250).  
Hormonal replacement therapy has been found increases the longevity in both 
genders. Testosterone replacement therapy for men with late onset hypogonadism 
increased the survival rate by 9-10% in 5 years, which is similar to that of 
eugonadal men with normal endogenous testosterone level, and in menopausal 
women with estrogen replacement therapy, their survival rate increased by 2.6% 
in 5 years (32).  
Fatty liver is also associated with low testosterone concentration in both 
human and animal studies. In 495 men diagnosed with non-alcoholic fatty liver 
disease, 251 of them have low serum testosterone level with absence of an 
alternative cause (76). In animal studies, mice with liver-specific androgen 
receptor deletion have higher liver steatosis than obese controls (134). On the 
other hand, estrogen signaling has been shown interrelated with the metabolic 
syndrome and its risk factors (153).  It is also reported that LCR is known as a 
genetic model of metabolic syndrome (183).  Epidemiological studies provided a 
strong evidence that hormone replacement therapy gives cardioprotection in 
postmenopausal women (100), while other studies do not (91). It has been 
suggested that inconsistency in these results is due to heterogeneity in response to 
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hormonal replacement therapy. LCR and HCR rats are generated from 
heterogeneous N: NIH founder population.  
 
D1R/D3R Differential Changes Between HCR and LCR After Acute Ligation: 
Dopamine receptors play an important role in regulating vascular 
pathophysiology. In this study we predict three possible causes that explain HCR 
benefits following hind limb ischemia, which summarized in (Figure 4.13). In our 
study we examined the differential changes in the protein expression of D1R and 
D3R, which are the stimulatory and inhibitory receptors respectively for dopamine 
release and synthesis after 14 days of abrupt ligation of unilateral femoral artery. 
The distribution of these receptors in non-ischemic and ischemic limbs were not 
statistically different between the HCR and LCR rats although they were higher in 
HCR than LCR. The possible interpretation of these results could be that these 
receptors are different functionally and not at the level of protein expression. 
Again, the level of these proteins that have been identified between the 
phenotypes represent the total distribution of these receptors in the cell whether 
that stored in vesicles (in active) or on the cell membrane (active). It is possible 
that in LCR rats the receptors are present mostly in the inactive form while HCR 
receptors are present in the active form. What we have shown in our study is the 
total distribution, indicating possible functional differences in these receptors 
between HCR and LCR. Studies on D3R are lacking in skeletal muscle. Most 
studies were conducted on kidney and central nervous system. In spinal cord 
neurons, it has been shown that in D3KO mice, the mRNA of D3R was higher 
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than that of WT mice. The study also showed that the distribution of the D3R was 
locally different between WT and D3KO where the receptor found bind with 
membrane in WT but not in D3KO as evidence for functional knockout in D3KO 
mice (251). This study also supported our findings in D3KO mice as compared to 
WT mice that the immunofluorescence staining for D3R and D1R were 
unchanged between the groups indicating functional knockout instead of protein 
expression levels differences although D3R was overall lower in D3KO mice than 
WT mice.  
D1R has been linked to muscle mass preservation and muscle force 
production (188). We have reported early in this study (Figure 2.1 E) that the area of 
muscle fiber of HCR ischemic limb was significantly higher than LCR counterpart. 
However, it has been shown that D1R centrally in different brain areas was not 
different between HCR and LCR (53). A study conducted by Teresa E. Foley et al. 
they used high capacity runners (HCR) and low capacity runners (LCR) and studied 
various brain areas involved in movements, motivation and fatigue and found D2R 
(and not D1R) in HCR was higher than LCR (53).  It is possible that the D2R and not 
D1R or D3R is responsible for regulating skeletal muscle cell repair during injury or 
even physiologically. Another way of interpretation is that peripheral dopamine 
system regulating skeletal muscle cell repair during injury, or even physiologically, is 
different than central dopaminergic signaling or by other dopamine receptors.  D1R 
stimulation in model for hind limb arterial ligation was associated with enhanced 
bone marrow-derived cell mobilization & post ischemic angiogenesis (187). In our 
study, we did not investigate the infiltration of immune cells. However, we found
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 increased gene expression of angiogenic markers Vegfa and Angiop2 in LCR but not 
in HCR (Table 2.A) suggesting different mechanism that LCR own or different 
dopamine receptor type involvement for vascular remodeling during ischemia such as 
D2R. It has been shown that in unilateral hind limb ischemia of D2KO mice there 
was increased recovery and angiogenesis stimulation compared to WT mice (194) 
which is most likely that LCR differs from HCR in the lack or dysfunction of D2R. 
However, in vitro studies can answer the functional query about D1R and D3R in 
HCR and LCR. 
 
The Effect of the Interaction Between Androgen Receptor and Dopamine D3 
Receptor During Cell Growth of Sprague Dawley Rat Satellite Cells In Vitro: 
Culturing satellite skeletal muscle cells isolated from adults female Sprague 
Dawley rats treated with D3R antagonist were helpful in determining the functional 
status of dopamine receptor. They were also helpful in building a relationship 
between the protein levels and function during SSC growth in normal culture medium 
for 36-48 hr. D3R antagonist (SB277011A) caused significant decrease in the cell 
growth at early time point (6 hr) then it increased the growth to very high level at 36 
hr. This means its dysfunctional negative effect was shown after 6 hr of incubation 
for 2 hr in serum free media and that effect was time dependent specifically at 36 hr 
when the growth peak was the highest. It has been shown that the expression of 
dopamine receptors depends on the state of cellular activation and the concentration 
and time of exposure to dopamine (6). Dihydrotestosterone (DHT) treated cells 
showed an increase in growth only at 48 hr indicating that DHT works through
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 genomic receptors since Flutamide had no effect on cell growth at all and it did not 
abolish the effect of DHT on cell growth. This suggests that DHT worked on non-
androgenic receptors such as estrogen receptors beta through its metabolite 3β-
androstanediol which is a potent and selective agonist ERβ (113). DHT abolished the 
effect of SB 277011A on cell growth at 36 hr. This means DHT/R act as transcription 
factor and upregulate D3R. This led to two opposite reactions: D3R inhibition by SB 
and D3R upregulated (activated) by DHT. Thus, the end result of these two reactions 
is zero because they subtracted each other. The final response was for DHT effect at 
48 hr through non-AR response. Cells received D3R agonist (Pramipexole) and DHT 
did not show increase cell growth before 48 hr while at 48 hr the cell growth effect 
not different from DHT effect. However, in the first 6 hr cell growth decreased as in 
SB 277011A and Pramipexole treated groups. This could be due to the 48 hr length of 
the study, as others used up to 24 hr (248) although we replaced the drugs and media 
first at 6hr then after 12 hr until the experiment was complete. It is also possible due 
to rebound effect of the drugs as these drugs are sensitive to the air and have short 
bioactivity at 36 hr. When the drug activity reduced, the effect was rebound as in SB 
277011A treated group. In Pramipexole treated cells, we did not see any effect after 6 
hr so it could be the drug not associated with rebound effect because it is activating to 
the receptors or due to drug toxicity since these cells are satellite skeletal muscle cells 
and their dopamine receptors expressions were not high (Fig. 4.4). One would say 
why the toxicity in the first 6 hr only, it is possible that cells tolerated the drugs in the 
late time points. Clinically Pramipexole was associated with augmentation and 
tolerance with long-term treatment of restless leg syndrome (238). Another study 
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reported that long-term and not acute stimulation of D3R was found to promote 
neuronal proliferation in rat hippocampus (82, 85). This controversy effect strongly 
suggests a time-dependent effect. The treatment by SB277011A, Pramipexole, and 
DHT together interestingly decreased cell growth at 36 hr. The cell growth due to the 
effect of SB277011A was attenuated by the activation of D3R (Pramipexole) 
although D3R agonist by itself at 10 µM concentration had no effect on skeletal 
muscle satellite cell growth. Simultaneous inhibition and activation of D3R had an 
inhibitory effect at 36 hr. 
  Studies reported contradictory effects of D2R function on cell proliferation. It has 
been reported that D2R antagonist increased cell proliferation and decreased cell death of 
pancreatic β-cells in human (193) and in animals (58). On the other hand, D2-like 
receptor activation increased cell proliferation in the embryonic mouse Telencephalon by 
dopamine (180).   
D3R agonist (PD-128907) has been shown to have no effect on vascular 
smooth muscle cell proliferation (130), which is similar to what we found in our 
study.  However, we used pramipexole as D3R agonist instead of PD-128907 while 
others studied the activation of D4R by (PD 168077) on vascular smooth muscle cells 
proliferation and migration in vivo and found inhibitory effect on neointemal 
formation (rat model of hyperinsulinemia) (249). However, D3R antagonist (U-
99194A) in neonatal sub-ventricular neurons showed decreased cell proliferation 
(106). This study is opposite to what we reported here. The differences in the D3R 
antagonists and the cell type that they used in their studies were different than our 
study, which could suggest that the effect of D3R inhibition on cell growth is drug 
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and cell type dependent.   Other studies showed that stimulation of D3R attenuates 
renal ischemia/reperfusion injury via increased linkage with Gα12 (230) while other 
studies reported inhibition of D3R by SB277011A it increase survival rate in mice 
model of Anorexia nervosa (110). 
 
The Effect of the Interaction Between Androgen Receptor and Dopamine D3 
Receptor on LCR and HCR Satellite Cells Growth In Vitro:  
Previous work has confirmed that HCR intrinsically differs in prolonged 
dopamine availability in the brain when compared to LCR (53). Clinical and basic 
experimental studies provided huge evidences about the atheroprotective effect of 
testosterone on blood vessels (68, 104, 152, 200). In vivo, we studied the distribution 
of AR and D3R in ischemic and non-ischemic gastrocnemius of HCR and LCR. 
Although we did not find significant differences between these phenotypes in term of 
availability of these receptors, however, not always availability of protein is an 
indicator of functioning cells. The important determinant of cell function is based on 
how is the condition of signaling pathway of the receptor. Signaling pathway can be 
activated or inhibited in order to initiate cellular response, whether through direct 
action of the receptor on the cell or indirectly through interaction with other receptor 
which also is as important as the direct effect.  Therefore, we conducted an in vitro 
study to determine the signaling pathway resulted from the interaction of AR and 
D3R in isolated satellite cells from each phenotype. This study helped better 
understand the mechanism by which HCR differs from LCR, which may explain the 
differential response between the phenotype to various stimuli in vivo and in vitro. 
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 Here we conducted in vitro experiment to study satellite cell growth at two 
different time points to investigate the early effects of signaling pathway interaction 
at 6 hr and the late effect at 36 hr. We chose two time points because of the limitation 
in using primary stem cells isolated from adult animal, where cell yield is low. These 
time points were based on the several conducted experiments that we have done on 
satellite cells of Sprague Dawley rats and fibroblasts that isolated from mice.  This 
preliminary data showed that androgen has a late effect after 24 hr and dopamine 
effect occurred at early ours.  
In these phenotypes we found interesting differential effects resulting from the 
interaction of AR and D3R. Early time point, when cells treated with DHT and D3R 
antagonist, we found that there is an opposite effect on cell growth between the 
phenotypes. In LCR, cell number was increased while in HCR, cell number was 
decreased. At late time point, LCR showed an effect that was opposite to what we see at 
6 hr while the effect in HCR at late time point was similar to what we see at early time 
point. These data indicate that the growth of satellite cells progeny in both phenotypes 
are enhanced with the exposure to DHT and Pramipexole, and suppressed when cells 
exposed to DHT and D3R antagonist, and these effects occur only at 36 hr. However, at 
6 hr, DHT and Pramipexole only increased the number of HCR cells and decreased it in 
LCR cells. These results are in line with several studies that have reported the effect of 
Pramipexole on promoting neuronal cell proliferation (221, 222), and the role of D3R 
stimulation in improving neurological function, learning, and memory in a model of 
global cerebral ischemia/reperfusion (71, 229). Stimulation of D3R has also been 
suggested as playing a protective role toward the attenuation of renal 
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ischemia/reperfusion injury (230). However, D3R antagonist (U-99194A) in neonatal 
sub-ventricular neurons showed decreased cell proliferation (153). This study is opposite 
to what we reported here in LCR. The differences in the agents that they used for D3R 
antagonists and the cell type in their studies were different from our study, which could 
suggest that the effect of D3R inhibition on cell growth is drug, cell type dependent, and 
or phenotype dependent.    
Cells that were stimulated with Pramipexole  (D3R agonist) and treated with 
androgen receptor agonist, at the early time point, androgen receptor agonist in LCR 
decreased cell number and androgen antagonist increased cell number in LCR, but 
not in HCR. At late time point, the effect of androgen antagonist on cell number was 
no longer protective as at 6 hr, it decreased cell number in LCR while treatment with 
androgen receptor agonist improved the LCR cell number. On the other hand, 
treatment with androgen or its receptor blocker not significantly changed cell number 
at both time points in HCR.  
These interesting data showed that intrinsic aerobic capacity is an important 
factor in regulating myocyte cellular response to growth through the interaction of 
neuroendocrine signaling pathway. In high capacity runner phenotype, AR and D3R 
need to interact together to enhance the cell growth at early and late time points while 
in LCR, early time point requires only one of these receptor to be blocked in order to 
enhance the growth as early as 6 hr, while at 36 hr (late time point), both receptors 
need to be activated in order to enhance the cell growth.    
These data indicate that both phenotypes have differential mechanisms through 
the interactions between the two receptors in response to cell growth at early time 
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point. One of these mechanisms in LCR satellite cells is that suppression of cell 
growth occurs through activation of both AR and D3R simultaneously while activation 
of one of any of them with blocking the other one has an enhancement effect on cell 
growth. However, the mechanism for HCR satellite cell growth is different from LCR. 
HCR requires an activation of both receptors to enhance the growth at early time point.  
 
These data also may explain the controversial effect of androgen and 
dopamine in cardiovascular diseases. The time points that are required to initiate the 
effect of the interaction between the two signaling pathways of AR and D3R are very 
important in low intrinsic aerobic capacity phenotype, which is the phenotype that is 
more prone to developing metabolic disease. It also may explain the detrimental 
effect of cardiovascular diseases in female population as compare to the male 
population (9,173, 240, 252). Although the effect of testosterone on cardiovascular 
events and mortality in women has not yet been evaluated in large cohort studies, a 
prospective cohort study in more than 2000 women, that were followed up after more 
than four years from the start of the study, found that women with the lowest levels of 
testosterone had the greatest risk of a cardiovascular event independent of traditional 
risk factors (68). In LCR satellite cells, at late time point, treatment with androgen 
blocker caused significant reduction in cell number as compared with treatment with 
androgen although this is not the case at early time point when androgen blocker 
worked better than androgen.  
As clearly shown at early time point, HCR results infer that there is an 
androgen effect dependent on activation of dopamine receptor. This effect is through 
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the rapid non-genomic signaling pathway. This is supported by our results when we 
treated with androgen blocker, it did not abrogate the effect on cell growth. This 
results also in line with a study that showed androgen alters brain catecholamine 
content and blood pressure in the testicular feminized male rats. They found 
testosterone manipulation increases blood pressure and correlates with dopamine 
content in the different brain regions through non-genomic or non-classic androgen 
receptor signaling (49). This suggests that androgen receptor pathway requires 
activating dopamine D3 receptor in order to initiate cell growth at early time point 
possibly through non-genomic pathway.  
On the other hand, LCR story at early time point is much more complicated 
than in HCR, because the results infer uncommon effect of DHT and D3R agonist on 
cell growth (opposite to HCR). LCR showed increased the growth when treated with 
(DHT + D3R antagonist) and with (Pramipexole + AR antagonist). In the first group, 
(DHT + D3R antagonist), there was no significant difference when we compared it to 
(DHT + D3R agonist) although cell number was increased, indicating that androgen 
signaling pathway may not depend on dopamine signaling pathway. In the second 
group (Pramipexole + AR antagonist), the cell number significantly increased as 
compared to cells treated with androgen instead of the blocker. This indicates that 
dopamine signaling pathway depends on androgen signaling, and that effect has 
negative response, which may be point to that dopamine D3 receptor activation 
interrupts androgen signaling pathway causing negative effect on cell growth. 
However, interestingly, this mechanism of action is not activated when androgen 
receptor is blocked. This result was supported by the idea that activation of inhibitory 
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dopamine receptor (D2R), reduced androgen receptor level through mediating protein 
degradation pathway in prostate cancer cell line, and induced cell-cycle arrest (247). 
In HCR at late time point, receptors signaling in cell treated with DHT was 
similar as in the early time point although the effect between treated groups with 
dopamine agonist/or antagonist was not different, which may indicate that signaling 
pathway is mainly due to the effect of D3R activation. These results are supported by 
our finding that showed blocking of androgen receptor caused cell decreased cell 
number, and D3R activation is not enough to initiate similar effect of androgen on 
cell growth. This data indicates that AR signaling requires an active D3R to initiate 
cell growth and vice versa. The results are in line with several studies that reported 
androgen modulates dopamine system (98). A study showed that androgen treatment 
increased the activity of tyrosine hydroxylase, rate limiting enzyme in dopamine 
synthesis (1), and its gene expression (1, 73, 207, 217). On the other hand, dopamine 
also regulated androgen signaling (116). A study recorded that the ability of 
nandrolone (anabolic androgen steroid) to modulate motivation and reward-related 
effects of psychostimulant drugs, such as amphetamine, is dependent on activation of 
androgen receptor (116).
In LCR, late time point cell number was not different than HCR. This 
indicates that there is no differential effect on satellite cells growth between the 
phenotypes in respect to AR/D3R signaling interaction. However, at late time point, it 
was interesting because the effect of the signaling interaction was opposite to what 
we see at early time point. This indicates that LCR phenotype uses different 
mechanism at two different time points. These differences may be contribute to the 
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controversial effects of androgen and dopamine in cardiovascular disease that found 
in the literatures. At early time point, LCR cell number was depended on one of the 
receptor activation and inactivation of the other receptor. However, in the late time 





This study showed that low intrinsic aerobic capacity phenotype satellite cells 
have different AR/D3R signaling interaction between early and late growth time points 
while high intrinsic aerobic capacity phenotype have similar interaction between early 
and late time points, which involved activation of both receptors signaling pathways.  
  



















HCR better adapter than LCR 14 days post hind limb arterial ligation 
Prediction 1 Prediction 3 Prediction 2 
      IF Cell Culture 
If DR in 
HCR > LCR 
If AR     DR’s 
function in cell 
proliferation 
test 
Most likely that AR interacts 
with DR, which interprets 
some of HCR benefits after 
ligation  
      IF Cell Culture 
If DR in 
HCR > LCR 
If AR did not 
change DR’s 
response in cell 
proliferation 
test 
AR not interacts with DR, which not 
likely to interpret some of HCR benefits 
after ligation  
      IF Cell Culture 
If DR in 
HCR = LCR 
If AR  DR’s 
function in cell 
proliferation 
test 
AR can interact with DR, but 
this mechanism is not likely 
interpret some of HCR benefits 
after ligation  
Figure 4.15. Approach to Prediction of mechanism for differences in vascular adaptive response between HCR and LCR 14 days post 
hind limb arterial ligation. HCR, high capacity runner rat; LCR, low capacity runner rat; IF, immunofluorescent; DR, dopamine receptor; 
AR, androgen receptor; Black arrow indicates the flow of the chart; Red arrow indicates increase in the parameter.  
 
 
CHAPTER 5: INTRINSIC EXERCISE CAPACITY ON HIND LIMB 
ARTERIAL LIGATION: DIFFERENTIAL IMPACT OF ACTIVE EXERCISE 
AND ANDROGEN SIGNALING ON POST-ISCHEMIC RECOVERY  
 
Peripheral arterial disease (PAD) is a common disease that affects 8.5 million 
people in the United States and around 202 million people worldwide (174). Exercise 
response in humans is determined mainly by 70% of intrinsic aerobic capacity (70%) 
and by active exercise (10-40%) (16). This suggests that genetic predisposition or 
intrinsic aerobic capacity are likely to contribute in vascular injury pathogenesis and 
remodeling. Studying how genetic factors interact with active exercise and 
determining the mechanisms that drive peripheral arterial disease in susceptible 
phenotypes is crucial for two reasons: first, it helps in optimizing exercise to receive 
beneficial outcomes; and second, it may provide an understanding of novel 
mechanisms in the development of PAD in intrinsic aerobic phenotypes that can 
contribute to the pathophysiology of the disease process.                                                                                                                                                 
  This thesis evaluated the interaction of active exercise capacity with intrinsic aerobic 
capacity and their impact on musculovascular adaptive response to hind limb ischemia 
injury. The data presented in this thesis is built on a strong body of knowledge that high 
intrinsic aerobic capacity running phenotype is a disease resistant to several models and 
risk factors of metabolic and cardiovascular diseases. This includes factors such excess 
weight, insulin resistance, elevated blood pressure (239), dyslipidemia (13, 156, 218), 
and previous unpublished work on peripheral occlusive disease. We hypothesized that 
high capacity running phenotype depends on androgen/dopamine signaling as one of the 
adaptive mechanisms that protects against peripheral arterial ischemia, making exercise 
and hind limb ischemia interact in favorable responsive outcomes, opposite to the low 
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capacity running phenotype. Herein we discovered that rats selectively bred for high 
endurance running capacity (HCR) and low endurance running capacity (LCR) have 
different responses to exercise post-ligation in a model of peripheral arterial obstructive 
disease. The results also provide distinct elements supporting notion that the low 
endurance running capacity phenotype has a higher risk for developing exercise post-
ligation injury due to insufficient priming in the anatomical structure for adapting to 
ischemic stress.  
  Additionally, in this same phenotype, treadmill exercise can precondition hind 
limb arterial occlusive disease through remodeling the musculovascular adaptive 
response. Thus, the underlying differences in HCR and LCR phenotypes might 
suggest there are differences in factors regulating musculovascular adaptive response, 
such as angiogenic and inflammatory gene expressions during ischemia. The 
importance of exercise capacity, exercise post–ligation as a therapeutic modality in 
PAD (72), exercise pre-ligation as a preventive method against developing PAD 
(199), and the importance of sex steroid receptors, and dopamine receptor in 
modulating cardiovascular stresses lead us to hypothesize: in a model of femoral 
arterial occlusion, there are differences in outcomes resulting from the interaction of 
exercise capacity and the underlying intrinsic aerobic capacity phenotypes that 
modifies the AR/D3R signaling pathway during skeletal muscle injury. 
To test this hypothesis, we used a model of PAD, through ligation of the left 
femoral artery, that our lab previously used and evaluated in these phenotypic rats, 
where muscle vascular adaptations were different between female LCR & HCR 
phenotypes after acute ligation and without exercise. We used this model for several 
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reasons. It is a commonly employed hind limb ischemia model, simple, cheap, 
provides well-developed outcomes, develops milder ischemia, has normal rest blood 
flow, and has a low level of necrosis due to collateral involvement, similar to what is 
seen clinically in PAD patients (115). For the second part of the hypothesis, we used 
cell culture for an in vitro study of satellite cell growth to investigate the differential 
interaction of AR/D3R signaling pathway between the phenotypes, because we 
believe that knowing the pathophysiology at baseline may help understanding how 
these phenotypes respond differentially to ischemia. The reason for our selection to 
cell culture study, because it provides excellent model systems for studying the 
normal physiology and cell growth response to drugs with consistency and 
reproducibility.  
To investigate the interaction between active exercise and intrinsic exercise 
capacities on muscle-capillary relationship and gene expressions 14d post-ligation, 
we divided each phenotype into exercise pre-ligation and exercise post-ligation. 
Exercise pre-ligation animals were exposed to exercise preconditioning before 
ligation (-14 days) while exercise post-ligation were exposed to exercise after ligation 
(beginning on day 3 post-surgery) and continuing until day 14, when the animals 
were sacrificed. Each exercised animal engaged in motorized treadmill running as a 
type of mild intensity supervised exercise training. Animals were subjected to 5 days 
on the treadmill at a very low speed (10 m/min) to condition them to the treadmill 
environment. Next, animals began exercising for sessions of 5 minutes at 14-16 
m/min for 5 days per week for two weeks; the duration of exercise was gradually 
increased by 5 min per day, until they were trained for 60 minutes. Another group of 
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each phenotype was not subject to exercise sessions so as to compare the changes in 
the muscle-capillary relationship, angiogenic and inflammatory gene expressions, and 
protein expressions between the two phenotypes. 
  The effect of acute ligation on the phenotypes was distinct. There were not 
observed changes in the muscle-capillary relationship of HCR rats except for muscle 
hypertrophy, which may be due to the presence of body weight (resistant exercise) 
and blood flow restrictions (139). In LCR rats there was an observed decrease in both 
NCAF and SF, in addition to muscle hypertrophy. Changes in the muscle fiber area in 
addition to the low number of capillaries indicates the severity of ischemic muscle 
injury (191, 205). The differences between the phenotypes in response to arterial 
ligation suggest that HCR rats have an underlying intrinsic resistant mechanism, as is 
seen by the low muscle fiber area (88) and higher capillary density as compared to 
LCR (87).   
Consistent with the histology results, HCR rats have no changes in angiogenic 
and inflammatory genes expression at day 14 post-ligation while LCR showed an 
increase in the gene and protein levels of Vegfa, indicating effective angiogenic drive 
(18). These results indicate that LCR rats respond to acute arterial ligation by initial 
muscle fiber atrophy and necrosis, then by functional gene expression of angiogenic 
markers, and lastly by angiogenesis. Since the number of capillaries did not increase, 
this confirms that active angiogenesis will take place later on to influence a closer 
muscle-capillary relationship. On the other hand, HCR rats resist the arterial ligation 
injury. A possible underlying mechanism may be due to the presence of functional 
collateral circulation.
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Some of the most interesting findings in this overall project resulted from our 
study of exercise post- (discussed in chapter 2) and exercise pre-ligation (discussed 
in chapter 3). Exercise post-ligation was observed to improve the muscle-capillary 
relationship in HCR while it deteriorated the same relationship in LCR. 
Additionally, although exercise pre-ligation improved the ischemia in LCR, there 
was almost no observed effect on ischemia in HCR! In exercise post-ligation, muscle 
capillary parameters in HCR rats, including CD, CFPE, and NCAF were increased 
while they were decreased in LCR rats. In HCR, muscle cross-sectional area was 
lower than LCR with higher CD and CFPE, indicating surviving muscle tissue 
underlying the muscle atrophy mechanism, despite lower Vegfa gene expression. In 
LCR, CD decreased with association of an 8-fold increase in muscle cross-sectional 
area, suggesting the presence of muscle tissue necrosis due to blood flow restriction 
(139) and compensatory hypertrophy. In LCR, lower CFPE is due to decreases in 
both CD and number of fibers, which in turn may be due to necrosis and increased 
mean muscle fiber cross-sectional area.  
Taken together, these results show that HCR responds to exercise post-
ligation by increasing CD, muscle atrophy, and collateral artery involvement, or 
faster angiogenic response. Therefore, it is expected to have accelerated muscle 
regeneration and normotrophy. On the other hand, LCR may have responded to 
exercise post-ligation via early muscle necrosis with compensatory hypertrophy, 
increased expression of angiogenic markers, late capillary formation, and 
insufficient early collateral artery involvement, as is explained by lower share factor-
related inflammatory gene expressions in comparison with HCR. 
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In exercise pre-ligation, the muscle-capillary relationship caused improved 
outcomes in LCR while there was no effect in HCR. Increased mean cross-sectional 
area, NCAF, SF, and CFPE are all favorable effects of muscle-capillary parameters in 
LCR, with increased angiogenic gene expression (Vegfa, Flt1, Kdr, and Angiopoietin 
2).  
Although our study was on permanent occlusion, this data is similar to a study 
that showed when exercise was followed by intermittent occlusion of the lower limb, 
muscle structure and function was improved (172). Interestingly, the adhesion 
molecules Icam and Vcam were elevated in LCR compared to HCR. Icam and Vcam 
have been reported to be associated with endothelial dysfunction (56). This may 
suggest that low intrinsic aerobic capacity phenotype has a higher risk to develop 
endothelial dysfunction with the possibility of an increased risk of atherosclerosis and 
atherothrombosis; furthermore, exercise pre-ligation may not protect from endothelial 
dysfunction. In HCR rats subjected to exercise before ligation, we did not find 
changes in muscle-capillary interaction. However, there was only elevated gene 
expression in Pdgfa, one of the share stress-related inflammatory genes, indicating 
that Pdgfa alone is not enough to improve the muscle-capillary relationship in 
exercise pre-ligation.  
Interestingly, LCR rats showed elevation in Pdgfrb and not Pdgfa, indicating 
different myogenesis signaling pathways between the phenotypes, since HCR may 
rely more on Pdgfa than Pdgfb. Accordingly, Pdgfa ligand only binds to the Pdgfa 
receptor, while LCR may rely more on Pdgfb/Pdgfd than Pdgfa since Pdgfb/Pdgfd 
have high affinities to Pdgfrb. These results are important to understand the 
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pathophysiology of the interaction between exercise capacity and intrinsic aerobic 
capacity with respect to peripheral arterial disease. It is inferred that each PAD patient 
needs to be treated differently in respect to preventing the onset of the disease. 
Although this project will add additional knowledge to this field of study, further 
work is needed to determine specific targets that successfully translate clinically 
toward sorting PAD patients into “high and low capacity runners” for improved 
disease outcomes.   
As can be seen in the beginning of this dissertation, clinical and basic 
experimental studies have provided evidence about the atheroprotective effect of 
estrogen, testosterone, and dopamine on blood vessels. Herein, we were wondering 
whether the background of these phenotypes differentially modulate these receptors, 
specifically AR and Dopamine receptor, as these receptors commonly associated with 
controversial effect on cardiovascular disease. The heterogeneity of these phenotypes 
makes studying these receptors interesting. To determine whether there are 
differential associations of sex steroid receptors (AR and ERα) and dopamine 
receptors (D1R and D3R) between HCR and LCR after acute femoral arterial 
ligation, protein and gene expression were investigated from gastrocnemius muscle of 
ischemic and non-ischemic HCR and LCR rats. The results of this study showed that 
AR/ERα gene ratio was differentially expressed between the phenotypes, in that HCR 
rats have a higher ratio than LCR rats (P=0.005). However, the protein expression 
ratio of these receptors was not significantly changed between the phenotypes. D1R 
and D3R protein expressions were also not significantly different between the 
phenotypes. We also evaluated the protein expression of D1R and D3R in WT and
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 D3KO mouse to determine whether there are differential changes at baseline. 
Nonetheless, we found there are no differences between WT and D3KO in expression 
of D1R and D3R. Therefore, we concluded that there is possible functional knockout 
(251) of these receptors in HCR and LCR.  
Here we conducted in vitro experiment to study satellite cell growth at two 
different time points to investigate the early effects of signaling pathway interaction 
at 6 hr and the late effect at 36 hr. To evaluate the role of these receptors and their 
interactions with each other in satellite cell growth, we performed a satellite cell 
growth study at two different time points, early time point that was tested at 6 hr, and 
late time point that was tested at 36 hr. We chose two time points because of the 
limitation in using primary stem cells isolated from adult animal, where cell yield is 
low. These time points were based on the several conducted experiments that we have 
done on satellite cells of Sprague Dawley rats and fibroblasts that isolated from mice.  
This preliminary data showed that androgen has a late effect after 24 hr and dopamine 
effect occurred at early hours. Cells from each phenotype were incubated with 
various combinations of the drugs: DHT (10 nM), Pramipexole (10µM), Flutamide 
(50 nM), and SB277011A (10µM).                                                                                                                  
In vitro study showed that intrinsic aerobic capacity is an important factor in 
regulating cellular response to growth through the interaction of neuroendocrine 
signaling pathway. In high capacity runner phenotype, AR and D3R need to interact 
together to enhance the cell growth at early and late time points while in LCR, at early 
time point, cells requires only one of these receptor to be blocked in order to replicate as 
early as 6 hr, while at 36 hr (late time point), both receptors need to be activated in order 
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to enhance the cell growth.  These results suggesting that both phenotypes have 
differential molecular mechanisms and interactions between the two receptors in 
response to cell growth at early time point.  
This data also may explain the controversial effect of androgen and dopamine in 
cardiovascular diseases. The time points of the effect of the interaction between the two 
signaling pathways of AR and D3R are very important in low intrinsic aerobic capacity 
phenotype, which is the phenotype that is more prone to developing metabolic disease. It 
also may explain the detrimental effect of cardiovascular diseases in female population as 
compare to the male population (9,173, 240, 252).   
In response to D3R agonist, early time point LCR cells showed better 
response to cell growth with Androgen blocker. However, this effect is no longer 
present at late time point. Oppositely, in HCR, androgen has no detrimental effect 
neither at early time point nor at late time point.  This is interesting finding! This 
finding may explain some of the differential changes in vascular adaptive response to 
ischemia alone or to ischemia with exercise between the phenotypes. In both 
situations, HCR phenotype was protected from the ischemic effect while LCR was 
severely deteriorated (without exercise and with exercise post-ligation). It is possible 
that the negative outcomes that LCR faced 14 days after ligation could be due to the 
early negative effect of the interaction of androgen receptor with dopamine signaling 
pathway. This effect might cause delay in muscle repair as it was shown, in vitro, 
suppressing the satellite cell growth. Satellite cells play crucial role in skeletal muscle 
regeneration which also depend on androgen receptor signaling pathway. In LCR, this 
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signaling pathway for somehow interacts negatively while in HCR this signaling 
interaction is more favorable causing them to grow.  
This data also might explain why LCR responded to exercise pre-ligation 
better than exercise post-ligation. At early time point, LCR cells showed decreased in 
the cell number when treated with D3R agonist in response to androgen. It has been 
reported that androgen decreased the gene expression of D3R in the brain (185). Our 
data suggests that this signaling occurs through genomic pathway. When cells treated 
with androgen blocker, it caused an increase in cell number. Since this mechanism 
takes hours to days to occur, exercise pre-ligation may helpful in the LCR phenotype 
to precondition this negative effect resulting from the interaction between AR and 
D3R. This preconditioning masked the early effect of this interaction and allow for 
better late response to face the insult, causing better outcome, as when exposed to 
ligation after the exercise. In exercise post-ligation, LCR cannot stop the reaction and 
the muscle will go through the early phase of this signaling which faces the time 
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